Details of Disease

General Information of Disease (ID: DIS5N2GV)

• Disease Name: Esophageal squamous cell carcinoma
• Synonyms: esophagus squamous cell carcinoma; oesophagus squamous cell carcinoma; scc of esophagus; esophageal squamous cell cancer; esophageal squamous cell carcinoma; scc of the oesophagus; esophagus scc; oesophagus scc; scc of oesophagus; squamous cell carcinoma of the esophagus; squamous cell car. - esophagus; squamous cell carcinoma of the oesophagus; squamous cell carcinoma of oesophagus; scc of the esophagus; ESCC; squamous cell car. - oesophagus; esophageal scc; squamous cell carcinoma of esophagus; esophageal epidermoid carcinoma
• Disease Class: 2E60: Oral cavity/oesophagus/stomach in situ carcinoma
• Definition: Esophageal squamous cell carcinoma (ESCC) is a type of esophageal carcinoma (EC) that can affect any part of the esophagus, but is usually located in the upper or middle third.
• Disease Hierarchy:
  DISQVIFL: Squamous cell carcinoma
  DISS6G4D: Carcinoma of esophagus
  DIS5N2GV: Esophageal squamous cell carcinoma
• ICD Code:
  ICD-11: ICD-11: 2E60.1
  ICD-10: ICD-10: D00.1
  ICD-9: ICD-9: 150
  Expand ICD-9: 150
• Disease Identifiers:
  MONDO ID: MONDO_0005580
  MESH ID: D000077277
  UMLS CUI: C0279626
  MedGen ID: 124635
  Orphanet ID: 99977
  SNOMED CT ID: 276804009

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 3 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Cisplatin	DMRHGI9	Approved	Small molecular drug	[1]
Fluorouracil	DMUM7HZ	Approved	Small molecular drug	[2]
Toripalimab	DMSGA6Z	Approved in China	Monoclonal antibody	[3]

This Disease is Treated as An Indication in 3 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
INCSHR1210	DMZA2K0	Phase 3	Monoclonal antibody	[4]
PDR001	DM53J6B	Phase 3	Antibody	[5]
RO7121661	DM8A120	Phase 2	Antibody	[6]

This Disease is Treated as An Indication in 1 Preclinical Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
PR-619	DMW5PKM	Preclinical	Small molecular drug	[7]

This Disease is Treated as An Indication in 1 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Deguelin	DMXT7WG	Investigative	Small molecular drug	[8]

Molecular Interaction Atlas (MIA) of This Disease

This Disease Is Related to 409 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
BMI1	TTIPNSR	Limited	Altered Expression	[9]
BSG	TT5UJWD	Limited	Biomarker	[10]
CCN1	TTPK79J	Limited	Biomarker	[11]
CEACAM3	TTPX7I5	Limited	Biomarker	[12]
CEACAM5	TTY6DTE	Limited	Biomarker	[13]
CREBBP	TTFRCTK	Limited	Altered Expression	[14]
CRP	TTWRN6M	Limited	Biomarker	[15]
EGF	TTED8JB	Limited	Altered Expression	[16]
ENG	TTB30LE	Limited	Biomarker	[17]
EPHB2	TTKPV6O	Limited	Biomarker	[18]
ERBB4	TTWALCO	Limited	Biomarker	[19]
EZH2	TT9MZCQ	Limited	Biomarker	[20]
FBXW7	TT29KY7	Limited	Altered Expression	[21]
FGF4	TTCEKVZ	Limited	Biomarker	[22]
FOSL1	TTY8LZG	Limited	Altered Expression	[23]
GSTP1	TT40K12	Limited	Altered Expression	[24]
HOXA5	TTXSVQP	Limited	Biomarker	[25]
IFNW1	TTS2TGF	Limited	Genetic Variation	[26]
IL2RB	TT9721Y	Limited	Altered Expression	[27]
KDM1A	TTNR0UQ	Limited	Biomarker	[28]
KDM4C	TTV8CRH	Limited	Altered Expression	[29]
MTDH	TTH6SA5	Limited	Altered Expression	[30]
MUC1	TTBHFYQ	Limited	Altered Expression	[31]
PDE4D	TTSKMI8	Limited	Genetic Variation	[32]
PIK3CB	TT9H4P3	Limited	Biomarker	[33]
SKP2	TT5B2EO	Limited	Altered Expression	[34]
SLC39A6	TTZN1CF	Limited	Altered Expression	[35]
SMYD3	TTKLJYX	Limited	Biomarker	[36]
SOD2	TT9O4C5	Limited	Biomarker	[37]
STAT1	TTN7R6K	Limited	Genetic Variation	[38]
STMN1	TT7W5OT	Limited	Biomarker	[39]
TCF3	TTULOD8	Limited	Altered Expression	[27]
TWIST1	TTX1MY7	Limited	Altered Expression	[40]
VEGFC	TT0QUFV	Limited	Altered Expression	[41]
CCR7	TT2GIDQ	Disputed	Biomarker	[42]
CD47	TT28S46	Disputed	Biomarker	[43]
LILRB1	TTC0QRJ	Disputed	Biomarker	[44]
PTK2	TTON5IT	Disputed	Altered Expression	[45]
EGFR	TTGKNB4	moderate	Biomarker	[46]
ABCC2	TTFLHJV	Strong	Biomarker	[47]
ADAM9	TTTYQNS	Strong	Biomarker	[48]
ADH1A	TT5AHZ0	Strong	Altered Expression	[49]
ADH7	TT3LE7P	Strong	Biomarker	[50]
AGK	TTJETQC	Strong	Altered Expression	[51]
AHCY	TTE2KUJ	Strong	Altered Expression	[52]
AKT3	TTO6SGY	Strong	Altered Expression	[53]
ALOX12	TT12ABZ	Strong	Biomarker	[54]
ALOX15	TTN9T81	Strong	Biomarker	[54]
ANO1	TTOJI4S	Strong	Biomarker	[55]
ANXA1	TTUCK4B	Strong	Biomarker	[56]
ANXA10	TT0NL6U	Strong	Biomarker	[57]
ANXA5	TT2Z83I	Strong	Biomarker	[58]
APLNR	TTJ8E43	Strong	Biomarker	[59]
APOB	TTN1IE2	Strong	Biomarker	[60]
AQP3	TTLDNMQ	Strong	Altered Expression	[61]
ASPH	TT2KHP7	Strong	Biomarker	[62]
ATAD2	TT9A0HI	Strong	Altered Expression	[63]
ATF4	TTQCKWT	Strong	Biomarker	[64]
ATG7	TTLVB9Z	Strong	Biomarker	[65]
ATP1A1	TTWK8D0	Strong	Altered Expression	[66]
AURKA	TTPS3C0	Strong	Altered Expression	[67]
AURKB	TT9RTBL	Strong	Biomarker	[8]
AZGP1	TTUPYLV	Strong	Biomarker	[68]
B2M	TTY7FKA	Strong	Altered Expression	[69]
BAGE	TTS5GLJ	Strong	Altered Expression	[70]
BCAT1	TTES57P	Strong	Altered Expression	[71]
BGN	TT0JPVF	Strong	Altered Expression	[72]
BIRC2	TTQ5LRD	Strong	Biomarker	[73]
BST2	TT90BJT	Strong	Biomarker	[74]
CA2	TTANPDJ	Strong	Altered Expression	[75]
CACNA1C	TTZIFHC	Strong	Biomarker	[76]
CACNA2D3	TTN7T29	Strong	Biomarker	[33]
CALCR	TTLWS2O	Strong	Biomarker	[77]
CALR	TTUZ7OA	Strong	Biomarker	[77]
CASP4	TT6KIOT	Strong	Biomarker	[78]
CCK	TT90CMU	Strong	Biomarker	[79]
CCL21	TTLZK1U	Strong	Biomarker	[42]
CCNA2	TTAMQ62	Strong	Altered Expression	[80]
CCND1	TTFCJ7S	Strong	Biomarker	[81]
CD163	TTTZ9DE	Strong	Biomarker	[82]
CD3E	TTZAT79	Strong	Biomarker	[83]
CDC25A	TTLZS4Q	Strong	Biomarker	[84]
CDC7	TTSMTDI	Strong	Biomarker	[85]
CDK2	TT7HF4W	Strong	Altered Expression	[86]
CDK7	TTQYF7G	Strong	Biomarker	[87]
CDKN1A	TT9GUW0	Strong	Genetic Variation	[88]
CHEK1	TTTU902	Strong	Biomarker	[89]
CHEK2	TT9ABMF	Strong	Genetic Variation	[90]
CHKA	TT10AWB	Strong	Biomarker	[91]
CHRNA7	TTLA931	Strong	Altered Expression	[92]
CHRNB4	TTTVAFQ	Strong	Altered Expression	[92]
CHST15	TTFK7E1	Strong	Biomarker	[93]
CLDN4	TTMTS9H	Strong	Biomarker	[94]
CLIC1	TT8KZG6	Strong	Altered Expression	[95]
CLK2	TT85TPS	Strong	Biomarker	[96]
CNTN1	TTPR8FK	Strong	Altered Expression	[97]
COL7A1	TTBCOKN	Strong	Altered Expression	[98]
COPS5	TTSTNJR	Strong	Biomarker	[99]
CTAG1A	TTE5ITK	Strong	Biomarker	[40]
CTCFL	TTY0RZT	Strong	Altered Expression	[100]
CUL3	TTPCU0Q	Strong	Biomarker	[101]
CYP11A1	TTSYVO6	Strong	Genetic Variation	[102]
CYP1B1	TTI84H7	Strong	Genetic Variation	[103]
CYP24A1	TT82UI1	Strong	Genetic Variation	[104]
CYP2A6	TTAQ6ZW	Strong	Genetic Variation	[105]
CYP2C19	TTZ58XG	Strong	Genetic Variation	[106]
CYP2C9	TTR40YJ	Strong	Altered Expression	[107]
CYSLTR2	TT0PZR5	Strong	Biomarker	[108]
DCK	TTJOCE4	Strong	Altered Expression	[109]
DEFB4A	TTIVY12	Strong	Biomarker	[110]
DEK	TT1NMGV	Strong	Altered Expression	[111]
DEPTOR	TTLYP6D	Strong	Biomarker	[112]
DFFA	TTYVQ9C	Strong	Altered Expression	[113]
DGKA	TTGL8F0	Strong	Biomarker	[114]
DHPS	TTBO2A9	Strong	Altered Expression	[115]
DKK3	TTY2ZV6	Strong	Biomarker	[116]
DTL	TT8396I	Strong	Biomarker	[117]
E2F1	TTASI04	Strong	Altered Expression	[118]
ECE1	TTQ9RYT	Strong	Altered Expression	[119]
EEF2K	TT1QFLA	Strong	Altered Expression	[120]
EGFL7	TT7WD0H	Strong	Posttranslational Modification	[48]
EIF4E	TTZGCP6	Strong	Biomarker	[121]
EP300	TTGH73N	Strong	Altered Expression	[122]
EPCAM	TTZ8WH4	Strong	Altered Expression	[27]
EPHA1	TTLFZVU	Strong	Altered Expression	[123]
EPHA2	TTRJB2G	Strong	Altered Expression	[124]
EPHA3	TTHS2LR	Strong	Biomarker	[125]
EYA2	TTUY9C6	Strong	Biomarker	[126]
F2RL3	TTD0652	Strong	Biomarker	[127]
FASN	TT7AOUD	Strong	Biomarker	[128]
FAT1	TTGUJYV	Strong	Genetic Variation	[129]
FGF19	TTGCH11	Strong	Biomarker	[130]
FGFR4	TT1KX2S	Strong	Altered Expression	[131]
FHIT	TTMS54D	Strong	Biomarker	[132]
FHL1	TTI7ENL	Strong	Biomarker	[133]
FOXC2	TTLBAP1	Strong	Biomarker	[134]
FOXM1	TTD3KOX	Strong	Altered Expression	[135]
FOXO1	TTLRVIA	Strong	Altered Expression	[136]
FOXQ1	TTEJZOL	Strong	Genetic Variation	[137]
FUT4	TTNV1KZ	Strong	Altered Expression	[138]
FYN	TT2B9KF	Strong	Biomarker	[139]
FZD7	TTUQMO5	Strong	Biomarker	[140]
GAPDH	TTUGSWA	Strong	Altered Expression	[141]
GCH1	TTLSWP6	Strong	Biomarker	[142]
GGH	TTZJRL0	Strong	Altered Expression	[143]
GHRHR	TTG4R8V	Strong	Altered Expression	[144]
GLI1	TTJOMH6	Strong	Altered Expression	[145]
GPR139	TTOL9B0	Strong	Biomarker	[146]
GPR39	TTTPCNU	Strong	Altered Expression	[147]
GPRC5D	TTHRAPJ	Strong	Altered Expression	[148]
GRIN2B	TTN9D8E	Strong	Posttranslational Modification	[149]
HDAC2	TTSHTOI	Strong	Altered Expression	[150]
HDAC6	TT5ZKDI	Strong	Biomarker	[151]
HIF1A	TTSN6QU	Strong	Biomarker	[152]
HIPK2	TTOB49C	Strong	Altered Expression	[153]
HLA-G	TTLKFB3	Strong	Biomarker	[154]
HMGA2	TTSTVM0	Strong	Biomarker	[155]
HMGB1	TTWQYB7	Strong	Biomarker	[156]
HMGCS2	TTS0EZJ	Strong	Biomarker	[157]
HNF4A	TT2F3CD	Strong	Biomarker	[158]
HOXA13	TTN26OM	Strong	Altered Expression	[159]
HOXB13	TTZ6I58	Strong	Altered Expression	[160]
HSF1	TTN6STZ	Strong	Altered Expression	[161]
HSPA5	TTW26OG	Strong	Altered Expression	[162]
HTRA1	TT8POQR	Strong	Biomarker	[163]
IDO1	TTZJYKH	Strong	Altered Expression	[164]
IGFBP3	TTZHNQA	Strong	Genetic Variation	[165]
IGFBP7	TTUQ01B	Strong	Biomarker	[166]
IL11	TTGUYTR	Strong	Biomarker	[167]
IL15RA	TTGN89I	Strong	Genetic Variation	[168]
IL23R	TT6H4QR	Strong	Biomarker	[169]
IL7R	TTAWI51	Strong	Altered Expression	[170]
IMP3	TTEJA2R	Strong	Altered Expression	[171]
INHBA	TTVB30D	Strong	Altered Expression	[172]
IRF1	TT4TU3L	Strong	Altered Expression	[135]
ISG15	TTVOH3T	Strong	Biomarker	[173]
ITCH	TT5SEWD	Strong	Biomarker	[174]
ITGA6	TT165T3	Strong	Biomarker	[175]
ITGB1	TTBVIQC	Strong	Biomarker	[176]
KAT2B	TTVK7SB	Strong	Biomarker	[177]
KCND3	TTPLQO0	Strong	Altered Expression	[178]
KCNH2	TTQ6VDM	Strong	Biomarker	[179]
KDM4A	TTZHPB8	Strong	Biomarker	[180]
KDM5B	TTCLI75	Strong	Altered Expression	[181]
KHDRBS1	TTAT6C7	Strong	Altered Expression	[34]
KIF11	TTBGTCW	Strong	Biomarker	[182]
KLF4	TTTI53X	Strong	Biomarker	[183]
KMT5A	TTGC95K	Strong	Biomarker	[184]
KRT17	TTKV0EC	Strong	Altered Expression	[185]
LAMP1	TTC214J	Strong	Altered Expression	[186]
LAMP2	TTULDG7	Strong	Altered Expression	[187]
LAPTM4B	TTEJQT0	Strong	Genetic Variation	[188]
LASP1	TTZJA87	Strong	Biomarker	[189]
LATS2	TTML7FG	Strong	Altered Expression	[190]
LCN2	TTKTLAI	Strong	Biomarker	[179]
LDHA	TTW76JE	Strong	Altered Expression	[191]
LGR5	TTTSGRH	Strong	Altered Expression	[192]
LHCGR	TT2O4W9	Strong	Biomarker	[60]
LIFR	TTID542	Strong	Biomarker	[193]
LIMK1	TTWL9TY	Strong	Altered Expression	[194]
LIN28A	TTO50LN	Strong	Altered Expression	[195]
LONP1	TTM1VPZ	Strong	Biomarker	[196]
LOXL2	TTFSUHX	Strong	Biomarker	[197]
LRP6	TTSXOWE	Strong	Altered Expression	[198]
LTA	TTP73TM	Strong	Biomarker	[128]
LY6K	TT5GKHN	Strong	Biomarker	[199]
LYVE1	TTG8DNU	Strong	Biomarker	[200]
MAGEA1	TT63M7Q	Strong	Altered Expression	[201]
MAGEA3	TTWSKHD	Strong	Biomarker	[202]
MAGEA4	TT9EQUY	Strong	Biomarker	[203]
MAGEA6	TTJIWMO	Strong	Altered Expression	[204]
MANF	TT56RYE	Strong	Genetic Variation	[205]
MAP2K7	TT6QY3J	Strong	Biomarker	[206]
MAP3K9	TTUNSIX	Strong	Altered Expression	[207]
MAP4	TT0VFPN	Strong	Altered Expression	[208]
MAPK8	TT0K6EO	Strong	Biomarker	[209]
MASP2	TTR01E9	Strong	Altered Expression	[210]
MCL1	TTL53M6	Strong	Biomarker	[211]
MCM7	TT1RM3F	Strong	Altered Expression	[212]
MDM4	TT9OUDQ	Strong	Biomarker	[213]
MFGE8	TT1GLAJ	Strong	Altered Expression	[214]
MGMT	TTJ8DV7	Strong	Biomarker	[215]
MMP10	TTXLEG7	Strong	Biomarker	[216]
MMP11	TTZW4MV	Strong	Altered Expression	[217]
MMP13	TTHY57M	Strong	Biomarker	[218]
MMP14	TTJ4QE7	Strong	Altered Expression	[219]
MMP16	TTNP4CU	Strong	Altered Expression	[220]
MMP21	TTYRF5E	Strong	Altered Expression	[154]
MMP3	TTUZ2L5	Strong	Biomarker	[55]
MSH2	TTCAWRT	Strong	Genetic Variation	[221]
MSI1	TTSM4BA	Strong	Altered Expression	[222]
MSI2	TTTXQF6	Strong	Biomarker	[223]
MTA1	TTO4HUS	Strong	Biomarker	[206]
MTAP	TTDBX7N	Strong	Altered Expression	[224]
MTR	TTUTO39	Strong	Genetic Variation	[225]
MUTYH	TTNB0ZK	Strong	Altered Expression	[226]
NCL	TTK1V5Q	Strong	Altered Expression	[227]
NDUFAF2	TTCHGVF	Strong	Altered Expression	[228]
NEDD8	TTNDC4K	Strong	Altered Expression	[229]
NELL1	TT7H4BF	Strong	Biomarker	[230]
NGFR	TTEDJN4	Strong	Biomarker	[231]
NLRC5	TTWZC78	Strong	Biomarker	[232]
NLRP1	TTQX29T	Strong	Biomarker	[233]
NME1	TTDY8JH	Strong	Biomarker	[234]
NOTCH2	TT82FVD	Strong	Altered Expression	[235]
NOTCH3	TTVX7IA	Strong	Biomarker	[28]
NPR1	TTM9IYA	Strong	Altered Expression	[236]
NQO1	TT8XK6L	Strong	Biomarker	[237]
NQO2	TTJLP0R	Strong	Genetic Variation	[238]
NR1H2	TTXA6PH	Strong	Genetic Variation	[239]
NRP2	TTRXUVC	Strong	Biomarker	[240]
ODC1	TTUMGNO	Strong	Biomarker	[241]
OGG1	TTRU01G	Strong	Altered Expression	[242]
ORAI1	TTE76YK	Strong	Biomarker	[243]
PABPC1	TTHC8EF	Strong	Altered Expression	[244]
PADI4	TTQHAXM	Strong	Altered Expression	[245]
PAH	TTGSVH2	Strong	Biomarker	[246]
PARG	TT39J16	Strong	Altered Expression	[127]
PAWR	TT3I4WV	Strong	Biomarker	[127]
PDCD1LG2	TTW14O3	Strong	Biomarker	[247]
PDGFD	TTSN0GA	Strong	Biomarker	[248]
PDPK1	TTYMGWX	Strong	Altered Expression	[249]
PDX1	TT8SGZK	Strong	Altered Expression	[250]
PEBP1	TT1BGU8	Strong	Biomarker	[251]
PFKFB3	TTTHMQJ	Strong	Altered Expression	[252]
PGD	TTZ3IFB	Strong	Altered Expression	[253]
PHB	TT6U071	Strong	Altered Expression	[254]
PHGDH	TT8DRCK	Strong	Altered Expression	[253]
PIN1	TTJNTSI	Strong	Altered Expression	[255]
PKM	TT4LOT8	Strong	Biomarker	[256]
PKMYT1	TTB4PAZ	Strong	Altered Expression	[257]
PLA2G4A	TTT1JVS	Strong	Altered Expression	[258]
PLK1	TTH4IP0	Strong	Biomarker	[259]
PLOD1	TTEKJP3	Strong	Biomarker	[260]
PLOD2	TT8MEUD	Strong	Biomarker	[260]
POLB	TTA0XPV	Strong	Biomarker	[261]
PRKCI	TTWJTHX	Strong	Altered Expression	[262]
PRKD1	TTSLUMT	Strong	Altered Expression	[263]
PRKDC	TTK3PY9	Strong	Biomarker	[264]
PRMT1	TTVOJAI	Strong	Altered Expression	[265]
PRSS8	TTT4N0Q	Strong	Posttranslational Modification	[266]
PSCA	TT9T4AV	Strong	Genetic Variation	[267]
PSIP1	TTH9LDP	Strong	Genetic Variation	[88]
PSMB8	TTEAD9J	Strong	Genetic Variation	[268]
PSMB9	TTOUSTQ	Strong	Genetic Variation	[268]
PTGES	TTYLQ8V	Strong	Biomarker	[269]
PTGES2	TTWU04I	Strong	Biomarker	[270]
PTGS2	TTVKILB	Strong	Biomarker	[271]
PTK7	TTXH2ZN	Strong	Biomarker	[272]
PTP4A1	TTA8GFO	Strong	Altered Expression	[273]
PTPN1	TTELIN2	Strong	Biomarker	[46]
RACK1	TTJ10AL	Strong	Biomarker	[274]
RARA	TTW38KT	Strong	Biomarker	[275]
RARB	TTISP28	Strong	Altered Expression	[276]
RECK	TTRZBW7	Strong	Altered Expression	[277]
RHCG	TTN5MZ3	Strong	Biomarker	[278]
RICTOR	TT143WL	Strong	Altered Expression	[279]
RNF6	TT4S09X	Strong	Genetic Variation	[280]
ROBO1	TTND1YP	Strong	Biomarker	[281]
RPS6KA3	TTUM2ZR	Strong	Biomarker	[282]
RUNX1	TTWIN3H	Strong	Genetic Variation	[283]
RUNX3	TTKCVO7	Strong	Altered Expression	[284]
S100A4	TTPR5SX	Strong	Biomarker	[285]
S1PR1	TT9JZCK	Strong	Biomarker	[286]
SATB1	TTLFRIC	Strong	Biomarker	[287]
SDC2	TT5H2F0	Strong	Altered Expression	[288]
SEMA4D	TT5UT28	Strong	Biomarker	[289]
SERPINB5	TT1KW50	Strong	Altered Expression	[290]
SERPINH1	TTPSWQG	Strong	Altered Expression	[291]
SLC12A1	TTS087L	Strong	Biomarker	[292]
SLC16A3	TTG6VD5	Strong	Biomarker	[293]
SLC23A2	TTOP832	Strong	Genetic Variation	[294]
SLC6A8	TTYUHB5	Strong	Biomarker	[77]
SLC7A5	TTPH2JB	Strong	Biomarker	[295]
SLC9A1	TTGSEFH	Strong	Biomarker	[296]
SLIT2	TTDWK85	Strong	Biomarker	[281]
SMYD2	TT7YJFO	Strong	Biomarker	[297]
SOCS1	TT8COJM	Strong	Biomarker	[298]
SOX2	TTCNOT6	Strong	Altered Expression	[9]
SP1	TTZEP6S	Strong	Biomarker	[79]
SPOCK1	TTF23RE	Strong	Altered Expression	[299]
SQLE	TTE14XG	Strong	Biomarker	[179]
SREBF2	TTRQ4AP	Strong	Biomarker	[300]
SRGN	TTCHB06	Strong	Genetic Variation	[301]
SRPK1	TTU3WV6	Strong	Altered Expression	[302]
ST14	TTPRO7W	Strong	Biomarker	[303]
STC1	TTDLUER	Strong	Altered Expression	[304]
STOML2	TTOI329	Strong	Altered Expression	[305]
SUV39H1	TTUWQTK	Strong	Biomarker	[306]
TAGLN	TTDRZ9H	Strong	Altered Expression	[307]
TAGLN2	TTP6BIJ	Strong	Altered Expression	[308]
TAP1	TT7JZI8	Strong	Biomarker	[268]
TBX21	TTNF9PH	Strong	Genetic Variation	[309]
TDO2	TTXNCBV	Strong	Altered Expression	[310]
TERF1	TT1Y6J2	Strong	Altered Expression	[311]
TFF1	TTNOJIZ	Strong	Posttranslational Modification	[312]
TGFBR2	TTZE3P7	Strong	Posttranslational Modification	[313]
THRB	TTGER3L	Strong	Biomarker	[314]
TIAM1	TTNU6I5	Strong	Biomarker	[315]
TMPRSS2	TT1GM2Z	Strong	Altered Expression	[316]
TMSB4X	TTMVAIU	Strong	Altered Expression	[317]
TNFRSF10B	TTW20TU	Strong	Biomarker	[318]
TNFRSF14	TTWGTC1	Strong	Altered Expression	[319]
TNFRSF1B	TT63WSF	Strong	Altered Expression	[320]
TRIM24	TT9Q7AE	Strong	Biomarker	[321]
TRIM27	TTTO3QN	Strong	Biomarker	[322]
TRIM28	TTQ2BKV	Strong	Altered Expression	[323]
TRPC6	TTRBT3W	Strong	Biomarker	[324]
TRPM7	TTFPVZO	Strong	Altered Expression	[325]
TRPV2	TTBECWA	Strong	Altered Expression	[326]
TRPV6	TTBK14N	Strong	Altered Expression	[327]
TTK	TTP7EGM	Strong	Altered Expression	[328]
TUSC2	TTJ8O14	Strong	Biomarker	[329]
TYMP	TTO0IB8	Strong	Biomarker	[330]
UCHL5	TTSX29Z	Strong	Altered Expression	[331]
UCP1	TTI12YJ	Strong	Biomarker	[332]
ULK1	TT4D7MJ	Strong	Altered Expression	[333]
UMPS	TTAFJUD	Strong	Altered Expression	[334]
USP14	TTVSYP9	Strong	Altered Expression	[331]
USP7	TTXU3EQ	Strong	Biomarker	[335]
VCP	TTHNLSB	Strong	Altered Expression	[336]
VIPR2	TT4O5P0	Strong	Biomarker	[76]
VTCN1	TTCK85E	Strong	Altered Expression	[181]
WAS	TTE8T73	Strong	Biomarker	[337]
WDR5	TT7OFWB	Strong	Altered Expression	[338]
WNK1	TTJ9UMX	Strong	Altered Expression	[339]
XIAP	TTK3WBU	Strong	Biomarker	[340]
XRCC5	TTCB9KW	Strong	Altered Expression	[341]
YAP1	TT8UN2D	Strong	Biomarker	[129]
ZAP70	TTUMHT8	Strong	Biomarker	[342]
ADCYAP1	TTW4LYC	Definitive	Biomarker	[343]
ATF3	TTCE793	Definitive	Altered Expression	[344]
BMP6	TT07RIB	Definitive	Altered Expression	[345]
CA1	TTHQPL7	Definitive	Biomarker	[343]
CA9	TT2LVK8	Definitive	Biomarker	[269]
CCNB1	TT9P6OW	Definitive	Altered Expression	[346]
CDC25B	TTR0SWN	Definitive	Altered Expression	[347]
CEBPB	TTUI35N	Definitive	Biomarker	[348]
CHRNA5	TTH2QRX	Definitive	Altered Expression	[92]
CRYZ	TTP6UO8	Definitive	Genetic Variation	[238]
CYP3A5	TTHS0OK	Definitive	Genetic Variation	[102]
DSG3	TTEO4P8	Definitive	Altered Expression	[349]
EIF4EBP1	TTKGEBL	Definitive	Altered Expression	[350]
EIF5A2	TTH53G9	Definitive	Biomarker	[351]
EPHB4	TTI4ZX2	Definitive	Biomarker	[352]
ETS2	TT9AH0M	Definitive	Biomarker	[353]
FKBP1A	TTMW94E	Definitive	Biomarker	[343]
GLO1	TTV9A7R	Definitive	Biomarker	[343]
GSTO1	TTWO3SH	Definitive	Biomarker	[343]
HAX1	TT21BYA	Definitive	Altered Expression	[354]
HTATIP2	TTC6IX5	Definitive	Biomarker	[355]
LAMB3	TT2WOUQ	Definitive	Genetic Variation	[356]
MAP3K7	TTJQT60	Definitive	Biomarker	[76]
MSMB	TTYH1ZK	Definitive	Biomarker	[357]
MSR1	TT2TDH9	Definitive	Biomarker	[358]
NCOA3	TT124R0	Definitive	Altered Expression	[359]
OSMR	TTAH0KM	Definitive	Altered Expression	[193]
PHF8	TT81PFE	Definitive	Biomarker	[360]
PINX1	TT4FJ3A	Definitive	Altered Expression	[361]
PLA2G2A	TTO8QRU	Definitive	Altered Expression	[362]
PTK6	TT6TH8V	Definitive	Altered Expression	[363]
PTP4A3	TT7YM8D	Definitive	Biomarker	[364]
RHBDF2	TTH1ZOP	Definitive	Genetic Variation	[365]
SERPINB3	TT6QLPX	Definitive	Biomarker	[343]
STC2	TT4EFTR	Definitive	Biomarker	[133]
TKTL1	TTNQ1J3	Definitive	Altered Expression	[366]
TPX2	TT0PHL4	Definitive	Altered Expression	[367]
TRAF6	TTCDR6M	Definitive	Biomarker	[368]
XPO1	TTCJUR4	Definitive	Altered Expression	[369]

This Disease Is Related to 11 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
ABCA12	DT7LDG0	Strong	Altered Expression	[370]
SLC12A2	DTHKL3Q	Strong	Altered Expression	[292]
SLC22A17	DTXI9E6	Strong	Altered Expression	[371]
SLC25A20	DTQOUM4	Strong	Altered Expression	[75]
SLC27A5	DT0TQS3	Strong	Biomarker	[372]
SLC30A7	DTQK38X	Strong	Altered Expression	[373]
SLC39A5	DTN9ACR	Strong	Altered Expression	[374]
SLC4A1	DTB0Q3P	Strong	Biomarker	[375]
SLC4A2	DTF7GAL	Strong	Biomarker	[376]
SLC9A9	DT8LP62	Strong	Altered Expression	[377]
SLCO6A1	DTIFXNS	Strong	Genetic Variation	[378]

This Disease Is Related to 31 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
ABO	DESIA7R	Limited	Genetic Variation	[379]
ADH1C	DEM1HNL	Limited	Genetic Variation	[380]
ACP6	DER6BCE	Strong	Altered Expression	[381]
ACSS2	DEE76VW	Strong	Altered Expression	[382]
ADH1B	DEEN9RD	Strong	Genetic Variation	[383]
ADH4	DEOCWU3	Strong	Genetic Variation	[384]
ADH5	DEIOH6A	Strong	Genetic Variation	[49]
AKR1A1	DED2FW3	Strong	Biomarker	[385]
AKR1B10	DEP6GT1	Strong	Genetic Variation	[205]
AKR1C1	DE7P2FB	Strong	Biomarker	[386]
AKR1C2	DEOY5ZM	Strong	Biomarker	[386]
ALDH1A1	DE2JP1Y	Strong	Altered Expression	[271]
BAAT	DERA3OF	Strong	Genetic Variation	[387]
CPA4	DEXKD7J	Strong	Altered Expression	[388]
CYP26B1	DEZT8FM	Strong	Genetic Variation	[128]
DCTD	DEXL3P2	Strong	Genetic Variation	[389]
GGCT	DEKW6PB	Strong	Genetic Variation	[390]
GSTO2	DEHMPZR	Strong	Altered Expression	[391]
HPGD	DEHKSC6	Strong	Altered Expression	[253]
LAP3	DENZF0O	Strong	Altered Expression	[392]
NAT1	DE7OAB3	Strong	Genetic Variation	[393]
NAT10	DEZV4AP	Strong	Biomarker	[394]
NNMT	DECVGJ3	Strong	Biomarker	[395]
SULT1A1	DEYWLRK	Strong	Genetic Variation	[396]
SULT1A2	DERUZL7	Strong	Genetic Variation	[396]
SULT2A1	DE0P6LK	Strong	Biomarker	[342]
UGT1A8	DE2GB8N	Strong	Altered Expression	[397]
UGT2B17	DEAZDL8	Strong	Biomarker	[398]
UGT2B4	DENUPDX	Strong	Genetic Variation	[397]
UPP1	DEFZWAX	Strong	Biomarker	[399]
PSAT1	DEBS17P	Definitive	Altered Expression	[400]

This Disease Is Related to 736 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
ABCB10	OT1C44F9	Limited	Biomarker	[401]
ABI1	OT5H4M62	Limited	Altered Expression	[402]
ARL6IP5	OTYZ6BEQ	Limited	Altered Expression	[403]
BHLHE40	OTITX14U	Limited	Altered Expression	[404]
CDKN2B	OTAG24N1	Limited	Genetic Variation	[405]
CEACAM7	OTKFDTZY	Limited	Biomarker	[12]
CLPTM1L	OTDJWQXI	Limited	Genetic Variation	[406]
COX2	OTTMVBJJ	Limited	Biomarker	[271]
CUX1	OTU1LCNJ	Limited	Altered Expression	[27]
DSC2	OTODVH8K	Limited	Biomarker	[183]
ELAVL2	OT6EJ8MQ	Limited	Biomarker	[407]
FARP2	OTNRQIMK	Limited	Biomarker	[408]
FERMT2	OTZNPWWX	Limited	Biomarker	[409]
FLACC1	OTZN9TZV	Limited	Genetic Variation	[32]
FOXA1	OTEBY0TD	Limited	Biomarker	[126]
HCLS1	OTX7WGYN	Limited	Altered Expression	[27]
KMT2D	OTTVHCLY	Limited	Altered Expression	[304]
KRT16	OTGA0EQN	Limited	Biomarker	[410]
LINGO2	OT3N88Q1	Limited	Genetic Variation	[26]
MAD2L1	OTXNGZCG	Limited	Altered Expression	[411]
MTO1	OT7HCZ1D	Limited	Biomarker	[401]
PSG2	OT2EIXAI	Limited	Biomarker	[12]
PUF60	OTG90DYF	Limited	Biomarker	[408]
RASSF1	OTEZIPB7	Limited	Altered Expression	[412]
RRM2B	OTE8GBUR	Limited	Biomarker	[413]
SFMBT2	OTZQT61Q	Limited	Biomarker	[401]
SIGLEC7	OTNDLURR	Limited	Altered Expression	[27]
SMAD2	OTC6VB4K	Limited	Altered Expression	[414]
SMUG1	OT2YIOCQ	Limited	Genetic Variation	[415]
TBC1D9	OTSSCTB5	Limited	Altered Expression	[416]
DCTN6	OTI8PIN9	Disputed	Altered Expression	[417]
IFI27	OTI2XGIT	Disputed	Altered Expression	[417]
MAML1	OTQA4DDN	Disputed	Biomarker	[418]
PSMD9	OT6Y5CC3	Disputed	Altered Expression	[417]
RETREG1	OTYOSLZX	Disputed	Biomarker	[419]
SRY	OT516T6D	Disputed	Altered Expression	[420]
TICAM2	OTK7GIJ5	Disputed	Altered Expression	[417]
TMED7	OTONO8E6	Disputed	Altered Expression	[417]
DLG1	OTCRZYWT	moderate	Biomarker	[401]
SHMT1	OTIINA3J	moderate	Genetic Variation	[421]
SPRR1A	OTJMI34A	moderate	Altered Expression	[422]
AADAC	OT8VACT2	Strong	Altered Expression	[423]
ABI2	OT8GIIS5	Strong	Biomarker	[424]
ABRAXAS2	OTAW1I4C	Strong	Biomarker	[64]
ACADL	OTP7Y0UF	Strong	Altered Expression	[425]
ACOT7	OT7C68YV	Strong	Genetic Variation	[309]
ACTBL2	OTD6B81U	Strong	Genetic Variation	[309]
ACTG2	OTRDWUO0	Strong	Genetic Variation	[309]
ACTL6A	OT0EC5BQ	Strong	Biomarker	[426]
ACTN4	OTCNZAJ5	Strong	Altered Expression	[339]
ACTRT1	OTHFKSIZ	Strong	Biomarker	[424]
ADAM12	OTZKOTDB	Strong	Altered Expression	[427]
ADAMTS12	OTG7HEA2	Strong	Biomarker	[428]
ADAMTS16	OTTKUH99	Strong	Altered Expression	[429]
ADAMTS6	OTSZE6L4	Strong	Altered Expression	[430]
ADAMTS9	OTV3Q0DS	Strong	Biomarker	[431]
ADARB1	OTGKSZEV	Strong	Altered Expression	[432]
ADGRG1	OTQBB8NT	Strong	Altered Expression	[148]
AFAP1L2	OTJBI0VN	Strong	Biomarker	[433]
AIFM1	OTKPWB7Q	Strong	Altered Expression	[434]
AJAP1	OTAAW121	Strong	Altered Expression	[435]
AJUBA	OTNW7YPK	Strong	Genetic Variation	[436]
AKAP12	OTCVRDDX	Strong	Posttranslational Modification	[437]
AKT1S1	OT4JHN4Y	Strong	Biomarker	[438]
ALDH7A1	OTV57BZD	Strong	Genetic Variation	[439]
ALG3	OTPOL1QW	Strong	Altered Expression	[440]
AMDHD1	OTBRFQF8	Strong	Genetic Variation	[389]
ANKRD36B	OT3MW415	Strong	Altered Expression	[441]
APOBEC3B	OTHLNI51	Strong	Biomarker	[442]
ARFGEF3	OTGQV0CU	Strong	Biomarker	[443]
ARFRP1	OTP1OV78	Strong	Genetic Variation	[205]
ARL6IP1	OT536XAV	Strong	Biomarker	[424]
ASH1L	OTUT5NLJ	Strong	Biomarker	[444]
ATP1B2	OTYTBYVU	Strong	Genetic Variation	[32]
AXIN1	OTRGZGZ5	Strong	Posttranslational Modification	[445]
AZIN1	OTX5W77I	Strong	Biomarker	[446]
AZIN2	OT8OB7CG	Strong	Biomarker	[447]
BAG1	OTRQNIA4	Strong	Biomarker	[448]
BANF1	OTP7Z38L	Strong	Biomarker	[449]
BARX1	OT2VP73H	Strong	Biomarker	[450]
BCCIP	OTFFKG79	Strong	Altered Expression	[451]
BCL10	OT47MCLI	Strong	Biomarker	[452]
BEX1	OTBQIF0H	Strong	Altered Expression	[453]
BHLHE41	OTY9GJ1Y	Strong	Biomarker	[454]
BIN1	OTK8O0X8	Strong	Posttranslational Modification	[455]
BIRC6	OTCQJAB0	Strong	Biomarker	[456]
BMF	OT90NSLI	Strong	Biomarker	[457]
BMS1	OTEGQ8ZO	Strong	Genetic Variation	[309]
BPTF	OTD1RZAD	Strong	Biomarker	[458]
BRAP	OTB7BAFQ	Strong	Altered Expression	[459]
BRF2	OT2C6TH2	Strong	Biomarker	[460]
BRI3BP	OTWCFPRM	Strong	Altered Expression	[461]
BRINP1	OTEUVSCP	Strong	Altered Expression	[462]
BTRC	OT2EZDGR	Strong	Biomarker	[463]
BUB1B	OT8KME51	Strong	Biomarker	[464]
C1GALT1	OT2ZSZ6P	Strong	Biomarker	[465]
CADM1	OTRWG9QS	Strong	Altered Expression	[466]
CADM2	OT45PVKC	Strong	Altered Expression	[467]
CAP1	OTYM8A2N	Strong	Biomarker	[468]
CAPN10	OTS9LJW4	Strong	Altered Expression	[469]
CAPN3	OTCHG3YK	Strong	Biomarker	[470]
CAPNS1	OT95EBBD	Strong	Altered Expression	[471]
CAPS	OTC9GZ2M	Strong	Biomarker	[472]
CAV2	OT1FGRQX	Strong	Altered Expression	[473]
CBX8	OT4U5V1T	Strong	Biomarker	[474]
CCAR2	OTLUDG5T	Strong	Altered Expression	[462]
CCDC34	OTZ3AGSQ	Strong	Altered Expression	[475]
CCDC54	OTW5WCX9	Strong	Altered Expression	[476]
CCHCR1	OT22C116	Strong	Biomarker	[128]
CCL1	OT23NON8	Strong	Genetic Variation	[477]
CCL26	OT2B7HR9	Strong	Biomarker	[478]
CCL28	OTY6XNQ7	Strong	Altered Expression	[479]
CCL8	OTCTWYN8	Strong	Biomarker	[480]
CCN5	OTADU8JJ	Strong	Altered Expression	[481]
CCNA1	OTX4HD45	Strong	Biomarker	[482]
CCNG1	OT17IA9L	Strong	Biomarker	[483]
CCS	OTXHT3QO	Strong	Biomarker	[484]
CCT8	OTA7GQN9	Strong	Altered Expression	[485]
CD63	OT2UGZA9	Strong	Biomarker	[486]
CD82	OTH8MC64	Strong	Biomarker	[487]
CDC34	OTNBK390	Strong	Biomarker	[332]
CDC42	OT5QBC5M	Strong	Biomarker	[488]
CDC42EP3	OTUZ3U9Z	Strong	Biomarker	[489]
CDCA5	OTZLCQ5U	Strong	Altered Expression	[490]
CDCA7	OT12HDZY	Strong	Biomarker	[491]
CDCP1	OTD7RRWK	Strong	Altered Expression	[492]
CDH23	OTOJGQ7S	Strong	Altered Expression	[493]
CDK14	OT385ZH1	Strong	Altered Expression	[494]
CDKL3	OTJ0TQ9T	Strong	Altered Expression	[495]
CDR2	OTD3ZJST	Strong	Genetic Variation	[496]
CDX4	OTD1SQKM	Strong	Biomarker	[250]
CEP126	OTUMFEME	Strong	Biomarker	[497]
CEP55	OTGSG2PA	Strong	Biomarker	[498]
CFL1	OTT6D5MH	Strong	Biomarker	[343]
CHAF1A	OTXSSY4H	Strong	Biomarker	[177]
CHD1L	OT7CZK7C	Strong	Biomarker	[499]
CHRNA6	OTT6W86V	Strong	Genetic Variation	[500]
CHRNB3	OTE5XENW	Strong	Genetic Variation	[500]
CKS1B	OTNUPLUJ	Strong	Altered Expression	[501]
CKS2	OTPTMHIV	Strong	Altered Expression	[502]
CLDN1	OT27KV99	Strong	Biomarker	[503]
CLDN7	OTNE0XHQ	Strong	Biomarker	[504]
CLTA	OTLHOXMQ	Strong	Biomarker	[505]
CMTM3	OTS75IGC	Strong	Altered Expression	[506]
CNMD	OTHND8EL	Strong	Altered Expression	[507]
CNPY2	OTGY8ESX	Strong	Genetic Variation	[508]
COL11A1	OTB0DRMS	Strong	Altered Expression	[509]
COLQ	OT4BHUGQ	Strong	Biomarker	[510]
COX5A	OTP0961M	Strong	Biomarker	[511]
CPNE5	OTU882I6	Strong	Altered Expression	[512]
CPOX	OTIAY121	Strong	Biomarker	[511]
CPT1A	OTI862QH	Strong	Altered Expression	[513]
CRABP1	OTISDG5X	Strong	Biomarker	[514]
CRABP2	OTY01V9G	Strong	Biomarker	[515]
CRCT1	OTPYME8V	Strong	Biomarker	[516]
CREM	OTJIJ5AL	Strong	Altered Expression	[517]
CRIP2	OTVVJSYX	Strong	Biomarker	[518]
CRISP1	OTDI4B55	Strong	Genetic Variation	[205]
CRISP2	OT8HLTV5	Strong	Altered Expression	[519]
CRISPLD2	OTVSFHTL	Strong	Posttranslational Modification	[520]
CRNN	OTAORBR4	Strong	Biomarker	[521]
CSRP1	OTUS7RM2	Strong	Biomarker	[518]
CST1	OTE4I83Q	Strong	Altered Expression	[522]
CSTA	OT1K68KE	Strong	Altered Expression	[523]
CTAG1B	OTIQGW6U	Strong	Biomarker	[40]
CTAG2	OT8HISP4	Strong	Altered Expression	[524]
CTBP2	OTGZGT87	Strong	Biomarker	[525]
CTHRC1	OTV88X2G	Strong	Altered Expression	[219]
CTTN	OTJRG4ES	Strong	Altered Expression	[143]
CUL4A	OTTBV70J	Strong	Altered Expression	[526]
CUL4B	OT2QX4DO	Strong	Biomarker	[527]
CUZD1	OTDQJVZ8	Strong	Biomarker	[179]
CXCL3	OTSL94KH	Strong	Biomarker	[528]
DAB2IP	OTF456VC	Strong	Altered Expression	[424]
DACT1	OT19Z704	Strong	Altered Expression	[529]
DACT2	OTNLCC0K	Strong	Altered Expression	[529]
DAP	OT5YLL7E	Strong	Biomarker	[530]
DCAF15	OTWBXZ0E	Strong	Biomarker	[531]
DCDC1	OTQEHINP	Strong	Biomarker	[436]
DCUN1D1	OT8UJLZU	Strong	Biomarker	[532]
DDX20	OT6G8YF3	Strong	Genetic Variation	[533]
DDX46	OTB2X9TO	Strong	Altered Expression	[534]
DEFB104A	OTLQZR6K	Strong	Biomarker	[110]
DENND2D	OTXEFJWM	Strong	Altered Expression	[535]
DERL1	OTJUS74N	Strong	Altered Expression	[536]
DHDH	OTKA2AL6	Strong	Altered Expression	[537]
DHRS2	OTFHWIY8	Strong	Altered Expression	[538]
DIRAS1	OT07F6PE	Strong	Biomarker	[539]
DLX6	OT0FIJHY	Strong	Altered Expression	[540]
DMRT2	OTA39QNR	Strong	Biomarker	[478]
DNAH11	OT6IYFVV	Strong	Genetic Variation	[541]
DNAH9	OTI2QIZQ	Strong	Biomarker	[542]
DOK7	OTR2V7HO	Strong	Posttranslational Modification	[543]
DRG1	OTIFYMI3	Strong	Biomarker	[544]
DROSHA	OTCE68KZ	Strong	Altered Expression	[545]
DSG2	OTJPB2TO	Strong	Biomarker	[349]
DSP	OTB2MOP8	Strong	Biomarker	[349]
DUSP6	OT4H6RKW	Strong	Altered Expression	[546]
DVL2	OTMNYNCM	Strong	Biomarker	[547]
DVL3	OTPRROHJ	Strong	Biomarker	[548]
E2F5	OT1XWING	Strong	Altered Expression	[549]
E2F8	OTQKZGFP	Strong	Altered Expression	[550]
ECM1	OT1K65VW	Strong	Altered Expression	[551]
EFNA1	OTU2NUA2	Strong	Biomarker	[552]
EHD2	OTTX391J	Strong	Altered Expression	[553]
EHF	OTY6TPWD	Strong	Altered Expression	[554]
EI24	OTD4NOYS	Strong	Biomarker	[555]
EIF3B	OTF67VPH	Strong	Biomarker	[556]
EIF3E	OTI0WG98	Strong	Altered Expression	[557]
ELK1	OTH9MXD6	Strong	Altered Expression	[558]
EPB41L3	OTS6CHG2	Strong	Biomarker	[559]
EPC2	OTTG0W9R	Strong	Biomarker	[560]
ERAS	OT528IZO	Strong	Genetic Variation	[561]
ERCC1	OTNPYQHI	Strong	Altered Expression	[562]
ERCC2	OT1C8HQ4	Strong	Genetic Variation	[563]
ERCC3	OTVAW3P1	Strong	Altered Expression	[564]
ESCO1	OTZ9P12A	Strong	Biomarker	[40]
ESD	OTUSIBPS	Strong	Biomarker	[565]
ESPN	OT7Z6LX2	Strong	Biomarker	[566]
EVX1	OT4A84VD	Strong	Altered Expression	[567]
EYA4	OTINGR3Z	Strong	Biomarker	[568]
FAM135B	OTCSYBI7	Strong	Biomarker	[444]
FAM3B	OTC2S91N	Strong	Biomarker	[569]
FAM3C	OTBR6U9G	Strong	Altered Expression	[570]
FAM83F	OTGGJRO7	Strong	Altered Expression	[571]
FBXO31	OTF96IC2	Strong	Biomarker	[572]
FBXO32	OTUE978R	Strong	Biomarker	[573]
FBXO4	OT6VYX67	Strong	Biomarker	[574]
FBXW4	OTEGSZOX	Strong	Altered Expression	[423]
FEN1	OT6QGG7O	Strong	Genetic Variation	[575]
FGF12	OTBM9QIO	Strong	Altered Expression	[576]
FGF3	OT9PK2SI	Strong	Biomarker	[577]
FGF5	OTQXGHBY	Strong	Posttranslational Modification	[578]
FGFRL1	OT8HZ3ZL	Strong	Biomarker	[579]
FHL5	OT6C00Z1	Strong	Genetic Variation	[309]
FLII	OT7G9JG6	Strong	Biomarker	[580]
FLNC	OT3F8J6Y	Strong	Biomarker	[581]
FMNL3	OTRP8R4W	Strong	Altered Expression	[582]
FNDC3B	OTBILGDR	Strong	Biomarker	[583]
FOXD2	OTAF63YV	Strong	Altered Expression	[584]
FOXF2	OTV20NGX	Strong	Biomarker	[585]
FOXK2	OTFXDZ3R	Strong	Biomarker	[586]
FSD1	OT8P6PT3	Strong	Biomarker	[587]
FSD1L	OTBQ48RF	Strong	Biomarker	[587]
FSTL1	OT6KEZUD	Strong	Biomarker	[588]
FUBP1	OT77SC9N	Strong	Altered Expression	[589]
FXYD3	OT9PPRHE	Strong	Altered Expression	[590]
FZD6	OTBCPII8	Strong	Biomarker	[591]
GADD45A	OTDRV63V	Strong	Biomarker	[592]
GADL1	OTJM4A0R	Strong	Biomarker	[447]
GALNT14	OT9BSDDQ	Strong	Genetic Variation	[593]
GALNT7	OTUJSCAO	Strong	Altered Expression	[594]
GBE1	OTK2N05B	Strong	Genetic Variation	[595]
GCA	OTAJ7ZHG	Strong	Genetic Variation	[596]
GCNT2	OTRUIMC4	Strong	Biomarker	[597]
GEMIN4	OTX7402E	Strong	Genetic Variation	[533]
GNL3	OTILGYO4	Strong	Altered Expression	[598]
GOLGA7B	OT6VAFR8	Strong	Biomarker	[599]
GOLM1	OTOZSV6O	Strong	Biomarker	[600]
GOLPH3	OTDLGYM3	Strong	Biomarker	[601]
GORASP1	OTQS91S7	Strong	Altered Expression	[339]
GPC1	OTQKRSSV	Strong	Biomarker	[602]
GPD2	OTV232Y7	Strong	Genetic Variation	[143]
GPRC5A	OTPOCWR7	Strong	Biomarker	[603]
GPRC5C	OT45AJT3	Strong	Altered Expression	[148]
GPSM1	OTA0SJBG	Strong	Altered Expression	[604]
GPT2	OTS5VF7N	Strong	Altered Expression	[605]
GPX3	OT6PK94R	Strong	Altered Expression	[606]
GRB7	OTF8Y9XY	Strong	Biomarker	[607]
GRHL1	OTZ4MNEW	Strong	Biomarker	[608]
GRP	OT8JDFNI	Strong	Biomarker	[609]
GSTK1	OTDNGWAF	Strong	Genetic Variation	[378]
GTF2B	OTAH5NSO	Strong	Altered Expression	[610]
H2AC12	OTLXVB97	Strong	Altered Expression	[127]
H4C1	OTB71W46	Strong	Biomarker	[265]
HAS3	OTPM8IL8	Strong	Biomarker	[611]
HAT1	OT307KEN	Strong	Biomarker	[612]
HECTD3	OTTGP4OK	Strong	Altered Expression	[613]
HELQ	OTL1STJT	Strong	Genetic Variation	[614]
HEY2	OTU4J3ZI	Strong	Altered Expression	[615]
HIC1	OTI9TWY4	Strong	Altered Expression	[616]
HLA-E	OTX1CTFB	Strong	Biomarker	[617]
HLA-F	OT76CM19	Strong	Altered Expression	[618]
HLTF	OTRX2OSF	Strong	Posttranslational Modification	[619]
HMGN5	OTUUAHVQ	Strong	Biomarker	[620]
HNRNPC	OT47AK4C	Strong	Biomarker	[621]
HNRNPD	OT5UO1FA	Strong	Altered Expression	[142]
HNRNPH1	OTFRWOLM	Strong	Altered Expression	[622]
HOOK2	OTPO4NQV	Strong	Biomarker	[531]
HOPX	OTBSR6C9	Strong	Altered Expression	[623]
HOXB2	OTTD6HMV	Strong	Biomarker	[624]
HOXB7	OTC7WYU8	Strong	Biomarker	[625]
HOXC13	OT52AVNA	Strong	Biomarker	[626]
HOXC6	OTBCRAZV	Strong	Biomarker	[627]
HOXC8	OTJUYU8J	Strong	Altered Expression	[625]
HOXD10	OT0NOWU2	Strong	Altered Expression	[628]
HSPA2	OTSDET7B	Strong	Altered Expression	[629]
HSPB2	OTS01646	Strong	Altered Expression	[630]
HSPH1	OTVRR73T	Strong	Biomarker	[631]
IBSP	OT29944Y	Strong	Biomarker	[632]
IFITM1	OTECO1G8	Strong	Biomarker	[633]
IFITM3	OT2QP8D3	Strong	Biomarker	[634]
IFNA17	OTHXRYG3	Strong	Biomarker	[635]
IGBP1	OTTHH4YE	Strong	Posttranslational Modification	[530]
IGF2BP3	OTB97VIK	Strong	Altered Expression	[171]
IKBKE	OT5VYOSM	Strong	Altered Expression	[636]
IL3	OT0CQ35N	Strong	Genetic Variation	[637]
ILF2	OTWWVM9X	Strong	Altered Expression	[638]
ILF3	OTKMZ5K5	Strong	Biomarker	[639]
ING1	OTEZBRKW	Strong	Altered Expression	[640]
ING5	OTRNNSFM	Strong	Biomarker	[641]
INTS2	OT2N5TCK	Strong	Biomarker	[577]
INTS6	OT6GDV46	Strong	Genetic Variation	[642]
IQGAP1	OTZRWTGA	Strong	Biomarker	[643]
IRF9	OTK4MYQJ	Strong	Altered Expression	[644]
IST1	OTSFEZ2O	Strong	Altered Expression	[645]
ITGA7	OTTBTAYW	Strong	Biomarker	[646]
ITGB4	OT28UK84	Strong	Biomarker	[647]
IVNS1ABP	OTYHL4I7	Strong	Altered Expression	[648]
JAKMIP2	OT2H3MRD	Strong	Posttranslational Modification	[623]
KCNH4	OTHJ8WTU	Strong	Altered Expression	[558]
KCNH8	OT3I5FLB	Strong	Altered Expression	[558]
KCTD12	OTPYKT4Z	Strong	Biomarker	[649]
KDM6A	OTZM3MJJ	Strong	Biomarker	[650]
KHSRP	OTDHZARB	Strong	Altered Expression	[27]
KIFC1	OTNQDS00	Strong	Altered Expression	[651]
KLF10	OT4F4UGS	Strong	Biomarker	[652]
KLF15	OTGMQMVR	Strong	Biomarker	[652]
KLF9	OTBFEJRQ	Strong	Biomarker	[653]
KLHL1	OTAX6SAD	Strong	Altered Expression	[47]
KLK11	OT5PKX7Y	Strong	Biomarker	[654]
KLK13	OT8LOD2U	Strong	Altered Expression	[655]
KMT2B	OTMMAZQX	Strong	Altered Expression	[304]
KMT2C	OTC59BCO	Strong	Biomarker	[656]
KNTC1	OTI2OOFN	Strong	Altered Expression	[657]
KPNA2	OTU7FOE6	Strong	Biomarker	[658]
KRT13	OTTYSKGX	Strong	Biomarker	[659]
KRT14	OTUVZ1DW	Strong	Biomarker	[660]
KRT18	OTVLQFIP	Strong	Biomarker	[661]
KRT5	OTVGI9HT	Strong	Biomarker	[662]
LAMA1	OTQZMP86	Strong	Altered Expression	[663]
LAMP3	OTN0XL3W	Strong	Biomarker	[486]
LAMTOR5	OTER0U8L	Strong	Altered Expression	[664]
LAT	OTZC1XZ1	Strong	Biomarker	[665]
LBX2	OTGWRSI2	Strong	Altered Expression	[621]
LEF1	OTWS5I5H	Strong	Altered Expression	[666]
LETM1	OT8N4MRU	Strong	Altered Expression	[667]
LETM2	OTCYGL4F	Strong	Biomarker	[491]
LETMD1	OTZTZ4RD	Strong	Biomarker	[461]
LGALS3BP	OT9AGQKH	Strong	Biomarker	[668]
LGALS9	OT7MF91K	Strong	Biomarker	[669]
LGI1	OTPS77HO	Strong	Biomarker	[670]
LIG3	OT48SKET	Strong	Genetic Variation	[671]
LLGL1	OTAIQSXZ	Strong	Biomarker	[672]
LMOD1	OTZ2MEMG	Strong	Biomarker	[176]
LOXL4	OT6XY2JL	Strong	Biomarker	[306]
LRATD2	OTEZBUUL	Strong	Biomarker	[673]
LRFN2	OTI2QPM2	Strong	Genetic Variation	[541]
LRG1	OTLD0KWA	Strong	Biomarker	[674]
LRP1B	OT4YZG2N	Strong	Posttranslational Modification	[675]
LRRC8A	OT23OE7H	Strong	Biomarker	[676]
LSR	OTR8Y32X	Strong	Altered Expression	[677]
LTBP2	OTS88GSD	Strong	Biomarker	[678]
LTBP3	OTME98V7	Strong	Biomarker	[678]
LYPD5	OTGP7UKA	Strong	Altered Expression	[206]
LZTS1	OTXXL864	Strong	Biomarker	[679]
MACC1	OTV3DLX0	Strong	Biomarker	[680]
MAD2L2	OT24ZO59	Strong	Altered Expression	[681]
MADD	OTUFYVGG	Strong	Genetic Variation	[535]
MAGEB6	OTOTV1FU	Strong	Biomarker	[682]
MAGED1	OT6EOLFC	Strong	Biomarker	[683]
MAGED4B	OTO37U7W	Strong	Biomarker	[441]
MAGI2	OTXDDKZS	Strong	Biomarker	[424]
MAPK13	OT0W9GE7	Strong	Biomarker	[576]
MARCHF8	OTH7PNN2	Strong	Altered Expression	[684]
MARCHF9	OTWF84QT	Strong	Biomarker	[685]
MASP1	OTWWCNZP	Strong	Altered Expression	[686]
MCM10	OTV0O3JN	Strong	Altered Expression	[687]
MCM4	OT19PNNG	Strong	Biomarker	[591]
MCRS1	OT8K2X8P	Strong	Biomarker	[688]
MCTS1	OT7SAOJP	Strong	Biomarker	[689]
MED15	OT0D0JVD	Strong	Posttranslational Modification	[690]
MED23	OTKZQT0R	Strong	Biomarker	[691]
MFN1	OTCBXQZF	Strong	Biomarker	[692]
MIB1	OT5C404P	Strong	Biomarker	[693]
MICB	OTS2DVDW	Strong	Altered Expression	[694]
MINDY4	OTBZ2SZB	Strong	Biomarker	[695]
MISP	OTRZDX0N	Strong	Biomarker	[652]
MLST8	OT8DNJSD	Strong	Genetic Variation	[696]
MLXIP	OT30UNI7	Strong	Biomarker	[697]
MMP23B	OT2OR6TS	Strong	Altered Expression	[154]
MMP26	OT9O89KU	Strong	Altered Expression	[698]
MOAP1	OTVF3LUG	Strong	Altered Expression	[686]
MPRIP	OT5FV5NS	Strong	Altered Expression	[699]
MRPL21	OT1BSWWH	Strong	Biomarker	[76]
MT1G	OTAV1OCR	Strong	Posttranslational Modification	[700]
MT3	OTVCZ7HI	Strong	Posttranslational Modification	[701]
MTHFD1L	OTV01EFP	Strong	Altered Expression	[702]
MTSS1	OT5DTDO2	Strong	Biomarker	[703]
MUC13	OTWKS9MF	Strong	Altered Expression	[704]
MUCL1	OT9QUFL3	Strong	Altered Expression	[705]
MYBL2	OTZ3JX8Q	Strong	Altered Expression	[706]
MYCL	OT1MFQ5U	Strong	Biomarker	[707]
MYEOV	OTDC7UHL	Strong	Biomarker	[708]
MYL4	OTURFCSE	Strong	Biomarker	[499]
MYL9	OT6B22JB	Strong	Altered Expression	[709]
MYLIP	OTL0PFGV	Strong	Biomarker	[697]
MYO1B	OTGZUJ0I	Strong	Biomarker	[538]
NAA25	OTS3QVF1	Strong	Genetic Variation	[710]
NAA35	OTHVXAXC	Strong	Biomarker	[711]
NABP1	OTFTNFHW	Strong	Posttranslational Modification	[198]
NANOG	OTUEY1FM	Strong	Biomarker	[29]
NCR3LG1	OT15YWU7	Strong	Altered Expression	[712]
NDC80	OTS7D306	Strong	Biomarker	[713]
NDP	OTGDJ4US	Strong	Biomarker	[714]
NDRG2	OT5L6KD7	Strong	Altered Expression	[715]
NECTIN2	OTIE0W6O	Strong	Altered Expression	[716]
NEFH	OTMSCW5I	Strong	Biomarker	[717]
NEIL1	OTHBU5DJ	Strong	Genetic Variation	[718]
NELFA	OT7O6E84	Strong	Altered Expression	[719]
NEO1	OTGJ1997	Strong	Altered Expression	[720]
NFATC2	OTK5T6HZ	Strong	Biomarker	[721]
NFIA	OTDHQ9CG	Strong	Altered Expression	[722]
NFIB	OTX94PD0	Strong	Biomarker	[722]
NFIX	OT1DPZAE	Strong	Altered Expression	[723]
NFYC	OTZVVEV7	Strong	Genetic Variation	[724]
NHEJ1	OTYOO05J	Strong	Altered Expression	[725]
NID2	OTHC33FF	Strong	Altered Expression	[726]
NKX2-8	OT6Q3DJ0	Strong	Biomarker	[727]
NONO	OTN36Q6U	Strong	Biomarker	[728]
NR2C2	OTDZWVOJ	Strong	Altered Expression	[729]
NR2F1	OTGWZWYL	Strong	Altered Expression	[730]
NRDC	OTWBBCXO	Strong	Altered Expression	[731]
NRIP1	OTIZOJQV	Strong	Biomarker	[732]
NSG1	OTRIMA50	Strong	Biomarker	[733]
NSUN2	OTZCNM33	Strong	Biomarker	[458]
NUDT1	OTZSES3W	Strong	Altered Expression	[734]
NUMB	OTMB586Q	Strong	Altered Expression	[735]
NUP98	OTNT12G2	Strong	Altered Expression	[432]
NUSAP1	OT85HIJ5	Strong	Altered Expression	[736]
OPCML	OT93PQ6Y	Strong	Altered Expression	[45]
OPN1LW	OTFNUZ7O	Strong	Biomarker	[121]
OPRPN	OT6K1ZD6	Strong	Altered Expression	[273]
OTUB1	OT8WWM9O	Strong	Altered Expression	[737]
PAG1	OTFOJUIQ	Strong	Biomarker	[121]
PAQR3	OTTKJ9Y4	Strong	Biomarker	[738]
PARP4	OTXBK59G	Strong	Biomarker	[739]
PAX1	OT0Y3MIM	Strong	Biomarker	[740]
PAX9	OT25J0F7	Strong	Biomarker	[741]
PCBP2	OTXCN9CG	Strong	Altered Expression	[742]
PCBP4	OTDLL4NB	Strong	Biomarker	[121]
PCDH17	OTRK0M05	Strong	Posttranslational Modification	[743]
PCLAF	OTMVIOUU	Strong	Biomarker	[744]
PCLO	OTXJZZ98	Strong	Biomarker	[745]
PDC	OT1UUVYY	Strong	Genetic Variation	[640]
PDCD6IP	OTS8T6A7	Strong	Biomarker	[424]
PDE4DIP	OTS15WNF	Strong	Biomarker	[746]
PDHA1	OTGEU8IK	Strong	Altered Expression	[747]
PDLIM2	OTEURRPD	Strong	Altered Expression	[748]
PDLIM4	OT23LZYY	Strong	Biomarker	[518]
PDLIM5	OTLQVV22	Strong	Biomarker	[749]
PDPN	OTBUV19I	Strong	Biomarker	[750]
PDS5A	OT34P56Z	Strong	Biomarker	[751]
PELP1	OTVXQNOT	Strong	Biomarker	[752]
PEX6	OTFAK5EF	Strong	Genetic Variation	[753]
PHB2	OTCAX3AW	Strong	Altered Expression	[754]
PHF2	OTJCIQR2	Strong	Altered Expression	[755]
PHLDA3	OTXFUDO2	Strong	Altered Expression	[756]
PHLDB2	OTDKMB2G	Strong	Altered Expression	[757]
PHLPP1	OTIFXW8D	Strong	Altered Expression	[758]
PHLPP2	OTXB1OUI	Strong	Altered Expression	[759]
PIK3C2B	OTY2PROB	Strong	Altered Expression	[760]
PIK3R2	OTZSUQK5	Strong	Biomarker	[761]
PIK3R3	OTXGJ8N1	Strong	Biomarker	[762]
PINK1	OT50NR57	Strong	Altered Expression	[763]
PITX1	OTA0UN4C	Strong	Biomarker	[764]
PITX2	OTWMXAOY	Strong	Biomarker	[765]
PLAAT1	OTM3M6P4	Strong	Genetic Variation	[766]
PLCD1	OT6WFVXZ	Strong	Biomarker	[767]
PLCL1	OTJL2C79	Strong	Genetic Variation	[768]
PLEK	OTB73XXA	Strong	Altered Expression	[759]
PLEKHA2	OTY2AP6T	Strong	Biomarker	[769]
PLRG1	OTIVZ5LL	Strong	Altered Expression	[273]
PLXNA1	OTN0BING	Strong	Altered Expression	[770]
PMAIP1	OTXEE550	Strong	Biomarker	[335]
POLD2	OTBNASP6	Strong	Genetic Variation	[389]
POLI	OTBA4DCE	Strong	Biomarker	[771]
POLQ	OTBHK0E6	Strong	Genetic Variation	[221]
POLR2E	OTH5IL2A	Strong	Genetic Variation	[772]
POTEG	OTGGSJW3	Strong	Altered Expression	[773]
POTEM	OT7L2HGH	Strong	Genetic Variation	[309]
POU3F3	OT6BBXPD	Strong	Biomarker	[774]
POU5F1	OTDHHN7O	Strong	Biomarker	[145]
PPIG	OTZ8BTTM	Strong	Genetic Variation	[775]
PPL	OTTM4WDO	Strong	Biomarker	[776]
PPP1R18	OT0JVGOZ	Strong	Biomarker	[652]
PRAF2	OT1QN4LV	Strong	Biomarker	[777]
PRB2	OTAD4JZ0	Strong	Altered Expression	[778]
PRDM2	OT8L7CGX	Strong	Biomarker	[779]
PRDX1	OTZ3BEC4	Strong	Biomarker	[780]
PRDX6	OTS8KC8A	Strong	Altered Expression	[781]
PRIMA1	OT9ITT3P	Strong	Altered Expression	[782]
PRM3	OT6574BF	Strong	Genetic Variation	[384]
PRR11	OT2JJ08Z	Strong	Biomarker	[783]
PRSS2	OTOMVUWL	Strong	Altered Expression	[210]
PRSS3	OTN3S5YB	Strong	Posttranslational Modification	[784]
PRSS55	OTXXWI5Y	Strong	Altered Expression	[519]
PSMD14	OTJWHMZ5	Strong	Altered Expression	[785]
PSMD7	OT7PZZ4K	Strong	Biomarker	[786]
PSME2	OTYPP33T	Strong	Biomarker	[307]
PTMA	OT2W4T1M	Strong	Biomarker	[176]
PTOV1	OT94WT5X	Strong	Altered Expression	[787]
PTPN12	OT5WA666	Strong	Altered Expression	[788]
PTPN9	OTNAR1I2	Strong	Altered Expression	[789]
PTPRD	OTZPJ3GX	Strong	Biomarker	[117]
PTPRO	OTFLKWOY	Strong	Biomarker	[790]
PTPRT	OTV5TXNN	Strong	Genetic Variation	[791]
PTRH2	OTBU39Q1	Strong	Altered Expression	[792]
PTTG1	OTIMYS4W	Strong	Altered Expression	[793]
PTTG2	OTXGZ8FV	Strong	Altered Expression	[793]
PXN	OTVMMUOF	Strong	Altered Expression	[794]
PYCR2	OTS2HLGD	Strong	Biomarker	[399]
PYGO2	OTZHB2OI	Strong	Biomarker	[795]
PYROXD2	OTJIX22S	Strong	Genetic Variation	[143]
QKI	OTTAUGLB	Strong	Altered Expression	[796]
RAB10	OT8ZN26V	Strong	Biomarker	[797]
RAB23	OTBAKFBR	Strong	Altered Expression	[798]
RAB25	OTW0W6NP	Strong	Biomarker	[799]
RAB31	OTMLXQZ0	Strong	Altered Expression	[800]
RAB37	OTRL8IUO	Strong	Biomarker	[519]
RAB3D	OTGKRR3C	Strong	Biomarker	[801]
RABGAP1L	OT7QO47I	Strong	Altered Expression	[802]
RAD17	OT1I93DT	Strong	Genetic Variation	[719]
RAD18	OTQ9PLNT	Strong	Biomarker	[803]
RAN	OT2TER5M	Strong	Genetic Variation	[533]
RAP1A	OT5RH6TI	Strong	Biomarker	[804]
RAP1B	OTHEIIMM	Strong	Biomarker	[547]
RARRES1	OTETUPP5	Strong	Posttranslational Modification	[690]
RASGRP3	OTEMEV3P	Strong	Altered Expression	[805]
RASSF10	OTGB7EBG	Strong	Posttranslational Modification	[806]
RASSF2	OT2JHDO4	Strong	Altered Expression	[807]
RASSF5	OT6Q41I2	Strong	Biomarker	[808]
RASSF6	OT25GVWY	Strong	Biomarker	[809]
RASSF8	OTXKGIB3	Strong	Biomarker	[810]
RBBP7	OTLB56HX	Strong	Altered Expression	[811]
RBM3	OTAJ7R31	Strong	Altered Expression	[812]
RERE	OT3G4GBZ	Strong	Genetic Variation	[205]
REV3L	OT0OP8EJ	Strong	Altered Expression	[813]
RFC2	OTJ9N6BD	Strong	Genetic Variation	[719]
RHOC	OTOLE1FT	Strong	Altered Expression	[814]
RHOF	OTPA3F8Q	Strong	Biomarker	[815]
RIT1	OTVNOGOH	Strong	Biomarker	[816]
RNASE1	OTKZ7CO9	Strong	Biomarker	[817]
RNASEH2C	OTJL9ZRN	Strong	Altered Expression	[604]
RND3	OTXMXPIH	Strong	Biomarker	[818]
RNF113A	OTR6N7HU	Strong	Biomarker	[819]
RNF128	OTJO86CJ	Strong	Biomarker	[820]
RNF2	OTFPLOIN	Strong	Altered Expression	[821]
RNF8	OTRR43PZ	Strong	Biomarker	[822]
RPN2	OTJ1SKOA	Strong	Altered Expression	[823]
RPS6	OTT4D1LN	Strong	Posttranslational Modification	[824]
RPTOR	OT4TQZ9F	Strong	Genetic Variation	[696]
RRAD	OTW2O4GD	Strong	Posttranslational Modification	[825]
RRAS	OTBBF28C	Strong	Biomarker	[826]
RRAS2	OT83NCEB	Strong	Biomarker	[827]
RSRC2	OTLE0KQM	Strong	Biomarker	[828]
RTRAF	OTJ6NVMW	Strong	Altered Expression	[829]
S100A11	OTI57KDN	Strong	Genetic Variation	[830]
S100A14	OTVFJJ91	Strong	Genetic Variation	[831]
SAFB	OTGRV2LW	Strong	Altered Expression	[832]
SALL2	OTQWI68Q	Strong	Biomarker	[833]
SALL4	OTC08PR5	Strong	Biomarker	[834]
SASH1	OTQA8BD4	Strong	Altered Expression	[835]
SATB2	OT2W80XC	Strong	Biomarker	[836]
SBF2	OTBB8NO8	Strong	Biomarker	[837]
SBK1	OTCO4NEI	Strong	Altered Expression	[838]
SBSN	OT89RKJH	Strong	Biomarker	[839]
SCAI	OTAK3TMO	Strong	Altered Expression	[840]
SCARA5	OTOVA96E	Strong	Altered Expression	[316]
SCEL	OT46SDNQ	Strong	Biomarker	[841]
SCO2	OTJQQDRS	Strong	Biomarker	[330]
SDR9C7	OTQY8SJ3	Strong	Biomarker	[217]
SEL1L	OTC0FB7T	Strong	Biomarker	[842]
SEMA3B	OTCZCPMS	Strong	Altered Expression	[843]
SEPTIN9	OT1VMRFQ	Strong	Biomarker	[624]
SERPINB2	OT72QLZB	Strong	Altered Expression	[844]
SERPINE2	OTYF5340	Strong	Biomarker	[845]
SERTAD1	OTBHKZQP	Strong	Altered Expression	[846]
SET	OTGYYQJO	Strong	Biomarker	[847]
SFN	OTLJCZ1U	Strong	Biomarker	[343]
SFRP2	OT8GZ0CA	Strong	Posttranslational Modification	[848]
SGTA	OTKOJ3JB	Strong	Biomarker	[849]
SHANK2	OTSQTPFQ	Strong	Biomarker	[130]
SHOX2	OTLCZZJW	Strong	Biomarker	[850]
SIRT4	OT5S0J23	Strong	Biomarker	[851]
SIX1	OT70YYWM	Strong	Altered Expression	[852]
SKA1	OTDYJ12A	Strong	Altered Expression	[853]
SLAMF1	OTBTT3ZQ	Strong	Biomarker	[854]
SLC12A9	OTR7VRAK	Strong	Genetic Variation	[88]
SLC16A4	OT1YXBKC	Strong	Biomarker	[293]
SLC22A18	OT9C3KR4	Strong	Altered Expression	[832]
SMARCA2	OTSGJ8SV	Strong	Altered Expression	[855]
SMG1	OTTS3SXE	Strong	Biomarker	[348]
SNAI1	OTDPYAMC	Strong	Biomarker	[737]
SORBS2	OTJSX44Y	Strong	Biomarker	[478]
SOX1	OTVI1RAR	Strong	Biomarker	[740]
SOX15	OTTB37I1	Strong	Altered Expression	[856]
SOX17	OT9H4WWE	Strong	Altered Expression	[420]
SOX3	OT1CRCOB	Strong	Biomarker	[857]
SOX4	OTSS40SS	Strong	Biomarker	[858]
SPA17	OT8J7T7U	Strong	Altered Expression	[476]
SPIN1	OT69VAOX	Strong	Biomarker	[859]
SPINK7	OTK3VOI3	Strong	Biomarker	[860]
SPINT1	OT1CLR5L	Strong	Altered Expression	[861]
SPINT2	OTQV7BKQ	Strong	Posttranslational Modification	[862]
SPPL2A	OTCVF6MM	Strong	Altered Expression	[171]
SPRR2A	OT62ZU6B	Strong	Altered Expression	[863]
SPRR3	OTN9QJKG	Strong	Altered Expression	[864]
SPRY4	OT2VK9N0	Strong	Altered Expression	[160]
SPSB3	OTHGEE2K	Strong	Altered Expression	[865]
SRPX2	OT6A63TX	Strong	Biomarker	[866]
SSBP2	OTYG1G80	Strong	Biomarker	[198]
ST13	OTNML6UP	Strong	Altered Expression	[623]
ST6GALNAC1	OT3JQD99	Strong	Altered Expression	[867]
STAT2	OTO9G2RZ	Strong	Altered Expression	[644]
STING1	OTDAP4G0	Strong	Genetic Variation	[32]
STIP1	OT7TXLOX	Strong	Biomarker	[868]
STX6	OTC5F5M6	Strong	Biomarker	[869]
SUB1	OTK71JYU	Strong	Altered Expression	[725]
SYCE1L	OTXU44F3	Strong	Altered Expression	[47]
SYNJ2BP	OT2Q677P	Strong	Biomarker	[143]
SYT1	OTVTPOI6	Strong	Altered Expression	[339]
SYTL2	OTUIOWKL	Strong	Altered Expression	[305]
TAB3	OT1ECMDL	Strong	Biomarker	[870]
TAS2R13	OTSTOX5G	Strong	Genetic Variation	[389]
TAS2R14	OTWA9CYC	Strong	Genetic Variation	[389]
TAS2R42	OTMEJBFJ	Strong	Genetic Variation	[389]
TAS2R46	OTK23I2G	Strong	Genetic Variation	[389]
TAS2R50	OTPRMVZW	Strong	Genetic Variation	[389]
TCEAL1	OTAPG2L5	Strong	Altered Expression	[871]
TCF21	OT393IMA	Strong	Altered Expression	[872]
TCF7	OT1ID822	Strong	Biomarker	[275]
TCHP	OTVDMHSY	Strong	Altered Expression	[424]
TCN2	OT41D0L3	Strong	Biomarker	[128]
TCTN1	OTG5KEV8	Strong	Altered Expression	[873]
TENM3	OTWY13GR	Strong	Altered Expression	[837]
TET3	OT76U3YF	Strong	Altered Expression	[874]
TEX10	OTNTU9CB	Strong	Altered Expression	[875]
TEX9	OTMYCDCW	Strong	Altered Expression	[556]
TFCP2	OTA246TE	Strong	Altered Expression	[876]
TGFB1I1	OTIK337D	Strong	Altered Expression	[877]
TGFBI	OTR443C5	Strong	Altered Expression	[878]
THSD1	OTKPGFHS	Strong	Posttranslational Modification	[879]
THSD7A	OT7249HH	Strong	Biomarker	[880]
THUMPD2	OTNNGX4U	Strong	Altered Expression	[881]
THY1	OTVONVTB	Strong	Altered Expression	[882]
TIGAR	OTR7NMRJ	Strong	Altered Expression	[31]
TIMM8A	OTDX9687	Strong	Biomarker	[883]
TIMP3	OTDGQAD1	Strong	Biomarker	[884]
TM4SF1	OTY0ECQN	Strong	Altered Expression	[885]
TMEM176A	OTOZDWXX	Strong	Biomarker	[886]
TMPRSS11A	OTB35677	Strong	Genetic Variation	[887]
TMPRSS11E	OTO5U2TK	Strong	Biomarker	[888]
TMPRSS4	OTCCGY2K	Strong	Biomarker	[889]
TNFAIP2	OTRZH80H	Strong	Altered Expression	[890]
TNFAIP8	OT1G9297	Strong	Biomarker	[39]
TNRC6B	OTGVT0SH	Strong	Genetic Variation	[533]
TNRC6C	OTBR07PM	Strong	Altered Expression	[469]
TNXB	OTVBWAV5	Strong	Biomarker	[128]
TOM1L1	OT37NXR0	Strong	Altered Expression	[891]
TP53BP2	OTOWJ2Y4	Strong	Altered Expression	[892]
TP53I3	OTSCM68G	Strong	Biomarker	[893]
TPM1	OTD73X6R	Strong	Altered Expression	[894]
TPM4	OTN4YLYR	Strong	Biomarker	[895]
TRAF4	OTJLRVMC	Strong	Altered Expression	[896]
TRAP1	OTNG0L8J	Strong	Altered Expression	[897]
TRIM16	OTLRXYOZ	Strong	Biomarker	[809]
TRIM3	OT704FQ0	Strong	Altered Expression	[339]
TRIM44	OT0B1T2B	Strong	Altered Expression	[898]
TRIP13	OTFM3TI9	Strong	Altered Expression	[899]
TSGA10	OTIF1O1T	Strong	Biomarker	[900]
TSPAN15	OTNQXXIG	Strong	Biomarker	[463]
TSPAN4	OTKFK57F	Strong	Altered Expression	[901]
TTC17	OTQV0VWV	Strong	Altered Expression	[902]
TTC39B	OTE2ZGFB	Strong	Biomarker	[221]
AKIP1	OT7XPG27	Definitive	Biomarker	[903]
AQP5	OT77GBY8	Definitive	Biomarker	[904]
BLVRB	OTHCFN2C	Definitive	Biomarker	[343]
C15orf48	OT85J32K	Definitive	Altered Expression	[905]
CAPZA1	OTAXA66U	Definitive	Biomarker	[343]
CCN4	OT69BER9	Definitive	Altered Expression	[906]
CDKN3	OTBE3H07	Definitive	Altered Expression	[907]
CENPF	OT7AG0SW	Definitive	Biomarker	[908]
CSTB	OT3U0JF8	Definitive	Biomarker	[343]
CTNND2	OTYKE30Y	Definitive	Biomarker	[909]
DCC	OT2C1SHW	Definitive	Posttranslational Modification	[910]
DIDO1	OT9PB547	Definitive	Biomarker	[834]
DLEC1	OTMKKBUW	Definitive	Genetic Variation	[911]
ECRG4	OTHZYUXX	Definitive	Biomarker	[912]
EFNB2	OT0DCUOM	Definitive	Altered Expression	[352]
EMP3	OTODMJ1D	Definitive	Biomarker	[913]
ERCC5	OTQAKFJM	Definitive	Biomarker	[914]
FADD	OTV7GFHH	Definitive	Biomarker	[915]
FAT2	OTRGT3E8	Definitive	Biomarker	[916]
FAT3	OT3C6H8W	Definitive	Biomarker	[916]
FAT4	OT7QONNV	Definitive	Biomarker	[916]
GBP1	OTUM7RPJ	Definitive	Altered Expression	[917]
GDI2	OTGLY3I7	Definitive	Biomarker	[343]
GSTM2	OTG4WT05	Definitive	Genetic Variation	[918]
H2BC14	OTSDZZZY	Definitive	Biomarker	[343]
KRT4	OT24PHPM	Definitive	Biomarker	[660]
LDHB	OT9B1CT3	Definitive	Altered Expression	[919]
LMLN	OTQF0JPY	Definitive	Biomarker	[357]
LTO1	OTQ17ZDT	Definitive	Altered Expression	[920]
MAP1LC3A	OTPMGIU4	Definitive	Altered Expression	[921]
MBD4	OTWR9YXE	Definitive	Genetic Variation	[922]
MUC20	OTYYE1GK	Definitive	Biomarker	[923]
PAK5	OT32WQGL	Definitive	Altered Expression	[924]
PCGF2	OTIY1J5L	Definitive	Biomarker	[925]
PDLIM7	OTAZVODU	Definitive	Altered Expression	[926]
PFN1	OTHTGA1H	Definitive	Biomarker	[343]
POLM	OT0SRIP4	Definitive	Biomarker	[927]
PPP1R1B	OTSIJMQ9	Definitive	Biomarker	[928]
PROX1	OT68R6IO	Definitive	Altered Expression	[929]
PSME1	OTDHLJWH	Definitive	Biomarker	[343]
PTX3	OTPXHRKU	Definitive	Altered Expression	[930]
RBMS3	OTFSC9MR	Definitive	Biomarker	[931]
REPS2	OTSE3TRP	Definitive	Biomarker	[932]
S100A1	OT1F2G4J	Definitive	Altered Expression	[933]
S100A2	OTTGHJ1H	Definitive	Biomarker	[934]
SMR3B	OTL5HNM8	Definitive	Biomarker	[364]
SOX6	OTT0W0LE	Definitive	Altered Expression	[935]
TMEFF2	OT1WZ2QO	Definitive	Biomarker	[936]
TMPRSS13	OTMAOAP3	Definitive	Biomarker	[357]
TPI1	OT14KP4B	Definitive	Biomarker	[343]
TPM2	OTA1L0P8	Definitive	Biomarker	[343]

References

• [1] Cisplatin FDA Label
• [2] Fluorouracil FDA Label
• [3] ClinicalTrials.gov (NCT03829969) A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Compare Toripalimab Injection (JS001) Combined With Standard Chemotherapy Versus Placebo Combined With Standard Chemotherapy in Treatment of Advanced or Metastatic Esophageal Squamous Cell Cancer (ESCC) Without Previous Systemic Chemotherapy. U.S.National Institutes of Health.
• [4] Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway.J Med Chem. 2019 Feb 28;62(4):1715-1730.
• [5] ClinicalTrials.gov (NCT03785496) Study to Evaluate Efficacy of PDR001 in Patients With Squamous Cell Carcinoma of the Esophagus. U.S. National Institutes of Health.
• [6] ClinicalTrials.gov (NCT04785820) A Study of RO7121661 and RO7247669 Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus. U.S. National Institutes of Health.
• [7] Emerging therapies targeting the ubiquitin proteasome system in cancer. J Clin Invest. 2014 Jan;124(1):6-12.
• [8] Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma. EBioMedicine. 2017 Dec;26:100-111.
• [9] Chlorogenic acid inhibits esophageal squamous cell carcinoma growth in vitro and in vivo by downregulating the expression of BMI1 and SOX2.Biomed Pharmacother. 2020 Jan;121:109602. doi: 10.1016/j.biopha.2019.109602. Epub 2019 Nov 7.
• [10] Expression of proteins associated with epithelial-mesenchymal transition in esophageal squamous cell carcinoma.Oncol Lett. 2018 Mar;15(3):3042-3048. doi: 10.3892/ol.2017.7701. Epub 2017 Dec 28.
• [11] Positive correlation of cysteine-rich 61 and target genes of Wnt/-catenin pathway in esophageal squamous cell carcinoma.J Cancer Res Ther. 2016 Oct;12(Supplement):19-22. doi: 10.4103/0973-1482.191622.
• [12] Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.BMC Cancer. 2019 May 31;19(1):526. doi: 10.1186/s12885-019-5755-5.
• [13] Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.Ann Surg Oncol. 2020 Apr;27(4):1233-1240. doi: 10.1245/s10434-019-07977-6. Epub 2019 Oct 24.
• [14] LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein.Cell Death Differ. 2018 Nov;25(11):1980-1995. doi: 10.1038/s41418-018-0084-9. Epub 2018 Mar 6.
• [15] Prognostic significance of platelet C-reactive protein multiplier in patients with esophageal squamous cell carcinoma.Surg Today. 2020 Feb;50(2):185-192. doi: 10.1007/s00595-019-01865-y. Epub 2019 Aug 30.
• [16] Induction of PD-L1 expression by epidermal growth factor receptor-mediated signaling in esophageal squamous cell carcinoma.Onco Targets Ther. 2017 Feb 13;10:763-771. doi: 10.2147/OTT.S118982. eCollection 2017.
• [17] Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer.Cancer. 2013 Oct 15;119(20):3604-9. doi: 10.1002/cncr.28276. Epub 2013 Jul 24.
• [18] miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.Biomed Pharmacother. 2019 Mar;111:476-484. doi: 10.1016/j.biopha.2018.12.057. Epub 2018 Dec 27.
• [19] LncRNA Erbb4-IR promotes esophageal squamous cell carcinoma (ESCC) by downregulating miR-145.J Cell Biochem. 2019 Oct;120(10):17566-17572. doi: 10.1002/jcb.29023. Epub 2019 May 22.
• [20] Long noncoding RNA linc-UBC1 promotes tumor invasion and metastasis by regulating EZH2 and repressing E-cadherin in esophageal squamous cell carcinoma.J BUON. 2018 Jan-Feb;23(1):157-162.
• [21] Correlation between high FBXW7 expression in pretreatment biopsy specimens and good response to chemoradiation therapy in patients with locally advanced esophageal cancer: A retrospective study.J Surg Oncol. 2018 Jul;118(1):101-108. doi: 10.1002/jso.25127. Epub 2018 Aug 11.
• [22] Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma.Hum Pathol. 2018 Oct;80:210-218. doi: 10.1016/j.humpath.2018.06.009. Epub 2018 Jun 22.
• [23] Fra-1 Regulates theExpression of HMGA1,Which is Associated with a Poor Prognosis in Human Esophageal Squamous Cell Carcinoma.Ann Surg Oncol. 2017 Oct;24(11):3446-3455. doi: 10.1245/s10434-016-5666-5. Epub 2016 Nov 23.
• [24] Overexpression of long noncoding RNA LINC01419 in esophageal squamous cell carcinoma and its relation to the sensitivity to 5-fluorouracil by mediating GSTP1 methylation.Ther Adv Med Oncol. 2019 Apr 12;11:1758835919838958. doi: 10.1177/1758835919838958. eCollection 2019.
• [25] Knockdown of HOXA5 inhibits the tumorigenesis in esophageal squamous cell cancer. Biomed Pharmacother. 2017 Feb;86:149-154.
• [26] Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers.Carcinogenesis. 2014 Dec;35(12):2698-705. doi: 10.1093/carcin/bgu203. Epub 2014 Sep 19.
• [27] Flow Cytometric Detection of Circulating Tumor Cells Using a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR).Methods Mol Biol. 2017;1634:211-217. doi: 10.1007/978-1-4939-7144-2_18.
• [28] LSD1 regulates Notch and PI3K/Akt/mTOR pathways through binding the promoter regions of Notch target genes in esophageal squamous cell carcinoma.Onco Targets Ther. 2019 Jul 2;12:5215-5225. doi: 10.2147/OTT.S207238. eCollection 2019.
• [29] A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.Int J Cancer. 2015 Mar 15;136(6):E569-77. doi: 10.1002/ijc.29211. Epub 2014 Sep 24.
• [30] Down-regulated miR-26a promotes proliferation, migration, and invasion via negative regulation of MTDH in esophageal squamous cell carcinoma.FASEB J. 2017 May;31(5):2114-2122. doi: 10.1096/fj.201601237. Epub 2017 Feb 7.
• [31] Inhibition of MUC1-C regulates metabolism by AKT pathway in esophageal squamous cell carcinoma.J Cell Physiol. 2019 Jul;234(7):12019-12028. doi: 10.1002/jcp.27863. Epub 2018 Dec 6.
• [32] Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations.Nat Genet. 2014 Sep;46(9):1001-1006. doi: 10.1038/ng.3064. Epub 2014 Aug 17.
• [33] CACNA2D3 Enhances the Chemosensitivity of Esophageal Squamous Cell Carcinoma to Cisplatin via Inducing Ca(2+)-Mediated Apoptosis and Suppressing PI3K/Akt Pathways.Front Oncol. 2019 Apr 2;9:185. doi: 10.3389/fonc.2019.00185. eCollection 2019.
• [34] Sequestosome 1 protects esophageal squamous carcinoma cells from apoptosis via stabilizing SKP2 under serum starvation condition.Oncogene. 2018 Jun;37(24):3260-3274. doi: 10.1038/s41388-018-0217-0. Epub 2018 Mar 19.
• [35] Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That RegulateMetastasis.Gastroenterology. 2017 Jun;152(8):1985-1997.e12. doi: 10.1053/j.gastro.2017.02.006. Epub 2017 Feb 14.
• [36] Network analyses elucidate the role of SMYD3 in esophageal squamous cell carcinoma.FEBS Open Bio. 2017 Jul 3;7(8):1111-1125. doi: 10.1002/2211-5463.12251. eCollection 2017 Aug.
• [37] TNFmediated upregulation of SOD? contributes to cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma.Oncol Rep. 2019 Oct;42(4):1497-1506. doi: 10.3892/or.2019.7252. Epub 2019 Jul 26.
• [38] Novel signal transducer and activator of transcription 1 mutation disrupts small ubiquitin-related modifier conjugation causing gain of function.J Allergy Clin Immunol. 2018 May;141(5):1844-1853.e2. doi: 10.1016/j.jaci.2017.07.027. Epub 2017 Aug 30.
• [39] Possible biomarkers for predicting lymph node metastasis of esophageal squamous cell carcinoma: a review.J Int Med Res. 2019 Feb;47(2):544-556. doi: 10.1177/0300060518819606. Epub 2019 Jan 7.
• [40] Linkage between EMT and stemness state through molecular association between TWIST1 and NY-ESO1 in esophageal squamouscell carcinoma.Biochimie. 2019 Aug;163:84-93. doi: 10.1016/j.biochi.2019.05.016. Epub 2019 May 31.
• [41] Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma.PeerJ. 2019 Dec 3;7:e8182. doi: 10.7717/peerj.8182. eCollection 2019.
• [42] Chemokines and their receptors as biomarkers in esophageal cancer.Esophagus. 2020 Apr;17(2):113-121. doi: 10.1007/s10388-019-00706-8. Epub 2019 Nov 26.
• [43] Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma.Cancer Med. 2019 Mar;8(3):1315-1325. doi: 10.1002/cam4.1894. Epub 2019 Feb 11.
• [44] Circular RNA ciRS-7 triggers the migration and invasion of esophageal squamous cell carcinoma via miR-7/KLF4 and NF-B signals.Cancer Biol Ther. 2019;20(1):73-80. doi: 10.1080/15384047.2018.1507254. Epub 2018 Sep 12.
• [45] Epigenetic deregulations of Wnt/-catenin and transforming growth factor beta-Smad pathways in esophageal cancer: Outcome of DNA methylation.J Cancer Res Ther. 2019 Jan-Mar;15(1):192-203. doi: 10.4103/jcrt.JCRT_634_17.
• [46] PTP1B up-regulates EGFR expression by dephosphorylating MYH9 at Y1408 to promote cell migration and invasion in esophageal squamous cell carcinoma.Biochem Biophys Res Commun. 2020 Jan 29;522(1):53-60. doi: 10.1016/j.bbrc.2019.10.168. Epub 2019 Nov 15.
• [47] Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma.Br J Cancer. 2011 Feb 15;104(4):707-13. doi: 10.1038/sj.bjc.6606071. Epub 2011 Jan 4.
• [48] DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.Clin Cancer Res. 2015 Feb 15;21(4):854-63. doi: 10.1158/1078-0432.CCR-14-1740. Epub 2014 Dec 15.
• [49] Genetic variant repressing ADH1A expression confers susceptibility to esophageal squamous-cell carcinoma.Cancer Lett. 2018 May 1;421:43-50. doi: 10.1016/j.canlet.2017.12.020. Epub 2017 Dec 15.
• [50] Replication study of ESCC susceptibility genetic polymorphisms locating in the ADH1B-ADH1C-ADH7 cluster identified by GWAS.PLoS One. 2014 Apr 10;9(4):e94096. doi: 10.1371/journal.pone.0094096. eCollection 2014.
• [51] Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells.J Clin Invest. 2013 Jun;123(6):2576-89. doi: 10.1172/JCI68143. Epub 2013 May 8.
• [52] Overexpression of S-adenosylhomocysteine hydrolase (SAHH) in esophageal squamous cell carcinoma (ESCC) cell lines: effects on apoptosis, migration and adhesion of cells.Mol Biol Rep. 2014;41(4):2409-17. doi: 10.1007/s11033-014-3095-8. Epub 2014 Jan 16.
• [53] Circular RNA circ-PRKCI functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-3680-3p in esophageal squamous cell carcinoma.J Cell Biochem. 2019 Jun;120(6):10021-10030. doi: 10.1002/jcb.28285. Epub 2019 Jan 18.
• [54] 12-lipoxygenase promotes tumor progress by TGF-1-mediated epithelial to mesenchymal transition and predicts poor prognosis in esophageal squamous cell carcinoma.Cancer Manag Res. 2019 Sep 11;11:8303-8313. doi: 10.2147/CMAR.S212478. eCollection 2019.
• [55] Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer.Cancer Med. 2020 Jan;9(2):575-585. doi: 10.1002/cam4.2744. Epub 2019 Dec 2.
• [56] miR-196a regulates the proliferation, invasion and migration of esophageal squamous carcinoma cells by targeting ANXA1.Oncol Lett. 2019 Jun;17(6):5201-5209. doi: 10.3892/ol.2019.10186. Epub 2019 Mar 22.
• [57] ANXA10 induction by interaction with tumor-associated macrophages promotes the growth of esophageal squamous cell carcinoma.Pathol Int. 2019 Mar;69(3):135-147. doi: 10.1111/pin.12771. Epub 2019 Feb 13.
• [58] Downregulation of miR-138 sustains NF-B activation and promotes lipid raft formation in esophageal squamous cell carcinoma.Clin Cancer Res. 2013 Mar 1;19(5):1083-93. doi: 10.1158/1078-0432.CCR-12-3169. Epub 2013 Jan 14.
• [59] Assessment of apelin, apelin receptor, resistin, and adiponectin levels in the primary tumor and serum of patients with esophageal squamous cell carcinoma.Adv Clin Exp Med. 2019 May;28(5):671-678. doi: 10.17219/acem/94135.
• [60] Prognostic nomogram integrated baseline serum lipids for patients with non-esophageal squamous cell carcinoma.Ann Transl Med. 2019 Oct;7(20):548. doi: 10.21037/atm.2019.09.86.
• [61] Co-expression of AQP3 and AQP5 in esophageal squamous cell carcinoma correlates with aggressive tumor progression and poor prognosis.Med Oncol. 2013;30(3):636. doi: 10.1007/s12032-013-0636-2. Epub 2013 Jun 25.
• [62] Combined detection of IL-6 and IL-8 is beneficial to the diagnosis of early stage esophageal squamous cell cancer: a preliminary study based on the screening of serum markers using protein chips.Onco Targets Ther. 2018 Sep 12;11:5777-5787. doi: 10.2147/OTT.S171242. eCollection 2018.
• [63] Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway.Am J Physiol Cell Physiol. 2020 Jul 1;319(1):C93-C104. doi: 10.1152/ajpcell.00133.2019. Epub 2019 Nov 20.
• [64] FAM175B promotes apoptosis by inhibiting ATF4 ubiquitination in esophageal squamous cell carcinoma.Mol Oncol. 2019 May;13(5):1150-1165. doi: 10.1002/1878-0261.12474. Epub 2019 Mar 23.
• [65] OV6(+) cancer stem cells drive esophageal squamous cell carcinoma progression through ATG7-dependent -catenin stabilization.Cancer Lett. 2017 Apr 10;391:100-113. doi: 10.1016/j.canlet.2017.01.026. Epub 2017 Jan 25.
• [66] Overexpression of ATPase Na+/+ transporting alpha 1 polypeptide, ATP1A1, correlates with clinical diagnosis and progression of esophageal squamous cell carcinoma.Oncotarget. 2016 Dec 20;7(51):85244-85258. doi: 10.18632/oncotarget.13267.
• [67] Upregulation of STK15 in esophageal squamous cell carcinomas in a Mongolian population.Asian Pac J Cancer Prev. 2014;15(15):6021-4. doi: 10.7314/apjcp.2014.15.15.6021.
• [68] Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China.Onco Targets Ther. 2016 Dec 20;10:85-94. doi: 10.2147/OTT.S113932. eCollection 2017.
• [69] Mesenchymal Stromal Cells-Derived 2-Microglobulin Promotes Epithelial-Mesenchymal Transition of Esophageal Squamous Cell Carcinoma Cells.Sci Rep. 2018 Apr 3;8(1):5422. doi: 10.1038/s41598-018-23651-5.
• [70] MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia.Cancer. 2001 May 15;91(10):1882-8.
• [71] The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma.BMC Cancer. 2019 Jun 21;19(1):609. doi: 10.1186/s12885-019-5815-x.
• [72] High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma.Int J Clin Exp Pathol. 2013 Oct 15;6(11):2497-505. eCollection 2013.
• [73] The Role of cIAP1 and XIAP in Apoptosis Induced by Tumor Necrosis Factor Alpha in Esophageal Squamous Cell Carcinoma Cells.Dig Dis Sci. 2017 Mar;62(3):652-659. doi: 10.1007/s10620-016-4430-9. Epub 2017 Jan 3.
• [74] Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer.Ann Surg Oncol. 2017 Feb;24(2):594-602. doi: 10.1245/s10434-016-5100-z. Epub 2016 Feb 1.
• [75] Genetic polymorphisms of NAMPT related with susceptibility to esophageal squamous cell carcinoma.BMC Gastroenterol. 2015 Apr 21;15:49. doi: 10.1186/s12876-015-0282-6.
• [76] Identification of genomic biomarkers associated with the clinicopathological parameters and prognosis of esophageal squamous cell carcinoma.Cancer Biomark. 2015;15(6):755-61. doi: 10.3233/CBM-150517.
• [77] Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities.Cancer Res Treat. 2020 Jan;52(1):31-40. doi: 10.4143/crt.2018.624. Epub 2019 Apr 30.
• [78] The loss of CASP4 expression is associated with poor prognosis in esophageal squamous cell carcinoma.Oncol Lett. 2017 Mar;13(3):1761-1766. doi: 10.3892/ol.2017.5646. Epub 2017 Jan 25.
• [79] MicroRNA-375 inhibits esophageal squamous cell carcinoma proliferation through direct targeting of SP1.Exp Ther Med. 2019 Mar;17(3):1509-1516. doi: 10.3892/etm.2018.7106. Epub 2018 Dec 17.
• [80] MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2.Cell Mol Biol Lett. 2019 Feb 5;24:4. doi: 10.1186/s11658-018-0129-6. eCollection 2019.
• [81] Triptolide prevents proliferation and migration of Esophageal Squamous Cell Cancer via MAPK/ERK signaling pathway.Eur J Pharmacol. 2019 May 15;851:43-51. doi: 10.1016/j.ejphar.2019.02.030. Epub 2019 Feb 16.
• [82] Association of tumour-associated macrophages with cancer cell EMT, invasion, and metastasis of Kazakh oesophageal squamous cell cancer.Diagn Pathol. 2019 Jun 12;14(1):55. doi: 10.1186/s13000-019-0834-0.
• [83] Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer.Oncotarget. 2018 May 4;9(34):23482-23493. doi: 10.18632/oncotarget.25235. eCollection 2018 May 4.
• [84] Exosome-derived miR-339-5p mediates radiosensitivity by targeting Cdc25A in locally advanced esophageal squamous cell carcinoma.Oncogene. 2019 Jun;38(25):4990-5006. doi: 10.1038/s41388-019-0771-0. Epub 2019 Mar 11.
• [85] Targeting CDC7 improves sensitivity to chemotherapy of esophageal squamous cell carcinoma.Onco Targets Ther. 2018 Dec 20;12:63-74. doi: 10.2147/OTT.S183629. eCollection 2019.
• [86] miR-200b induces cell cycle arrest and represses cell growth in esophageal squamous cell carcinoma.Carcinogenesis. 2016 Sep;37(9):858-869. doi: 10.1093/carcin/bgw079. Epub 2016 Aug 4.
• [87] Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma.Gut. 2017 Aug;66(8):1358-1368. doi: 10.1136/gutjnl-2016-311818. Epub 2016 May 10.
• [88] Polymorphism rs2395655 affects LEDGF/p75 binding activity and p21WAF1/CIP1 gene expression in esophageal squamous cell carcinoma.Cancer Med. 2019 May;8(5):2313-2324. doi: 10.1002/cam4.2067. Epub 2019 Mar 10.
• [89] Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.Toxicol Appl Pharmacol. 2019 Feb 15;365:71-83. doi: 10.1016/j.taap.2019.01.005. Epub 2019 Jan 8.
• [90] Association of genetic variants in CHEK2 with oesophageal squamous cell carcinoma in the South African Black population.Carcinogenesis. 2019 Jun 10;40(4):513-520. doi: 10.1093/carcin/bgz026.
• [91] Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.J Pharm Biomed Anal. 2018 Jun 5;155:148-156. doi: 10.1016/j.jpba.2018.03.062. Epub 2018 Mar 31.
• [92] Nicotinic cholinergic receptors in esophagus: Early alteration during carcinogenesis and prognostic value.World J Gastroenterol. 2016 Aug 21;22(31):7146-56. doi: 10.3748/wjg.v22.i31.7146.
• [93] CHST15 promotes the proliferation of TE? cells via multiple pathways in esophageal cancer.Oncol Rep. 2020 Jan;43(1):75-86. doi: 10.3892/or.2019.7395. Epub 2019 Oct 30.
• [94] High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma.Ther Adv Med Oncol. 2019 Sep 27;11:1758835919875324. doi: 10.1177/1758835919875324. eCollection 2019.
• [95] Chloride intracellular channel 1 as a switch among tumor behaviors in human esophageal squamous cell carcinoma.Oncotarget. 2018 May 1;9(33):23237-23252. doi: 10.18632/oncotarget.25296. eCollection 2018 May 1.
• [96] Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population.Carcinogenesis. 2013 Jul;34(7):1536-42. doi: 10.1093/carcin/bgt094. Epub 2013 Mar 15.
• [97] Contactin-1 (CNTN-1) overexpression is correlated with advanced clinical stage and lymph node metastasis in oesophageal squamous cell carcinomas.Jpn J Clin Oncol. 2012 Jul;42(7):612-8. doi: 10.1093/jjco/hys066. Epub 2012 May 11.
• [98] Clinical significance of LAMB3 and COL7A1 mRNA in esophageal squamous cell carcinoma.Eur J Surg Oncol. 2009 Jan;35(1):52-8. doi: 10.1016/j.ejso.2008.01.025. Epub 2008 Mar 10.
• [99] Significance of Jab1 expression in human esophageal squamous cell carcinoma.J Clin Gastroenterol. 2009 Jul;43(6):520-6. doi: 10.1097/MCG.0b013e3181919245.
• [100] Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer.Cancer Sci. 2012 Sep;103(9):1617-24. doi: 10.1111/j.1349-7006.2012.02355.x. Epub 2012 Jul 16.
• [101] Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus.J Biol Chem. 2019 Jan 4;294(1):327-340. doi: 10.1074/jbc.RA118.005963. Epub 2018 Nov 8.
• [102] Genetic variants in sex hormone metabolic pathway genes and risk of esophageal squamous cell carcinoma.Carcinogenesis. 2013 May;34(5):1062-8. doi: 10.1093/carcin/bgt030. Epub 2013 Jan 28.
• [103] A genetic polymorphism in the CYP1B1 gene in patients with squamous cell carcinoma of the esophagus: an Iranian Mashhad cohort study recruited over 10years.Pharmacogenomics. 2018 Apr;19(6):539-546. doi: 10.2217/pgs-2018-0197. Epub 2018 Apr 9.
• [104] Vitamin D Signaling Pathways Confer the Susceptibility of Esophageal Squamous Cell Carcinoma in a Northern Chinese Population.Nutr Cancer. 2017 May-Jun;69(4):593-600. doi: 10.1080/01635581.2017.1299873. Epub 2017 Mar 31.
• [105] DNA polymorphism and risk of esophageal squamous cell carcinoma in a population of North Xinjiang, China.World J Gastroenterol. 2010 Feb 7;16(5):641-7. doi: 10.3748/wjg.v16.i5.641.
• [106] Association of Genetic Variants of CYP2C19 and CYP2D6 with Esophageal Squamous Cell Carcinoma Risk in Northern India, Kashmir.Nutr Cancer. 2017 May-Jun;69(4):585-592. doi: 10.1080/01635581.2017.1299874. Epub 2017 Apr 3.
• [107] Esophageal cancer proliferation is mediated by cytochrome P450 2C9 (CYP2C9).Prostaglandins Other Lipid Mediat. 2011 Feb;94(1-2):25-33. doi: 10.1016/j.prostaglandins.2010.12.001. Epub 2010 Dec 15.
• [108] Leukotriene receptor expression in esophageal squamous cell cancer and non-transformed esophageal epithelium: a matched case control study.BMC Gastroenterol. 2016 Jul 30;16(1):85. doi: 10.1186/s12876-016-0499-z.
• [109] Metformin-induced alterations in nucleotide metabolism cause 5-fluorouracil resistance but gemcitabine susceptibility in oesophageal squamous cell carcinoma.J Cell Biochem. 2018 Jan;119(1):1193-1203. doi: 10.1002/jcb.26291. Epub 2017 Aug 23.
• [110] Overexpression of human -defensin 2 promotes growth and invasion during esophageal carcinogenesis.Oncotarget. 2014 Nov 30;5(22):11333-44. doi: 10.18632/oncotarget.2416.
• [111] Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence.PLoS Genet. 2018 Mar 14;14(3):e1007227. doi: 10.1371/journal.pgen.1007227. eCollection 2018 Mar.
• [112] Different functions of DEPTOR in modulating sensitivity to chemotherapy for esophageal squamous cell carcinoma.Exp Cell Res. 2017 Apr 1;353(1):35-45. doi: 10.1016/j.yexcr.2017.03.003. Epub 2017 Mar 4.
• [113] Decreased expression of DFF45/ICAD is correlated with a poor prognosis in patients with esophageal carcinoma.Cancer. 2002 Dec 15;95(12):2473-8. doi: 10.1002/cncr.10987.
• [114] The diacylglycerol kinase (DGK)/Akt/NF-B feedforward loop promotes esophageal squamous cell carcinoma (ESCC) progression via FAK-dependent and FAK-independent manner.Oncogene. 2019 Apr;38(14):2533-2550. doi: 10.1038/s41388-018-0604-6. Epub 2018 Dec 7.
• [115] The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma.Oncogene. 2016 Oct 6;35(40):5304-5316. doi: 10.1038/onc.2016.71. Epub 2016 Apr 4.
• [116] p63-Dependent Dickkopf3 Expression Promotes Esophageal Cancer Cell Proliferation via CKAP4.Cancer Res. 2018 Nov 1;78(21):6107-6120. doi: 10.1158/0008-5472.CAN-18-1749. Epub 2018 Sep 4.
• [117] Characterization of gene rearrangements resulted from genomic structural aberrations in human esophageal squamous cell carcinoma KYSE150 cells.Gene. 2013 Jan 15;513(1):196-201. doi: 10.1016/j.gene.2012.09.091. Epub 2012 Sep 28.
• [118] miR-424 coordinates multilayered regulation of cell cycle progression to promote esophageal squamous cell carcinoma cell proliferation.EBioMedicine. 2018 Nov;37:110-124. doi: 10.1016/j.ebiom.2018.10.043. Epub 2018 Oct 23.
• [119] High endothelin-converting enzyme-1 expression independently predicts poor survival of patients with esophageal squamous cell carcinoma.Tumour Biol. 2017 Sep;39(9):1010428317725922. doi: 10.1177/1010428317725922.
• [120] eEF2K promotes progression and radioresistance of esophageal squamous cell carcinoma.Radiother Oncol. 2017 Sep;124(3):439-447. doi: 10.1016/j.radonc.2017.04.001. Epub 2017 Apr 19.
• [121] A novel long noncoding RNA linc00460 up-regulated by CBP/P300 promotes carcinogenesis in esophageal squamous cell carcinoma.Biosci Rep. 2017 Oct 17;37(5):BSR20171019. doi: 10.1042/BSR20171019. Print 2017 Oct 31.
• [122] Intratumoral heterogeneity of esophageal squamous cell carcinoma and its clinical significance.Pathol Res Pract. 2019 Feb;215(2):308-314. doi: 10.1016/j.prp.2018.11.019. Epub 2018 Nov 24.
• [123] High expression of EphA1 in esophageal squamous cell carcinoma is associated with lymph node metastasis and advanced disease.APMIS. 2013 Jan;121(1):30-7. doi: 10.1111/j.1600-0463.2012.02941.x. Epub 2012 Jul 12.
• [124] EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma.J Thorac Dis. 2018 May;10(5):2779-2788. doi: 10.21037/jtd.2018.04.91.
• [125] Cryptotanshinone inhibits esophageal squamous-cell carcinoma in vitro and in vivo through the suppression of STAT3 activation.Onco Targets Ther. 2019 Jan 29;12:883-896. doi: 10.2147/OTT.S187777. eCollection 2019.
• [126] Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian Populations.Neoplasia. 2019 Jun;21(6):571-581. doi: 10.1016/j.neo.2019.03.013. Epub 2019 Apr 29.
• [127] Quantitative Proteomics Identify the Possible Tumor Suppressive Role of Protease-Activated Receptor-4 in Esophageal Squamous Cell Carcinoma Cells.Pathol Oncol Res. 2019 Jul;25(3):937-943. doi: 10.1007/s12253-018-0395-7. Epub 2018 Mar 4.
• [128] Exome-wide analyses identify low-frequency variant in CYP26B1 and additional coding variants associated with esophageal squamous cell carcinoma. Nat Genet. 2018 Mar;50(3):338-343. doi: 10.1038/s41588-018-0045-8. Epub 2018 Jan 29.
• [129] YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.Cancer Med. 2020 Mar;9(5):1628-1637. doi: 10.1002/cam4.2761. Epub 2019 Dec 18.
• [130] Genome-wide screening for genetic alterations in esophageal cancer by aCGH identifies 11q13 amplification oncogenes associated with nodal metastasis.PLoS One. 2012;7(6):e39797. doi: 10.1371/journal.pone.0039797. Epub 2012 Jun 25.
• [131] Blocking FGFR4 exerts distinct anti-tumorigenic effects in esophageal squamous cell carcinoma.Thorac Cancer. 2018 Dec;9(12):1687-1698. doi: 10.1111/1759-7714.12883. Epub 2018 Sep 28.
• [132] Genomic copy-number alterations of MYC and FHIT genes are associated with survival in esophageal squamous-cell carcinoma.Cancer Sci. 2012 Aug;103(8):1558-66. doi: 10.1111/j.1349-7006.2012.02329.x. Epub 2012 Jun 21.
• [133] Evaluation of protein expression pattern of stanniocalcin 2, insulin-like growth factor-binding protein 7, inhibin beta A and four and a half LIM domains 1 in esophageal squamous cell carcinoma.Cancer Biomark. 2012-2013;12(1):1-9. doi: 10.3233/CBM-120289.
• [134] FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma.Ann Surg Oncol. 2011 Feb;18(2):535-42. doi: 10.1245/s10434-010-1274-y. Epub 2010 Aug 28.
• [135] FOXM1c promotes oesophageal cancer metastasis by transcriptionally regulating IRF1 expression.Cell Prolif. 2019 Mar;52(2):e12553. doi: 10.1111/cpr.12553. Epub 2018 Nov 28.
• [136] FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas.Sci Rep. 2018 Nov 26;8(1):17370. doi: 10.1038/s41598-018-35459-4.
• [137] FOXQ1 promotes esophageal cancer proliferation and metastasis by negatively modulating CDH1.Biomed Pharmacother. 2015 Aug;74:89-94. doi: 10.1016/j.biopha.2015.07.010. Epub 2015 Aug 6.
• [138] Evaluating stem and cancerous biomarkers in CD15+CD44+ KYSE30 cells.Tumour Biol. 2013 Oct;34(5):2909-20. doi: 10.1007/s13277-013-0853-5.
• [139] LINC00152 facilitates tumorigenesis in esophageal squamous cell carcinoma via miR-153-3p/FYN axis.Biomed Pharmacother. 2019 Apr;112:108654. doi: 10.1016/j.biopha.2019.108654. Epub 2019 Feb 20.
• [140] FZD7 is a novel prognostic marker and promotes tumor metastasis via WNT and EMT signaling pathways in esophageal squamous cell carcinoma.Oncotarget. 2017 Jul 26;8(39):65957-65968. doi: 10.18632/oncotarget.19586. eCollection 2017 Sep 12.
• [141] Identification of reference genes and miRNAs for qRT-PCR in human esophageal squamous cell carcinoma.Med Oncol. 2017 Jan;34(1):2. doi: 10.1007/s12032-016-0860-7. Epub 2016 Nov 26.
• [142] Upregulation of AUF1 is involved in the proliferation of esophageal squamous cell carcinoma through GCH1.Int J Oncol. 2016 Nov;49(5):2001-2010. doi: 10.3892/ijo.2016.3713. Epub 2016 Sep 28.
• [143] A Novel Clinical Six-Flavoprotein-Gene Signature Predicts Prognosis in Esophageal Squamous Cell Carcinoma.Biomed Res Int. 2019 Oct 30;2019:3869825. doi: 10.1155/2019/3869825. eCollection 2019.
• [144] Prognostic role of HPV infection in esophageal squamous cell carcinoma.Infect Agent Cancer. 2018 Nov 29;13:38. doi: 10.1186/s13027-018-0210-9. eCollection 2018.
• [145] Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.J Cancer Res Clin Oncol. 2017 Feb;143(2):243-254. doi: 10.1007/s00432-016-2273-6. Epub 2016 Sep 28.
• [146] Serum pepsinogen assay is not recommended for the diagnosis of esophageal squamous cell carcinoma: a systematic review and meta-analysis.Cancer Manag Res. 2019 Jun 27;11:5643-5654. doi: 10.2147/CMAR.S196760. eCollection 2019.
• [147] Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma.BMC Cancer. 2011 Feb 25;11:86. doi: 10.1186/1471-2407-11-86.
• [148] Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinoma.Cancer Lett. 2006 Feb 28;233(2):265-70. doi: 10.1016/j.canlet.2005.03.018.
• [149] A promoter methylation pattern in the N-methyl-D-aspartate receptor 2B gene predicts poor prognosis in esophageal squamous cell carcinoma.Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6658-65. doi: 10.1158/1078-0432.CCR-07-1178.
• [150] Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway.J Cell Physiol. 2019 Dec;234(12):22400-22410. doi: 10.1002/jcp.28805. Epub 2019 May 23.
• [151] MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6.Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1069-1076. doi: 10.26355/eurrev_201902_16995.
• [152] Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1 axis in esophageal squamous cell carcinoma.Exp Mol Pathol. 2019 Aug;109:104239. doi: 10.1016/j.yexmp.2019.03.007. Epub 2019 Mar 20.
• [153] HIPK2 inhibits cell metastasis and improves chemosensitivity in esophageal squamous cell carcinoma.Exp Ther Med. 2018 Jan;15(1):1113-1118. doi: 10.3892/etm.2017.5468. Epub 2017 Nov 8.
• [154] TWIST1, MMP-21, and HLAG-1 co-overexpression is associated with ESCC aggressiveness.J Cell Biochem. 2019 Sep;120(9):14838-14846. doi: 10.1002/jcb.28745. Epub 2019 Apr 23.
• [155] MiR-490-3p inhibited the proliferation and metastasis of esophageal squamous cell carcinoma by targeting HMGA2.Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8298-8305. doi: 10.26355/eurrev_201812_16527.
• [156] Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1(+) TAM expansion.Oncogenesis. 2019 Feb 22;8(3):17. doi: 10.1038/s41389-019-0126-2.
• [157] Predictive significance of HMGCS2 for prognosis in resected Chinese esophageal squamous cell carcinoma patients.Onco Targets Ther. 2017 May 15;10:2553-2560. doi: 10.2147/OTT.S132543. eCollection 2017.
• [158] beta-Catenin/TCF pathway plays a vital role in selenium induced-growth inhibition and apoptosis in esophageal squamous cell carcinoma (ESCC) cells.Cancer Lett. 2010 Oct 1;296(1):113-22. doi: 10.1016/j.canlet.2010.04.001. Epub 2010 May 10.
• [159] Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy.Thorac Cancer. 2018 Jul;9(7):836-846. doi: 10.1111/1759-7714.12758. Epub 2018 May 14.
• [160] H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma.Nucleic Acids Res. 2017 Apr 7;45(6):3086-3101. doi: 10.1093/nar/gkw1247.
• [161] Prognostic role of HSF1 overexpression in solid tumors: a pooled analysis of 3,159 patients.Onco Targets Ther. 2018 Jan 17;11:383-393. doi: 10.2147/OTT.S153682. eCollection 2018.
• [162] High expression of glucose-regulated protein 78 (GRP78) is associated with metastasis and poor prognosis in patients with esophageal squamous cell carcinoma.Onco Targets Ther. 2017 Feb 9;10:617-625. doi: 10.2147/OTT.S123494. eCollection 2017.
• [163] Elevated serine protease HtrA1 inhibits cell proliferation, reduces invasion, and induces apoptosis in esophageal squamous cell carcinoma by blocking the nuclear factor-B signaling pathway.Tumour Biol. 2013 Feb;34(1):317-28. doi: 10.1007/s13277-012-0553-6. Epub 2012 Oct 19.
• [164] Indoleamine 2,3-dioxygenase 1 and Programmed Cell Death-ligand 1 Co-expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy.Cancers (Basel). 2019 Feb 1;11(2):169. doi: 10.3390/cancers11020169.
• [165] Polymorphisms of insulin-like growth factor binding protein-3 as a predictor for risk and patient survival in esophageal squamous cell carcinoma.Biomed Pharmacother. 2015 Aug;74:148-52. doi: 10.1016/j.biopha.2015.08.021. Epub 2015 Aug 15.
• [166] The Diagnostic Value of Serum IGFBP7 in Patients with Esophageal Squamous Cell Carcinoma.J Cancer. 2019 Jun 2;10(12):2687-2693. doi: 10.7150/jca.32393. eCollection 2019.
• [167] miR-204-5p regulates cell proliferation, invasion, and apoptosis by targeting IL-11 in esophageal squamous cell carcinoma.J Cell Physiol. 2020 Mar;235(3):3043-3055. doi: 10.1002/jcp.29209. Epub 2019 Sep 23.
• [168] IL-15 receptor alpha rs2228059 A>C polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.Mol Biol Rep. 2014;41(4):1951-7. doi: 10.1007/s11033-014-3042-8. Epub 2014 Jan 28.
• [169] Interleukin-23 receptor signaling mediates cancer dormancy and radioresistance in human esophageal squamous carcinoma cells via the Wnt/Notch pathway.J Mol Med (Berl). 2019 Feb;97(2):177-188. doi: 10.1007/s00109-018-1724-8. Epub 2018 Nov 27.
• [170] Oncogenic IL7R is downregulated by histone deacetylase inhibitor in esophageal squamous cell carcinoma via modulation of acetylated FOXO1.Int J Oncol. 2018 Jul;53(1):395-403. doi: 10.3892/ijo.2018.4392. Epub 2018 May 2.
• [171] Prognostic significance of IMP-3 expression pattern in esophageal squamous cell carcinoma.J Thorac Dis. 2019 Sep;11(9):3776-3784. doi: 10.21037/jtd.2019.09.25.
• [172] INHBA upregulation correlates with poorer prognosis in patients with esophageal squamous cell carcinoma.Cancer Manag Res. 2018 Jun 18;10:1585-1596. doi: 10.2147/CMAR.S160186. eCollection 2018.
• [173] ISG15 promotes esophageal squamous cell carcinoma tumorigenesis via c-MET/Fyn/-catenin signaling pathway.Exp Cell Res. 2018 Jun 1;367(1):47-55. doi: 10.1016/j.yexcr.2018.03.017. Epub 2018 Mar 17.
• [174] Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/-catenin pathway.Oncotarget. 2015 Mar 20;6(8):6001-13. doi: 10.18632/oncotarget.3469.
• [175] Integrin 6 promotes esophageal cancer metastasis and is targeted by miR-92b.Oncotarget. 2017 Jan 24;8(4):6681-6690. doi: 10.18632/oncotarget.14259.
• [176] Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB).Clin Proteomics. 2019 Apr 5;16:12. doi: 10.1186/s12014-019-9232-6. eCollection 2019.
• [177] Cancer-associated Fibroblast-promoted LncRNA DNM3OS Confers Radioresistance by Regulating DNA Damage Response in Esophageal Squamous Cell Carcinoma.Clin Cancer Res. 2019 Mar 15;25(6):1989-2000. doi: 10.1158/1078-0432.CCR-18-0773. Epub 2018 Nov 21.
• [178] The increase of voltage-gated potassium channel Kv3.4 mRNA expression in oral squamous cell carcinoma.J Oral Pathol Med. 2003 Nov;32(10):606-11. doi: 10.1034/j.1600-0714.2003.00197.x.
• [179] TCF7L2 and EGR1 synergistic activation of transcription of LCN2 via an ERK1/2-dependent pathway in esophageal squamous cell carcinoma cells.Cell Signal. 2019 Mar;55:8-16. doi: 10.1016/j.cellsig.2018.12.007. Epub 2018 Dec 14.
• [180] Identification and characterization of JMJD2 family genes in silico.Int J Oncol. 2004 Jun;24(6):1623-8.
• [181] Blockade of Immune-Checkpoint B7-H4 and Lysine Demethylase 5B in Esophageal Squamous Cell Carcinoma Confers Protective Immunity against P. gingivalis Infection.Cancer Immunol Res. 2019 Sep;7(9):1440-1456. doi: 10.1158/2326-6066.CIR-18-0709. Epub 2019 Jul 26.
• [182] KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer Cells.Anticancer Res. 2017 Jan;37(1):47-55. doi: 10.21873/anticanres.11287.
• [183] miR-92b-3p Functions As A Key Gene In Esophageal Squamous Cell Cancer As Determined By Co-Expression Analysis.Onco Targets Ther. 2019 Oct 14;12:8339-8353. doi: 10.2147/OTT.S220823. eCollection 2019.
• [184] miR-502 medaited histone methyltransferase SET8 expression is associated with outcome of esophageal squamous cell carcinoma.Sci Rep. 2016 Sep 8;6:32921. doi: 10.1038/srep32921.
• [185] Keratin 17 activates AKT signalling and induces epithelial-mesenchymal transition in oesophageal squamous cell carcinoma.J Proteomics. 2020 Jan 16;211:103557. doi: 10.1016/j.jprot.2019.103557. Epub 2019 Oct 24.
• [186] Altered expression of lysosomal associated membrane protein 1 in esophageal squamous cell carcinoma.Pathol Res Pract. 2017 Aug;213(8):938-942. doi: 10.1016/j.prp.2017.05.008. Epub 2017 May 31.
• [187] High expression of LAMP2 predicts poor prognosis in patients with esophageal squamous cell carcinoma.Cancer Biomark. 2017 Jul 4;19(3):305-311. doi: 10.3233/CBM-160469.
• [188] Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer.Ann Oncol. 2007 Feb;18(2):311-6. doi: 10.1093/annonc/mdl394. Epub 2006 Oct 30.
• [189] Upregulation of the long non-coding RNA PVT1 promotes esophageal squamous cell carcinoma progression by acting as a molecular sponge of miR-203 and LASP1.Oncotarget. 2017 May 23;8(21):34164-34176. doi: 10.18632/oncotarget.15878.
• [190] Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.J Exp Clin Cancer Res. 2017 Nov 16;36(1):161. doi: 10.1186/s13046-017-0622-1.
• [191] Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer.Cancer Sci. 2019 May;110(5):1705-1714. doi: 10.1111/cas.13995. Epub 2019 Apr 5.
• [192] B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma.Hum Pathol. 2018 Oct;80:152-162. doi: 10.1016/j.humpath.2018.05.021. Epub 2018 Jun 6.
• [193] Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma.Cell Oncol (Dordr). 2011 Jun;34(3):177-87. doi: 10.1007/s13402-011-0011-2. Epub 2011 Mar 11.
• [194] MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.Biomed Pharmacother. 2019 Jan;109:751-761. doi: 10.1016/j.biopha.2018.09.110. Epub 2018 Nov 5.
• [195] Lin28/microRNA-let-7a promotes metastasis under circumstances of hyperactive Wnt signaling in esophageal squamous cell carcinoma.Mol Med Rep. 2018 Apr;17(4):5265-5271. doi: 10.3892/mmr.2018.8548. Epub 2018 Feb 2.
• [196] Overexpression of Pim-1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma.J Surg Oncol. 2010 Nov 1;102(6):683-8. doi: 10.1002/jso.21627.
• [197] LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.Cancer Res. 2019 Oct 1;79(19):4951-4964. doi: 10.1158/0008-5472.CAN-19-0860. Epub 2019 Aug 13.
• [198] Cigarette smoke induces promoter methylation of single-stranded DNA-binding protein 2 in human esophageal squamous cell carcinoma.Int J Cancer. 2011 May 15;128(10):2261-73. doi: 10.1002/ijc.25569.
• [199] Serological antibodies against LY6K as a diagnostic biomarker in esophageal squamous cell carcinoma.Biomarkers. 2012 Jun;17(4):372-8. doi: 10.3109/1354750X.2012.680609. Epub 2012 Apr 19.
• [200] The expression of high mobility group box 1 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.Pathol Oncol Res. 2012 Oct;18(4):1021-7. doi: 10.1007/s12253-012-9539-3. Epub 2012 Apr 29.
• [201] Expressions of melanoma-associated antigen A1 as a prognostic factor in Chinese patients with resectable oesophageal squamous cell carcinoma.Interact Cardiovasc Thorac Surg. 2019 Oct 1;29(4):510-516. doi: 10.1093/icvts/ivz141.
• [202] Efficient induction of anti-tumor immune response in esophageal squamous cell carcinoma via dendritic cells expressing MAGE-A3 and CALR antigens.Cell Immunol. 2015 Jun;295(2):77-82. doi: 10.1016/j.cellimm.2015.03.011. Epub 2015 Apr 4.
• [203] [ARTICLE WITHDRAWN] MicroRNA-539 Inhibits the Epithelial-Mesenchymal Transition of Esophageal Cancer Cells by Twist-Related Protein 1-Mediated Modulation of Melanoma-Associated Antigen A4.Oncol Res. 2018 May 7;26(4):529-536. doi: 10.3727/096504017X14972679378357. Epub 2017 Jun 12.
• [204] Investigation into the expression levels of MAGEA6 in esophageal squamous cell carcinoma and esophageal adenocarcinoma tissues.Exp Ther Med. 2019 Sep;18(3):1816-1822. doi: 10.3892/etm.2019.7735. Epub 2019 Jul 5.
• [205] Polymorphic variation of the ARP gene on 3p21 in Japanese esophageal cancer patients.Oncol Rep. 2000 May-Jun;7(3):591-3. doi: 10.3892/or.7.3.591.
• [206] MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway.Carcinogenesis. 2020 Sep 24;41(9):1263-1272. doi: 10.1093/carcin/bgz200.
• [207] MicroRNA-148a regulates the MAPK/ERK signaling pathway and suppresses the development of esophagus squamous cell carcinoma via targeting MAP3K9.Eur Rev Med Pharmacol Sci. 2019 Aug;23(15):6497-6504. doi: 10.26355/eurrev_201908_18533.
• [208] Microtubule-associated protein 4 is an important regulator of cell invasion/migration and a potential therapeutic target in esophageal squamous cell carcinoma.Oncogene. 2016 Sep 15;35(37):4846-56. doi: 10.1038/onc.2016.17. Epub 2016 Feb 15.
• [209] Licochalcone H Synthesized by Modifying Structure of Licochalcone C Extracted from Glycyrrhiza inflata Induces Apoptosis of Esophageal Squamous Cell Carcinoma Cells.Cell Biochem Biophys. 2020 Mar;78(1):65-76. doi: 10.1007/s12013-019-00892-3. Epub 2019 Nov 9.
• [210] Clinical significance of mannose-binding lectin-associated serine protease-2 expression in esophageal squamous cell carcinoma.Int J Cancer. 2006 Jun 15;118(12):2930-5. doi: 10.1002/ijc.21721.
• [211] Pemetrexed exerts anticancer effects by inducing G(0)/G(1)-phase cell cycle arrest and activating the NOXA/Mcl-1 axis in human esophageal squamous cell carcinoma cells.Oncol Lett. 2019 Feb;17(2):1851-1858. doi: 10.3892/ol.2018.9753. Epub 2018 Nov 23.
• [212] MCM7 amplification and overexpression promote cell proliferation, colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1/mTOR signaling pathway.Oncol Rep. 2017 Jun;37(6):3590-3596. doi: 10.3892/or.2017.5614. Epub 2017 May 2.
• [213] miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway.Cancer Cell Int. 2019 Sep 30;19:250. doi: 10.1186/s12935-019-0943-6. eCollection 2019.
• [214] Immunoregulatory influence of abundant MFG-E8 expression by esophageal cancer treated with chemotherapy.Cancer Sci. 2018 Nov;109(11):3393-3402. doi: 10.1111/cas.13785. Epub 2018 Sep 22.
• [215] Promoter methylation of MGMT gene in serum of patients with esophageal squamous cell carcinoma in North East India.Asian Pac J Cancer Prev. 2014;15(22):9955-60. doi: 10.7314/apjcp.2014.15.22.9955.
• [216] Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.Dis Esophagus. 2012 Sep-Oct;25(7):656-63. doi: 10.1111/j.1442-2050.2011.01284.x. Epub 2011 Nov 28.
• [217] SDR9C7 promotes lymph node metastases in patients with esophageal squamous cell carcinoma.PLoS One. 2013;8(1):e52184. doi: 10.1371/journal.pone.0052184. Epub 2013 Jan 14.
• [218] Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.Int J Oncol. 2016 Dec;49(6):2255-2264. doi: 10.3892/ijo.2016.3745. Epub 2016 Oct 21.
• [219] High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.J Exp Clin Cancer Res. 2017 Jun 23;36(1):84. doi: 10.1186/s13046-017-0555-8.
• [220] MT3-MMP down-regulation promotes tumorigenesis and correlates to poor prognosis in esophageal squamous cell carcinoma.Cancer Med. 2016 Sep;5(9):2459-68. doi: 10.1002/cam4.790. Epub 2016 Jun 12.
• [221] BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese.Int J Cancer. 2020 Feb 15;146(4):1042-1051. doi: 10.1002/ijc.32619. Epub 2019 Aug 26.
• [222] WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma.Cell Mol Biol Lett. 2018 Sep 3;23:42. doi: 10.1186/s11658-018-0109-x. eCollection 2018.
• [223] Msi2 plays a carcinogenic role in esophageal squamous cell carcinoma via regulation of the Wnt/-catenin and Hedgehog signaling pathways.Exp Cell Res. 2017 Dec 1;361(1):170-177. doi: 10.1016/j.yexcr.2017.10.016. Epub 2017 Oct 18.
• [224] Genetic variants at 9p21.3 are associated with risk of esophageal squamous cell carcinoma in a Chinese population.Cancer Sci. 2017 Feb;108(2):250-255. doi: 10.1111/cas.13130.
• [225] Polymorphisms in methionine synthase (A2756G) and cystathionine beta-synthase (844ins68) and susceptibility to carcinomas of the upper gastrointestinal tract.J Cancer Res Clin Oncol. 2008 Mar;134(3):405-10. doi: 10.1007/s00432-007-0301-2. Epub 2007 Aug 29.
• [226] Downregulation of MUTYH contributes to cisplatinresistance of esophageal squamous cell carcinoma cells by promoting Twistmediated EMT.Oncol Rep. 2019 Dec;42(6):2716-2727. doi: 10.3892/or.2019.7347. Epub 2019 Oct 1.
• [227] The implications and mechanisms of the extra-nuclear nucleolin in the esophageal squamous cell carcinomas.Med Oncol. 2015 Mar;32(3):45. doi: 10.1007/s12032-015-0484-3. Epub 2015 Jan 29.
• [228] A novel Myc-target gene, mimitin, that is involved in cell proliferation of esophageal squamous cell carcinoma.J Biol Chem. 2005 May 20;280(20):19977-85. doi: 10.1074/jbc.M501231200. Epub 2005 Mar 17.
• [229] Neddylation inhibitor MLN4924 induces G(2) cell cycle arrest, DNA damage and sensitizes esophageal squamous cell carcinoma cells to cisplatin.Oncol Lett. 2018 Feb;15(2):2583-2589. doi: 10.3892/ol.2017.7616. Epub 2017 Dec 14.
• [230] Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma. Oncogene. 2007 Sep 20;26(43):6332-40. doi: 10.1038/sj.onc.1210461. Epub 2007 Apr 23.
• [231] Expression and clinical significance of p75NTR in esophageal squamous cell carcinoma.Math Biosci Eng. 2019 Sep 5;16(6):8060-8068. doi: 10.3934/mbe.2019405.
• [232] miR-4319 Suppresses the Growth of Esophageal Squamous Cell Carcinoma Via Targeting NLRC5.Curr Mol Pharmacol. 2020;13(2):144-149. doi: 10.2174/1874467212666191119094636.
• [233] Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for overall survival in patients with clinical Stage II/III esophageal squamous cell carcinoma (JCOG1406-A).Jpn J Clin Oncol. 2017 Jun 1;47(6):480-486. doi: 10.1093/jjco/hyx040.
• [234] Comparative proteomic analysis of beta-catenin-mediated malignant progression of esophageal squamous cell carcinoma.Dis Esophagus. 2010 Feb;23(2):175-84. doi: 10.1111/j.1442-2050.2009.01001.x. Epub 2009 Jul 31.
• [235] MicroRNA-1 suppresses proliferation, migration and invasion by targeting Notch2 in esophageal squamous cell carcinoma.Sci Rep. 2018 Mar 26;8(1):5183. doi: 10.1038/s41598-018-23421-3.
• [236] Expression of natriuretic peptide receptor-A in esophageal squamous cell carcinomas and the relationship with tumor invasion and migration.World J Surg Oncol. 2014 May 21;12:154. doi: 10.1186/1477-7819-12-154.
• [237] Combination treatment with highly bioavailable curcumin and NQO1 inhibitor exhibits potent antitumor effects on esophageal squamous cell carcinoma.J Gastroenterol. 2019 Aug;54(8):687-698. doi: 10.1007/s00535-019-01549-x. Epub 2019 Feb 8.
• [238] NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.Scand J Gastroenterol. 2014 Mar;49(3):317-22. doi: 10.3109/00365521.2013.873819. Epub 2013 Dec 19.
• [239] Genetic variants in nucleotide excision repair pathway predict survival of esophageal squamous cell cancer patients receiving platinum-based chemotherapy.Mol Carcinog. 2018 Nov;57(11):1553-1565. doi: 10.1002/mc.22877. Epub 2018 Aug 12.
• [240] Neuropilin-2 promotes tumourigenicity and metastasis in oesophageal squamous cell carcinoma through ERK-MAPK-ETV4-MMP-E-cadherin deregulation.J Pathol. 2016 Jul;239(3):309-19. doi: 10.1002/path.4728. Epub 2016 May 5.
• [241] Ornithine decarboxylase inhibition downregulates multiple pathways involved in the formation of precancerous lesions of esophageal squamous cell cancer.Mol Carcinog. 2020 Feb;59(2):215-226. doi: 10.1002/mc.23144. Epub 2019 Dec 3.
• [242] Effect of hOGG1 over-expression on cisplatin resistance in esophageal squamous carcinoma cells.Cancer Biother Radiopharm. 2013 Jul-Aug;28(6):433-40. doi: 10.1089/cbr.2012.1287. Epub 2013 Jun 27.
• [243] Selective inhibitory effects of zinc on cell proliferation in esophageal squamous cell carcinoma through Orai1.FASEB J. 2018 Jan;32(1):404-416. doi: 10.1096/fj.201700227RRR. Epub 2017 Sep 19.
• [244] Expression and prognostic roles of PABPC1 in esophageal cancer: correlation with tumor progression and postoperative survival.Oncol Rep. 2006 Mar;15(3):667-71.
• [245] PADI4 stimulates esophageal squamous cell carcinoma tumor growth and up-regulates CA9 expression.Mol Carcinog. 2019 Jan;58(1):66-75. doi: 10.1002/mc.22907. Epub 2018 Oct 21.
• [246] Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case-control study from Iran.Genet Mol Res. 2010 Feb 9;9(1):239-49. doi: 10.4238/vol9-1gmr693.
• [247] Clinical relevance of PD-L1 and PD-L2 overexpression in patients with esophageal squamous cell carcinoma.J Thorac Dis. 2018 Jul;10(7):4433-4444. doi: 10.21037/jtd.2018.06.167.
• [248] Down-regulation of platelet-derived growth factor-D expression blockades NF-B pathway to inhibit cell proliferation and invasion as well as induce apoptosis in esophageal squamous cell carcinoma.Mol Biol Rep. 2013 Mar;40(3):2473-83. doi: 10.1007/s11033-012-2328-y. Epub 2012 Nov 28.
• [249] Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro.Med Oncol. 2014 Dec;31(12):337. doi: 10.1007/s12032-014-0337-5. Epub 2014 Nov 22.
• [250] Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma.Oncol Rep. 2007 Apr;17(4):753-60.
• [251] Promoter methylation and expression of Raf kinase inhibitory protein in esophageal squamous cell carcinoma.Oncol Lett. 2017 Mar;13(3):1866-1872. doi: 10.3892/ol.2017.5617. Epub 2017 Jan 18.
• [252] APC/C-CDH1-Regulated IDH3 Coordinates with the Cell Cycle to Promote Cell Proliferation.Cancer Res. 2019 Jul 1;79(13):3281-3293. doi: 10.1158/0008-5472.CAN-18-2341. Epub 2019 May 3.
• [253] Expression of PGDH correlates with cell growth in both esophageal squamous cell carcinoma and adenocarcinoma.Asian Pac J Cancer Prev. 2015;16(3):997-1000. doi: 10.7314/apjcp.2015.16.3.997.
• [254] Pseudogene PHBP1 promotes esophageal squamous cell carcinoma proliferation by increasing its cognate gene PHB expression.Oncotarget. 2017 Apr 25;8(17):29091-29100. doi: 10.18632/oncotarget.16196.
• [255] Downregulation of microRNA-370 in esophageal squamous-cell carcinoma is associated with cancer progression and promotes cancer cell proliferation via upregulating PIN1.Gene. 2018 Jun 30;661:68-77. doi: 10.1016/j.gene.2018.03.090. Epub 2018 Mar 29.
• [256] PKM2-regulated STAT3 promotes esophageal squamous cell carcinoma progression via TGF-1-induced EMT.J Cell Biochem. 2019 Jul;120(7):11539-11550. doi: 10.1002/jcb.28434. Epub 2019 Feb 12.
• [257] Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma.Cancer Manag Res. 2019 Aug 19;11:7813-7824. doi: 10.2147/CMAR.S214243. eCollection 2019.
• [258] Association of serum annexin A1 with treatment response and prognosis in patients with esophageal squamous cell carcinoma.J Cancer Res Ther. 2018 Sep;14(Supplement):S667-S674. doi: 10.4103/0973-1482.187297.
• [259] A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma.EBioMedicine. 2019 Mar;41:244-255. doi: 10.1016/j.ebiom.2019.02.012. Epub 2019 Mar 12.
• [260] Association of ECRG4 with PLK1, CDK4, PLOD1 and PLOD2 in esophageal squamous cell carcinoma.Am J Transl Res. 2017 Aug 15;9(8):3741-3748. eCollection 2017.
• [261] DNA polymerase mutations and survival of patients with esophageal squamous cell carcinoma in Linzhou City, China.Tumour Biol. 2014 Jan;35(1):553-9. doi: 10.1007/s13277-013-1077-4.
• [262] PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma.Tumour Biol. 2016 Oct;37(10):13799-13809. doi: 10.1007/s13277-016-5193-9. Epub 2016 Aug 1.
• [263] Protein kinase D1mRNA level may predict cancer-specific survival in heavy smokers with esophageal squamous cell cancers.Dis Esophagus. 2014 Feb-Mar;27(2):188-95. doi: 10.1111/dote.12077. Epub 2013 Apr 26.
• [264] MicroRNA-488-3p inhibits proliferation and induces apoptosis by targeting ZBTB2 in esophageal squamous cell carcinoma.J Cell Biochem. 2019 Nov;120(11):18702-18713. doi: 10.1002/jcb.29178. Epub 2019 Jun 26.
• [265] PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation.Cell Death Dis. 2019 May 1;10(5):359. doi: 10.1038/s41419-019-1595-0.
• [266] PRSS8 methylation and its significance in esophageal squamous cell carcinoma.Oncotarget. 2016 May 10;7(19):28540-55. doi: 10.18632/oncotarget.8677.
• [267] Genetic variants at 8q24 are associated with risk of esophageal squamous cell carcinoma in a Chinese population.Cancer Sci. 2014 Jun;105(6):731-5. doi: 10.1111/cas.12399. Epub 2014 Apr 13.
• [268] Genetic variability in LMP2 and LMP7 is associated with the risk of esophageal squamous cell carcinoma in the Kazakh population but is not associated with HPV infection.PLoS One. 2017 Oct 26;12(10):e0186319. doi: 10.1371/journal.pone.0186319. eCollection 2017.
• [269] Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis.Carcinogenesis. 2010 Mar;31(3):427-34. doi: 10.1093/carcin/bgp326. Epub 2009 Dec 30.
• [270] The arachidonic acid metabolism protein-protein interaction network and its expression pattern in esophageal diseases.Am J Transl Res. 2018 Mar 15;10(3):907-924. eCollection 2018.
• [271] Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment.Mol Carcinog. 2018 Jan;57(1):78-88. doi: 10.1002/mc.22733. Epub 2017 Oct 9.
• [272] Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF.FASEB J. 2019 Nov;33(11):12960-12971. doi: 10.1096/fj.201900932R. Epub 2019 Sep 18.
• [273] Expression of phosphatase of regenerating liver 1 and 3 mRNA in esophageal squamous cell carcinoma.Arch Pathol Lab Med. 2008 Aug;132(8):1307-12. doi: 10.5858/2008-132-1307-EOPORL.
• [274] RACKI induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression.Onco Targets Ther. 2018 Jan 4;11:211-220. doi: 10.2147/OTT.S152818. eCollection 2018.
• [275] HiFreSP: A novel high-frequency sub-pathway mining approach to identify robust prognostic gene signatures.Brief Bioinform. 2020 Jul 15;21(4):1411-1424. doi: 10.1093/bib/bbz078.
• [276] 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone induces retinoic acid receptor hypermethylation through DNA methyltransferase 1 accumulation in esophageal squamous epithelial cells.Asian Pac J Cancer Prev. 2012;13(5):2207-12. doi: 10.7314/apjcp.2012.13.5.2207.
• [277] Promoter hypermethylation of the RECK gene is associated with its low expression and poor survival of esophageal squamous cell carcinoma.Oncol Lett. 2017 Mar;13(3):1911-1918. doi: 10.3892/ol.2017.5656. Epub 2017 Jan 27.
• [278] RHCG Suppresses Tumorigenicity and Metastasis in Esophageal Squamous Cell Carcinoma via Inhibiting NF-B Signaling and MMP1 Expression.Theranostics. 2018 Jan 1;8(1):185-198. doi: 10.7150/thno.21383. eCollection 2018.
• [279] RICTOR expression in esophageal squamous cell carcinoma and its clinical significance.Med Oncol. 2017 Mar;34(3):32. doi: 10.1007/s12032-017-0894-5. Epub 2017 Jan 28.
• [280] Identification of somatic mutations of the RNF6 gene in human esophageal squamous cell carcinoma.Cancer Res. 2002 Aug 1;62(15):4191-3.
• [281] miR-1179 promotes cell invasion through SLIT2/ROBO1 axis in esophageal squamous cell carcinoma.Int J Clin Exp Pathol. 2015 Jan 1;8(1):319-27. eCollection 2015.
• [282] Lapachol is a novel ribosomal protein S6 kinase 2 inhibitor that suppresses growth and induces intrinsic apoptosis in esophageal squamous cell carcinoma cells.Phytother Res. 2019 Sep;33(9):2337-2346. doi: 10.1002/ptr.6415. Epub 2019 Jun 21.
• [283] An Association and Meta-Analysis of Esophageal Squamous Cell Carcinoma Risk Associated with PLCE1 rs2274223, C20orf54 rs13042395 and RUNX1 rs2014300 Polymorphisms.Pathol Oncol Res. 2020 Apr;26(2):681-692. doi: 10.1007/s12253-019-00579-3. Epub 2019 Jan 21.
• [284] Effect and mechanism of RUNX3 gene on biological characteristics of human esophageal squamous cell carcinoma (ESCC).Med Oncol. 2015 Jan;32(1):357. doi: 10.1007/s12032-014-0357-1. Epub 2014 Nov 27.
• [285] The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma.PLoS One. 2014 Jun 19;9(6):e99955. doi: 10.1371/journal.pone.0099955. eCollection 2014.
• [286] S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.J Exp Clin Cancer Res. 2019 Aug 22;38(1):369. doi: 10.1186/s13046-019-1369-7.
• [287] Special AT-rich sequence binding protein 1 promotes tumor growth and metastasis of esophageal squamous cell carcinoma.Tumour Biol. 2017 Mar;39(3):1010428317694537. doi: 10.1177/1010428317694537.
• [288] Prognostic significance of altered expression of SDC2 and CYR61 in esophageal squamous cell carcinoma.Oncol Rep. 2009 Apr;21(4):1123-9. doi: 10.3892/or_00000332.
• [289] SEMA4D under the posttranscriptional regulation of HuR and miR-4319 boosts cancer progression in esophageal squamous cell carcinoma.Cancer Biol Ther. 2020;21(2):122-129. doi: 10.1080/15384047.2019.1669996. Epub 2019 Oct 25.
• [290] Association between SNPs in Serpin gene family and risk of esophageal squamous cell carcinoma.Tumour Biol. 2015 Aug;36(8):6231-8. doi: 10.1007/s13277-015-3308-3. Epub 2015 Mar 17.
• [291] Overexpression of HSP47 in esophageal squamous cell carcinoma: clinical implications and functional analysis.Dis Esophagus. 2016 Oct;29(7):848-855. doi: 10.1111/dote.12359. Epub 2015 May 8.
• [292] Role of the Na ?K ?2Cl?cotransporter NKCC1 in cell cycle progression in human esophageal squamous cell carcinoma.World J Gastroenterol. 2014 Jun 14;20(22):6844-59. doi: 10.3748/wjg.v20.i22.6844.
• [293] Prognostic value of monocarboxylate transporter 4 in patients with esophageal squamous cell carcinoma.Oncol Rep. 2018 Nov;40(5):2906-2915. doi: 10.3892/or.2018.6706. Epub 2018 Sep 13.
• [294] Genetic polymorphisms in SLC23A2 as predictive biomarkers of severe acute toxicities after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.Int J Med Sci. 2014 Feb 7;11(4):321-6. doi: 10.7150/ijms.7654. eCollection 2014.
• [295] Circ-SLC7A5, a potential prognostic circulating biomarker for detection of ESCC.Cancer Genet. 2020 Jan;240:33-39. doi: 10.1016/j.cancergen.2019.11.001. Epub 2019 Nov 5.
• [296] Na+/H+ exchanger 1 has tumor suppressive activity and prognostic value in esophageal squamous cell carcinoma.Oncotarget. 2017 Jan 10;8(2):2209-2223. doi: 10.18632/oncotarget.13645.
• [297] SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.Hum Pathol. 2016 Mar;49:145-55. doi: 10.1016/j.humpath.2015.08.025. Epub 2015 Nov 4.
• [298] Long noncoding RNA CASC2 suppresses esophageal squamous cell carcinoma progression by increasing SOCS1 expression.Cell Biosci. 2019 Nov 9;9:90. doi: 10.1186/s13578-019-0353-4. eCollection 2019.
• [299] Regulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma.J Hum Genet. 2017 Nov;62(11):935-944. doi: 10.1038/jhg.2017.69. Epub 2017 Jun 29.
• [300] SREBP2 is upregulated in esophageal squamous cell carcinoma and cooperates with cMyc to regulate HMGCR expression.Mol Med Rep. 2019 Oct;20(4):3003-3010. doi: 10.3892/mmr.2019.10577. Epub 2019 Aug 9.
• [301] Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.Nat Genet. 2012 Oct;44(10):1090-7. doi: 10.1038/ng.2411. Epub 2012 Sep 9.
• [302] The crucial role of SRPK1 in TGF--induced proliferation and apoptosis in the esophageal squamous cell carcinomas.Med Oncol. 2015 Jul;32(7):209. doi: 10.1007/s12032-015-0654-3. Epub 2015 Jun 23.
• [303] Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma: correlation with clinicopathological parameters.Dis Esophagus. 2006;19(6):482-6. doi: 10.1111/j.1442-2050.2006.00613.x.
• [304] MLL2 promotes cancer cell lymph node metastasis by interacting with RelA and facilitating STC1 transcription.Cell Signal. 2020 Jan;65:109457. doi: 10.1016/j.cellsig.2019.109457. Epub 2019 Oct 30.
• [305] Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.Clin Cancer Res. 2006 Mar 1;12(5):1639-46. doi: 10.1158/1078-0432.CCR-05-1858.
• [306] Clinical significance of LOXL4 expression and features of LOXL4-associated protein-protein interaction network in esophageal squamous cell carcinoma.Amino Acids. 2019 May;51(5):813-828. doi: 10.1007/s00726-019-02723-4. Epub 2019 Mar 21.
• [307] Identification of PA28 as a potential novel biomarker in human esophageal squamous cell carcinoma.Tumour Biol. 2017 Oct;39(10):1010428317719780. doi: 10.1177/1010428317719780.
• [308] The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma.J Gastroenterol Hepatol. 2016 Feb;31(2):384-93. doi: 10.1111/jgh.13180.
• [309] Association between the genetic variations within TBX21 gene promoter and the clinicopathological characteristics of esophageal squamous cell carcinoma in a high-risk Chinese population.Tumour Biol. 2015 May;36(5):3985-93. doi: 10.1007/s13277-015-3042-x. Epub 2015 Jan 11.
• [310] TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.Oncology. 2018;95(5):297-308. doi: 10.1159/000490725. Epub 2018 Aug 22.
• [311] Expression and mechanism of PinX1 and telomerase activity in the carcinogenesis of esophageal epithelial cells.Oncol Rep. 2013 Oct;30(4):1823-31. doi: 10.3892/or.2013.2649. Epub 2013 Aug 1.
• [312] TFF1 hypermethylation and decreased expression in esophageal squamous cell carcinoma and histologically normal tumor surrounding esophageal cells.Clin Epigenetics. 2017 Dec 20;9:130. doi: 10.1186/s13148-017-0429-0. eCollection 2017.
• [313] Concordant promoter methylation of transforming growth factor-beta receptor types I and II occurs early in esophageal squamous cell carcinoma.Am J Med Sci. 2012 May;343(5):375-81. doi: 10.1097/MAJ.0b013e3182253430.
• [314] THRB genetic polymorphisms can predict severe myelotoxicity after definitive chemoradiotherapy in patients with esophageal squamous cell carcinoma.Int J Med Sci. 2012;9(9):748-56. doi: 10.7150/ijms.5081. Epub 2012 Oct 23.
• [315] Tumor-suppressive microRNA-10a inhibits cell proliferation and metastasis by targeting Tiam1 in esophageal squamous cell carcinoma.J Cell Biochem. 2019 May;120(5):7845-7857. doi: 10.1002/jcb.28059. Epub 2018 Nov 13.
• [316] The analyses of SRCR genes based on protein-protein interaction network in esophageal squamous cell carcinoma.Am J Transl Res. 2019 May 15;11(5):2683-2705. eCollection 2019.
• [317] Thymosin 4 expression in human tissues and in tumors using tissue microarrays.Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):160-7. doi: 10.1097/PAI.0b013e3181f12237.
• [318] Neddylation Inhibition Activates the Extrinsic Apoptosis Pathway through ATF4-CHOP-DR5 Axis in Human Esophageal Cancer Cells.Clin Cancer Res. 2016 Aug 15;22(16):4145-57. doi: 10.1158/1078-0432.CCR-15-2254. Epub 2016 Mar 16.
• [319] Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma.Cancer. 2014 Mar 15;120(6):808-17. doi: 10.1002/cncr.28491. Epub 2013 Nov 18.
• [320] Clinical significance of tumor necrosis factor receptor 2 in middle and lower thoracic esophageal squamous cell carcinoma.Oncol Lett. 2018 Sep;16(3):2971-2978. doi: 10.3892/ol.2018.8998. Epub 2018 Jun 20.
• [321] Clinical significance and prognostic value of TRIM24 expression in esophageal squamous cell carcinoma.Aging (Albany NY). 2016 Sep 28;8(9):2204-2221. doi: 10.18632/aging.101037.
• [322] TRIM27 promotes the development of esophagus cancer via regulating PTEN/AKT signaling pathway.Cancer Cell Int. 2019 Nov 8;19:283. doi: 10.1186/s12935-019-0998-4. eCollection 2019.
• [323] Expression and Significance of TRIM 28 in Squamous Carcinoma of Esophagus.Pathol Oncol Res. 2019 Oct;25(4):1645-1652. doi: 10.1007/s12253-018-0558-6. Epub 2018 Nov 27.
• [324] Study on the role of transient receptor potential C6 channels in esophageal squamous cell carcinoma radiosensitivity.J Thorac Dis. 2017 Oct;9(10):3802-3809. doi: 10.21037/jtd.2017.09.108.
• [325] Transient Receptor Potential Melastatin 7 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma.Anticancer Res. 2017 Mar;37(3):1161-1167. doi: 10.21873/anticanres.11429.
• [326] The TRPV2 cation channels: from urothelial cancer invasiveness to glioblastoma multiforme interactome signature.Lab Invest. 2020 Feb;100(2):186-198. doi: 10.1038/s41374-019-0333-7. Epub 2019 Oct 25.
• [327] TRPV6 plays a new role in predicting survival of patients with esophageal squamous cell carcinoma.Diagn Pathol. 2016 Jan 27;11:14. doi: 10.1186/s13000-016-0457-7.
• [328] Identification of distinct gene expression profiles between esophageal squamous cell carcinoma and adjacent normal epithelial tissues.Tohoku J Exp Med. 2012 Apr;226(4):301-11. doi: 10.1620/tjem.226.301.
• [329] TUSC2P suppresses the tumor function of esophageal squamous cell carcinoma by regulating TUSC2 expression and correlates with disease prognosis.BMC Cancer. 2018 Sep 15;18(1):894. doi: 10.1186/s12885-018-4804-9.
• [330] Thymidine phosphorylase and angiogenesis in early stage esophageal squamous cell carcinoma.Esophagus. 2018 Jan;15(1):19-26. doi: 10.1007/s10388-017-0588-2. Epub 2017 Jul 24.
• [331] Deubiquitylatinase inhibitor b-AP15 induces c-Myc-Noxa-mediated apoptosis in esophageal squamous cell carcinoma.Apoptosis. 2019 Oct;24(9-10):826-836. doi: 10.1007/s10495-019-01561-9.
• [332] The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma.J Mol Med (Berl). 2009 Mar;87(3):307-20. doi: 10.1007/s00109-008-0430-3. Epub 2008 Dec 16.
• [333] Intensive expression of UNC-51-like kinase 1 is a novel biomarker of poor prognosis in patients with esophageal squamous cell carcinoma.Cancer Sci. 2011 Aug;102(8):1568-75. doi: 10.1111/j.1349-7006.2011.01964.x. Epub 2011 May 31.
• [334] High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus.Oncology. 2009;76(5):342-9. doi: 10.1159/000209964. Epub 2009 Mar 23.
• [335] Targeting the overexpressed USP7 inhibits esophageal squamous cell carcinoma cell growth by inducing NOXA-mediated apoptosis.Mol Carcinog. 2019 Jan;58(1):42-54. doi: 10.1002/mc.22905. Epub 2018 Sep 21.
• [336] Targeting valosin-containing protein enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma.Cancer Sci. 2019 Nov;110(11):3464-3475. doi: 10.1111/cas.14184. Epub 2019 Sep 13.
• [337] WASH overexpression enhances cancer stem cell properties and correlates with poor prognosis of esophageal carcinoma.Cancer Sci. 2017 Dec;108(12):2358-2365. doi: 10.1111/cas.13400. Epub 2017 Sep 26.
• [338] Transcriptional and posttranscriptional regulation of HOXA13 by lncRNA HOTTIP facilitates tumorigenesis and metastasis in esophageal squamous carci... Oncogene. 2017 Sep 21;36(38):5392-5406.
• [339] Targeting TRIM3 deletion-induced tumor-associated lymphangiogenesis prohibits lymphatic metastasis in esophageal squamous cell carcinoma.Oncogene. 2019 Apr;38(15):2736-2749. doi: 10.1038/s41388-018-0621-5. Epub 2018 Dec 12.
• [340] X-linked inhibitor of apoptosis protein accelerates migration by inducing epithelial-mesenchymal transition through TGF- signaling pathway in esophageal cancer cells.Cell Biosci. 2019 Sep 18;9:76. doi: 10.1186/s13578-019-0338-3. eCollection 2019.
• [341] Clinical values of Ku80 upregulation in superficial esophageal squamous cell carcinoma.Cancer Med. 2018 Apr;7(4):1006-1018. doi: 10.1002/cam4.1314. Epub 2018 Mar 13.
• [342] Correlation of CT texture changes with treatment response during radiation therapy for esophageal cancer: An exploratory study.PLoS One. 2019 Sep 26;14(9):e0223140. doi: 10.1371/journal.pone.0223140. eCollection 2019.
• [343] Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.J Proteome Res. 2011 Jun 3;10(6):2863-72. doi: 10.1021/pr200141c. Epub 2011 May 3.
• [344] ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma.Oncotarget. 2014 Sep 30;5(18):8569-82. doi: 10.18632/oncotarget.2322.
• [345] Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression.Cancer Sci. 2012 Jun;103(6):1145-54. doi: 10.1111/j.1349-7006.2012.02252.x. Epub 2012 Apr 3.
• [346] Expression of Hsp90 and cyclin B1 were related to prognosis of esophageal squamous cell carcinoma and keratin pearl formation.Int J Clin Exp Pathol. 2014 Mar 15;7(4):1544-52. eCollection 2014.
• [347] Overexpression of CDC25B and LAMC2 mRNA and protein in esophageal squamous cell carcinomas and premalignant lesions in subjects from a high-risk population in China.Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1424-35. doi: 10.1158/1055-9965.EPI-06-0666.
• [348] EGF-induced C/EBP participates in EMT by decreasing the expression of miR-203 in esophageal squamous cell carcinoma cells.J Cell Sci. 2014 Sep 1;127(Pt 17):3735-44. doi: 10.1242/jcs.148759. Epub 2014 Jul 2.
• [349] Prognostic significance of desmoglein 2 and desmoglein 3 in esophageal squamous cell carcinoma.Asian Pac J Cancer Prev. 2014;15(2):871-6. doi: 10.7314/apjcp.2014.15.2.871.
• [350] The 4E-BP1/eIF4E ratio is a determinant for rapamycin response in esophageal cancer cells.J Thorac Cardiovasc Surg. 2015 Jan;149(1):378-85. doi: 10.1016/j.jtcvs.2014.09.047. Epub 2014 Sep 18.
• [351] Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma.Oncotarget. 2015 Sep 22;6(28):26079-89. doi: 10.18632/oncotarget.4581.
• [352] Down-regulation of EphB4 phosphorylation is necessary for esophageal squamous cell carcinoma tumorigenecity.Tumour Biol. 2014 Jul;35(7):7225-32. doi: 10.1007/s13277-014-1955-4. Epub 2014 Apr 27.
• [353] Ets2 knockdown inhibits tumorigenesis in esophageal squamous cell carcinoma in vivo and in vitro.Oncotarget. 2016 Sep 20;7(38):61458-61468. doi: 10.18632/oncotarget.11369.
• [354] Analysis of HAX-1 gene expression in esophageal squamous cell carcinoma.Diagn Pathol. 2013 Mar 25;8:47. doi: 10.1186/1746-1596-8-47.
• [355] TGF-1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma.Oncotarget. 2015 Feb 10;6(4):2120-33. doi: 10.18632/oncotarget.2940.
• [356] The impact of pri-miR-218 rs11134527 on the risk and prognosis of patients with esophageal squamous cell carcinoma.Int J Clin Exp Pathol. 2014 Aug 15;7(9):6206-12. eCollection 2014.
• [357] MSH2 promoter hypermethylation in circulating tumor DNA is a valuable predictor of disease-free survival for patients with esophageal squamous cell carcinoma.Eur J Surg Oncol. 2012 Apr;38(4):326-32. doi: 10.1016/j.ejso.2012.01.008. Epub 2012 Jan 23.
• [358] Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.Cancer Med. 2015 Mar;4(3):437-46. doi: 10.1002/cam4.401. Epub 2015 Jan 26.
• [359] Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness.Cancer Med. 2016 Dec;5(12):3500-3511. doi: 10.1002/cam4.884. Epub 2016 Oct 26.
• [360] The histone demethylase PHF8 is an oncogenic protein in human non-small cell lung cancer.Biochem Biophys Res Commun. 2014 Aug 15;451(1):119-25. doi: 10.1016/j.bbrc.2014.07.076. Epub 2014 Jul 24.
• [361] The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas.J Pathol. 2013 Apr;229(5):765-74. doi: 10.1002/path.4163. Epub 2013 Feb 22.
• [362] Overexpression of phospholipase A2 Group IIA in esophageal squamous cell carcinoma and association with cyclooxygenase-2 expression.Asian Pac J Cancer Prev. 2014;15(21):9417-21. doi: 10.7314/apjcp.2014.15.21.9417.
• [363] Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma.Med Oncol. 2014 Dec;31(12):317. doi: 10.1007/s12032-014-0317-9. Epub 2014 Nov 7.
• [364] Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma.Int J Cancer. 2010 Aug 1;127(3):543-54. doi: 10.1002/ijc.25082.
• [365] Abnormalities of chromosome 17 in oesophageal cancer.J Clin Pathol. 2007 Sep;60(9):990-4. doi: 10.1136/jcp.2006.042416. Epub 2006 Oct 17.
• [366] TKTL1 promotes cell proliferation and metastasis in esophageal squamous cell carcinoma.Biomed Pharmacother. 2015 Aug;74:71-6. doi: 10.1016/j.biopha.2015.07.004. Epub 2015 Aug 3.
• [367] TPX2 expression is associated with cell proliferation and patient outcome in esophageal squamous cell carcinoma.J Gastroenterol. 2014 Aug;49(8):1231-40. doi: 10.1007/s00535-013-0870-6. Epub 2013 Aug 21.
• [368] TRAF6 promoted the metastasis of esophageal squamous cell carcinoma.Tumour Biol. 2014 Jan;35(1):715-21. doi: 10.1007/s13277-013-1098-z. Epub 2013 Sep 13.
• [369] Elevated expression of the nuclear export protein, Crm1 (exportin 1), associates with human oesophageal squamous cell carcinoma.Oncol Rep. 2014 Aug;32(2):730-8. doi: 10.3892/or.2014.3231. Epub 2014 Jun 4.
• [370] Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma.J Cell Biochem. 2020 Feb;121(2):1374-1387. doi: 10.1002/jcb.29373. Epub 2019 Sep 12.
• [371] NGALR is overexpressed and regulated by hypomethylation in esophageal squamous cell carcinoma.Clin Cancer Res. 2008 Dec 1;14(23):7674-81. doi: 10.1158/1078-0432.CCR-08-0420.
• [372] Protein-coding genes combined with long non-coding RNAs predict prognosis in esophageal squamous cell carcinoma patients as a novel clinical multi-dimensional signature.Mol Biosyst. 2016 Oct 18;12(11):3467-3477. doi: 10.1039/c6mb00585c.
• [373] Discovery of deregulation of zinc homeostasis and its associated genes in esophageal squamous cell carcinoma using cDNA microarray.Int J Cancer. 2007 Jan 15;120(2):230-42. doi: 10.1002/ijc.22246.
• [374] Knockdown of zinc transporter ZIP5 (SLC39A5) expression significantly inhibits human esophageal cancer progression.Oncol Rep. 2015 Sep;34(3):1431-9. doi: 10.3892/or.2015.4097. Epub 2015 Jul 1.
• [375] Expression and role of anion exchanger 1 in esophageal squamous cell carcinoma.Oncotarget. 2017 Mar 14;8(11):17921-17935. doi: 10.18632/oncotarget.14900.
• [376] Anion exchanger 2 suppresses cellular movement and has prognostic significance in esophageal squamous cell carcinoma.Oncotarget. 2018 May 25;9(40):25993-26006. doi: 10.18632/oncotarget.25417. eCollection 2018 May 25.
• [377] Prognostic significance of SLC9A9 in patients with resectable esophageal squamous cell carcinoma.Tumour Biol. 2015 Sep;36(9):6797-803. doi: 10.1007/s13277-015-3392-4. Epub 2015 Apr 3.
• [378] No role for glutathione S-transferase genotypes in Caucasian esophageal squamous cell or adenocarcinoma etiology: an European case-control study.BMC Gastroenterol. 2013 Jun 3;13:97. doi: 10.1186/1471-230X-13-97.
• [379] Interaction Between Prediabetes and the ABO Blood Types in Predicting Postsurgical Esophageal Squamous Cell Carcinoma-Specific Mortality: The FIESTA Study.Front Oncol. 2018 Oct 23;8:461. doi: 10.3389/fonc.2018.00461. eCollection 2018.
• [380] Alcohol metabolism and oesophageal cancer: a systematic review of the evidence.Carcinogenesis. 2017 Sep 1;38(9):859-872. doi: 10.1093/carcin/bgx067.
• [381] Expression of ACP6 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.Oncol Rep. 2006 Jun;15(6):1551-5.
• [382] ACSS2/AMPK/PCNA pathwaydriven proliferation and chemoresistance of esophageal squamous carcinoma cells under nutrient stress.Mol Med Rep. 2019 Dec;20(6):5286-5296. doi: 10.3892/mmr.2019.10735. Epub 2019 Oct 9.
• [383] Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma.Esophagus. 2019 Apr;16(2):141-146. doi: 10.1007/s10388-018-0643-7. Epub 2018 Sep 1.
• [384] Impact of alcohol dehydrogenase gene 4 polymorphisms on esophageal squamous cell carcinoma risk in a Chinese population.PLoS One. 2015 Jun 3;10(6):e0127304. doi: 10.1371/journal.pone.0127304. eCollection 2015.
• [385] Alcohol Intake Interacts with Functional Genetic Polymorphisms of Aldehyde Dehydrogenase (ALDH2) and Alcohol Dehydrogenase (ADH) to Increase Esophageal Squamous Cell Cancer Risk.J Thorac Oncol. 2019 Apr;14(4):712-725. doi: 10.1016/j.jtho.2018.12.023. Epub 2019 Jan 9.
• [386] The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate induced esophageal squamous cell carcinoma cell death.Oncotarget. 2016 Apr 19;7(16):21542-55. doi: 10.18632/oncotarget.7775.
• [387] Microsatellite instability in esophageal squamous cell carcinoma is not associated with hMLH1 promoter hypermethylation.Pathol Int. 2003 May;53(5):270-6. doi: 10.1046/j.1440-1827.2003.01478.x.
• [388] Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.Dis Esophagus. 2017 Jun 1;30(6):1-5. doi: 10.1093/dote/dox011.
• [389] Pathway, in silico and tissue-specific expression quantitative analyses of oesophageal squamous cell carcinoma genome-wide association studies data.Int J Epidemiol. 2016 Feb;45(1):206-20. doi: 10.1093/ije/dyv294. Epub 2015 Dec 3.
• [390] Single Nucleotide Polymorphisms in the PTPN1 Gene Are Associated with Susceptibility to Esophageal Squamous Cell Carcinoma: A Case-Control Study in Inner Mongolia, China.Genet Test Mol Biomarkers. 2017 May;21(5):305-311. doi: 10.1089/gtmb.2016.0194. Epub 2017 Mar 13.
• [391] Glutathione S-transferase omega 2 regulates cell growth and the expression of E-cadherin via post-transcriptional down-regulation of -catenin in human esophageal squamous cells.Carcinogenesis. 2020 Jul 14;41(7):875-886. doi: 10.1093/carcin/bgz189.
• [392] Overexpression of leucine aminopeptidase 3 contributes to malignant development of human esophageal squamous cell carcinoma.J Mol Histol. 2014 Jun;45(3):283-92. doi: 10.1007/s10735-014-9566-3. Epub 2014 Jan 30.
• [393] NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study.BMC Cancer. 2015 Mar 18;15:150. doi: 10.1186/s12885-015-1105-4.
• [394] The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma.Int Immunopharmacol. 2017 May;46:75-79. doi: 10.1016/j.intimp.2017.02.027. Epub 2017 Mar 6.
• [395] Downregulation of nicotinamide N-methyltransferase inhibits migration and epithelial-mesenchymal transition of esophageal squamous cell carcinoma via Wnt/-catenin pathway.Mol Cell Biochem. 2019 Oct;460(1-2):93-103. doi: 10.1007/s11010-019-03573-0. Epub 2019 Jul 5.
• [396] Genotypes of CYP1A1,SULT1A1 and SULT1A2 and risk of squamous cell carcinoma of esophagus: outcome of a case-control study from Kashmir, India.Dis Esophagus. 2016 Nov;29(8):937-943. doi: 10.1111/dote.12427. Epub 2015 Oct 12.
• [397] High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk.Int J Oncol. 2012 Jun;40(6):1789-96. doi: 10.3892/ijo.2012.1385. Epub 2012 Feb 22.
• [398] UGT2B17 and miR-224 contribute to hormone dependency trends in adenocarcinoma and squamous cell carcinoma of esophagus.Biosci Rep. 2019 Jul 5;39(7):BSR20190472. doi: 10.1042/BSR20190472. Print 2019 Jul 31.
• [399] Spatially resolved metabolomics to discover tumor-associated metabolic alterations.Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):52-57. doi: 10.1073/pnas.1808950116. Epub 2018 Dec 17.
• [400] Overexpression of Phosphoserine Aminotransferase 1 (PSAT1) Predicts Poor Prognosis and Associates with Tumor Progression in Human Esophageal Squamous Cell Carcinoma.Cell Physiol Biochem. 2016;39(1):395-406. doi: 10.1159/000445633. Epub 2016 Jul 4.
• [401] The biogenesis and biological functions of circular RNAs and their molecular diagnostic values in cancers.J Clin Lab Anal. 2020 Jan;34(1):e23049. doi: 10.1002/jcla.23049. Epub 2019 Sep 25.
• [402] E3B1/ABI-1 isoforms are down-regulated in cancers of human gastrointestinal tract.Dis Markers. 2012;32(4):273-9. doi: 10.3233/DMA-2011-0881.
• [403] Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma.BMC Cancer. 2015 Apr 30;15:331. doi: 10.1186/s12885-015-1364-0.
• [404] Overexpression of the DEC1 protein induces senescence in vitro and is related to better survival in esophageal squamous cell carcinoma.PLoS One. 2012;7(7):e41862. doi: 10.1371/journal.pone.0041862. Epub 2012 Jul 23.
• [405] A genetic variant in CDKN2A/2B locus was associated with poor prognosis in patients with esophageal squamous cell carcinoma.J Cell Physiol. 2019 Apr;234(4):5070-5076. doi: 10.1002/jcp.27310. Epub 2018 Sep 21.
• [406] The identification of two regulatory ESCC susceptibility genetic variants in the TERT-CLPTM1L loci.Oncotarget. 2016 Feb 2;7(5):5495-506. doi: 10.18632/oncotarget.6747.
• [407] Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.Mol Med Rep. 2019 Oct;20(4):3649-3660. doi: 10.3892/mmr.2019.10608. Epub 2019 Aug 23.
• [408] Anti-FIRexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma.Cancer Sci. 2019 Jun;110(6):2004-2013. doi: 10.1111/cas.14024. Epub 2019 May 20.
• [409] miR-338-5p inhibits cell proliferation, colony formation, migration and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2.Carcinogenesis. 2019 Jul 20;40(7):883-892. doi: 10.1093/carcin/bgy189.
• [410] Identification of cytokeratin subspecies altered in rat experimental esophageal tumors by subtractive cloning.Cancer Lett. 1996 Nov 12;108(1):119-27. doi: 10.1016/s0304-3835(96)04403-5.
• [411] Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy. Clin Oncol (R Coll Radiol). 2008 Oct;20(8):639-46. doi: 10.1016/j.clon.2008.06.010. Epub 2008 Aug 8.
• [412] Prognostic and predictive role of COX-2, XRCC1 and RASSF1 expression in patients with esophageal squamous cell carcinoma receiving radiotherapy.Oncol Lett. 2017 Apr;13(4):2549-2556. doi: 10.3892/ol.2017.5780. Epub 2017 Feb 24.
• [413] Correlation Between Biomarker Candidate Proteins with the Effect of Neoadjuvant Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma.Ann Surg Oncol. 2018 Feb;25(2):449-455. doi: 10.1245/s10434-017-6271-y. Epub 2017 Nov 29.
• [414] Enhanced Expression of miR-425 Promotes Esophageal Squamous Cell Carcinoma Tumorigenesis by Targeting SMAD2.J Genet Genomics. 2015 Nov 20;42(11):601-611. doi: 10.1016/j.jgg.2015.09.010. Epub 2015 Oct 9.
• [415] Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1485-1494. doi: 10.1007/s00259-019-04307-6. Epub 2019 Apr 4.
• [416] Entinostat reverses cisplatin resistance in esophageal squamous cell carcinoma via down-regulation of multidrug resistance gene 1.Cancer Lett. 2018 Feb 1;414:294-300. doi: 10.1016/j.canlet.2017.10.023. Epub 2017 Dec 5.
• [417] Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.Int J Cancer. 2019 Aug 15;145(4):1007-1019. doi: 10.1002/ijc.32285. Epub 2019 Apr 3.
• [418] Role of MAML1 in targeted therapy against the esophageal cancer stem cells.J Transl Med. 2019 Apr 16;17(1):126. doi: 10.1186/s12967-019-1876-5.
• [419] FAM134B promotes esophageal squamous cell carcinoma in vitro and its correlations with clinicopathologic features.Hum Pathol. 2019 May;87:1-10. doi: 10.1016/j.humpath.2018.11.033. Epub 2019 Feb 20.
• [420] SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes.J Biomed Sci. 2019 Feb 18;26(1):20. doi: 10.1186/s12929-019-0510-4.
• [421] Association of MTHFR C677T and SHMT(1) C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China.Cancer Causes Control. 2007 Mar;18(2):143-52. doi: 10.1007/s10552-006-0097-4. Epub 2007 Jan 6.
• [422] Clinical significance of SPRR1A expression in progesterone receptor-positive breast cancer.Tumour Biol. 2015 Apr;36(4):2601-5. doi: 10.1007/s13277-014-2879-8. Epub 2014 Nov 26.
• [423] Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.Biomed Pharmacother. 2019 Apr;112:108632. doi: 10.1016/j.biopha.2019.108632. Epub 2019 Feb 20.
• [424] Low expression level of ASK1-interacting protein-1 correlated with tumor angiogenesis and poor survival in patients with esophageal squamous cell cancer.Onco Targets Ther. 2018 Nov 1;11:7699-7707. doi: 10.2147/OTT.S178131. eCollection 2018.
• [425] Acyl-CoA dehydrogenase long chain expression is associated with esophageal squamous cell carcinoma progression and poor prognosis.Onco Targets Ther. 2018 Oct 31;11:7643-7653. doi: 10.2147/OTT.S171963. eCollection 2018.
• [426] SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma.Cancer Med. 2019 Nov;8(16):7055-7064. doi: 10.1002/cam4.2569. Epub 2019 Sep 27.
• [427] An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.Cancer Lett. 2018 May 28;422:118-128. doi: 10.1016/j.canlet.2018.02.031. Epub 2018 Feb 21.
• [428] Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.J Cell Biochem. 2020 Jan;121(1):468-481. doi: 10.1002/jcb.29218. Epub 2019 Jun 25.
• [429] Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma.Cancer Sci. 2010 Apr;101(4):1038-44. doi: 10.1111/j.1349-7006.2009.01477.x. Epub 2009 Dec 16.
• [430] ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.Exp Mol Pathol. 2018 Apr;104(2):134-139. doi: 10.1016/j.yexmp.2018.02.004. Epub 2018 Feb 21.
• [431] Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis.Cancer Res. 2010 Jul 1;70(13):5567-76. doi: 10.1158/0008-5472.CAN-09-4510. Epub 2010 Jun 15.
• [432] ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma.Int J Oncol. 2017 Feb;50(2):622-630. doi: 10.3892/ijo.2016.3823. Epub 2016 Dec 29.
• [433] XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma.Ann Surg Oncol. 2013 Sep;20(9):3140-50. doi: 10.1245/s10434-012-2474-4. Epub 2012 Jul 18.
• [434] Implications of Bit1 and AIF overexpressions in esophageal squamous cell carcinoma.Tumour Biol. 2014 Jan;35(1):519-27. doi: 10.1007/s13277-013-1073-8. Epub 2013 Aug 17.
• [435] Endogenous AJAP1 associates with the cytoskeleton and attenuates angiogenesis in endothelial cells.Biol Open. 2017 Jun 15;6(6):723-731. doi: 10.1242/bio.022335.
• [436] Comprehensive genomic analysis of Oesophageal Squamous Cell Carcinoma reveals clinical relevance.Sci Rep. 2017 Nov 10;7(1):15324. doi: 10.1038/s41598-017-14909-5.
• [437] Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):111-7. doi: 10.1158/1055-9965.EPI-07-0407.
• [438] Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.Biomed Pharmacother. 2018 Oct;106:1348-1356. doi: 10.1016/j.biopha.2018.07.075. Epub 2018 Jul 23.
• [439] The ALDH7A1 genetic polymorphisms contribute to development of esophageal squamous cell carcinoma.Tumour Biol. 2014 Dec;35(12):12665-70. doi: 10.1007/s13277-014-2590-9. Epub 2014 Sep 12.
• [440] Identification of putative target genes for amplification within 11q13.2 and 3q27.1 in esophageal squamous cell carcinoma.Clin Transl Oncol. 2014 Jul;16(7):606-15. doi: 10.1007/s12094-013-1124-z. Epub 2013 Nov 8.
• [441] Expression, Function, and Prognostic Value of MAGE-D4 Protein in Esophageal Squamous Cell Carcinoma.Anticancer Res. 2019 Nov;39(11):6015-6023. doi: 10.21873/anticanres.13807.
• [442] APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma.Med Oncol. 2016 Mar;33(3):26. doi: 10.1007/s12032-016-0739-7. Epub 2016 Feb 15.
• [443] Genome-wide analyses of long non-coding RNA expression profiles and functional network analysis in esophageal squamous cell carcinoma.Sci Rep. 2019 Jun 24;9(1):9162. doi: 10.1038/s41598-019-45493-5.
• [444] Identification of genomic alterations in oesophageal squamous cell cancer.Nature. 2014 May 1;509(7498):91-5. doi: 10.1038/nature13176. Epub 2014 Mar 16.
• [445] Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.World J Surg Oncol. 2007 Feb 19;5:21. doi: 10.1186/1477-7819-5-21.
• [446] Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.Cancer Res. 2014 Feb 1;74(3):840-51. doi: 10.1158/0008-5472.CAN-13-2545. Epub 2013 Dec 3.
• [447] Role of intravoxel incoherent motion MRI in early assessment of the response of esophageal squamous cell carcinoma to chemoradiotherapy: A pilot study.J Magn Reson Imaging. 2018 Aug;48(2):349-358. doi: 10.1002/jmri.25934. Epub 2018 Jan 3.
• [448] IGFBP3 and BAG1 enhance radiation-induced apoptosis in squamous esophageal cancer cells.Biochem Biophys Res Commun. 2011 Jan 28;404(4):1070-5. doi: 10.1016/j.bbrc.2010.12.115. Epub 2010 Dec 30.
• [449] Expression of VRK1 and the downstream gene BANF1 in esophageal cancer.Biomed Pharmacother. 2017 May;89:1086-1091. doi: 10.1016/j.biopha.2017.02.095. Epub 2017 Mar 11.
• [450] An esophageal adenocarcinoma susceptibility locus at 9q22 also confers risk to esophageal squamous cell carcinoma by regulating the function of BARX1.Cancer Lett. 2018 May 1;421:103-111. doi: 10.1016/j.canlet.2018.02.019. Epub 2018 Feb 14.
• [451] High Expression of BCCIP Can Promote Proliferation of Esophageal Squamous Cell Carcinoma.Dig Dis Sci. 2017 Feb;62(2):387-395. doi: 10.1007/s10620-016-4382-0. Epub 2016 Dec 19.
• [452] Relationship between Egr-1 gene expression and apoptosis in esophageal carcinoma and precancerous lesions.World J Gastroenterol. 2002 Dec;8(6):971-5. doi: 10.3748/wjg.v8.i6.971.
• [453] Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer.Oncol Rep. 2018 Nov;40(5):2778-2787. doi: 10.3892/or.2018.6647. Epub 2018 Aug 17.
• [454] DEC2 expression antagonizes cisplatininduced apoptosis in human esophageal squamous cell carcinoma.Mol Med Rep. 2017 Jul;16(1):43-48. doi: 10.3892/mmr.2017.6571. Epub 2017 May 11.
• [455] Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.Oncotarget. 2017 Mar 21;8(12):19661-19673. doi: 10.18632/oncotarget.14914.
• [456] Apollon modulates chemosensitivity in human esophageal squamous cell carcinoma.Oncotarget. 2014 Aug 30;5(16):7183-97. doi: 10.18632/oncotarget.2293.
• [457] MicroRNA-125b inhibits cell proliferation and induces cell apoptosis in esophageal squamous cell carcinoma by targeting BMF.Oncol Rep. 2018 Jul;40(1):61-72. doi: 10.3892/or.2018.6413. Epub 2018 May 2.
• [458] Novel long noncoding RNA NMR promotes tumor progression via NSUN2 and BPTF in esophageal squamous cell carcinoma.Cancer Lett. 2018 Aug 28;430:57-66. doi: 10.1016/j.canlet.2018.05.013. Epub 2018 May 12.
• [459] BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.Gastroenterology. 2017 Nov;153(5):1304-1319.e5. doi: 10.1053/j.gastro.2017.07.042. Epub 2017 Aug 2.
• [460] BRF2 as a promising indicator for radical lymph-node dissection surgery in patients with cN0 squamous cell carcinoma of the middle thoracic esophagus.Surg Today. 2019 Feb;49(2):158-169. doi: 10.1007/s00595-018-1711-2. Epub 2018 Sep 4.
• [461] Clinical implication of elevated human cervical cancer oncogene-1 expression in esophageal squamous cell carcinoma.J Histochem Cytochem. 2012 Jul;60(7):512-20. doi: 10.1369/0022155412444437. Epub 2012 Apr 17.
• [462] The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.Histol Histopathol. 2012 Jan;27(1):49-58. doi: 10.14670/HH-27.49.
• [463] TSPAN15 interacts with BTRC to promote oesophageal squamous cell carcinoma metastasis via activating NF-B signaling.Nat Commun. 2018 Apr 12;9(1):1423. doi: 10.1038/s41467-018-03716-9.
• [464] Gene set enrichment analysis and meta-analysis to identify six key genes regulating and controlling the prognosis of esophageal squamous cell carcinoma.J Thorac Dis. 2018 Oct;10(10):5714-5726. doi: 10.21037/jtd.2018.09.55.
• [465] Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma.Sci China Life Sci. 2018 Nov;61(11):1389-1395. doi: 10.1007/s11427-017-9345-7. Epub 2018 Aug 1.
• [466] CADM1 mRNA expression and clinicopathological significance in esophageal squamous cell carcinoma tissue.Genet Mol Res. 2017 May 10;16(2). doi: 10.4238/gmr16029178.
• [467] The CADM2/Akt pathway is involved in the inhibitory effect of miR-21-5p downregulation on proliferation and apoptosis in esophageal squamous cell carcinoma cells.Chem Biol Interact. 2018 May 25;288:76-82. doi: 10.1016/j.cbi.2018.04.021. Epub 2018 Apr 19.
• [468] Downregulated expression of the cyclase-associated protein 1 (CAP1) reduces migration in esophageal squamous cell carcinoma.Jpn J Clin Oncol. 2013 Sep;43(9):856-64. doi: 10.1093/jjco/hyt093. Epub 2013 Jul 30.
• [469] Oncogene GAEC1 regulates CAPN10 expression which predicts survival in esophageal squamous cell carcinoma.World J Gastroenterol. 2013 May 14;19(18):2772-80. doi: 10.3748/wjg.v19.i18.2772.
• [470] Genome-wide ChIP-seq data with a transcriptome analysis reveals the groups of genes regulated by histone demethylase LSD1 inhibition in esophageal squamous cell carcinoma cells.Oncol Lett. 2019 Jul;18(1):872-881. doi: 10.3892/ol.2019.10350. Epub 2019 May 13.
• [471] Capn4 promotes esophageal squamous cell carcinoma metastasis by regulating ZEB1 through the Wnt/-catenin signaling pathway.Thorac Cancer. 2019 Jan;10(1):24-32. doi: 10.1111/1759-7714.12893. Epub 2018 Nov 15.
• [472] Overexpression of calcyphosine is associated with poor prognosis in esophageal squamous cell carcinoma.Oncol Lett. 2017 Nov;14(5):6231-6237. doi: 10.3892/ol.2017.6973. Epub 2017 Sep 15.
• [473] The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.Oncol Rep. 2007 Sep;18(3):601-9.
• [474] CBX8 promotes tumorigenesis and confers radioresistance in esophageal squamous cell carcinoma cells through targeting APAF1.Gene. 2019 Aug 30;711:143949. doi: 10.1016/j.gene.2019.143949. Epub 2019 Jun 28.
• [475] Overexpression of Coiled-Coil Domain-Containing Protein 34 (CCDC34) and its Correlation with Angiogenesis in Esophageal Squamous Cell Carcinoma.Med Sci Monit. 2018 Feb 3;24:698-705. doi: 10.12659/msm.908335.
• [476] Clinical significance of sperm protein 17 expression and immunogenicity in esophageal cancer.Int J Cancer. 2007 Apr 15;120(8):1739-47. doi: 10.1002/ijc.22463.
• [477] Short tandem repeat polymorphism in a novel esophageal cancer-related gene (ECRG2) implicates susceptibility to esophageal cancer in Chinese population.Int J Cancer. 2004 Jan 10;108(2):232-6. doi: 10.1002/ijc.11560.
• [478] Genome-wide gene expression profile analyses identify CTTN as a potential prognostic marker in esophageal cancer.PLoS One. 2014 Feb 14;9(2):e88918. doi: 10.1371/journal.pone.0088918. eCollection 2014.
• [479] A truncated splice variant of human lysyl oxidase-like 2 promotes migration and invasion in esophageal squamous cell carcinoma.Int J Biochem Cell Biol. 2016 Jun;75:85-98. doi: 10.1016/j.biocel.2016.04.003. Epub 2016 Apr 8.
• [480] MCP2 activates NF-B signaling pathway promoting the migration and invasion of ESCC cells.Cell Biol Int. 2018 Mar;42(3):365-372. doi: 10.1002/cbin.10909. Epub 2017 Nov 22.
• [481] WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells.J Exp Clin Cancer Res. 2019 Feb 26;38(1):102. doi: 10.1186/s13046-019-1108-0.
• [482] Cyclin A1 is associated with poor prognosis in oesophageal squamous cell carcinoma.Oncol Lett. 2019 Jul;18(1):706-712. doi: 10.3892/ol.2019.10377. Epub 2019 May 20.
• [483] miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.Biomed Pharmacother. 2018 Oct;106:1650-1660. doi: 10.1016/j.biopha.2018.07.074. Epub 2018 Jul 29.
• [484] Combination of c-reactive protein and squamous cell carcinoma antigen in predicting postoperative prognosis for patients with squamous cell carcinoma of the esophagus.Oncotarget. 2017 Jun 27;8(38):63132-63139. doi: 10.18632/oncotarget.18667. eCollection 2017 Sep 8.
• [485] Chaperonin-containing Tcomplex protein 1 subunit 8 promotes cell migration and invasion in human esophageal squamous cell carcinoma by regulating -actin and -tubulin expression.Int J Oncol. 2018 Jun;52(6):2021-2030. doi: 10.3892/ijo.2018.4335. Epub 2018 Mar 27.
• [486] Impact of tumor-infiltrating LAMP-3 dendritic cells on the prognosis of esophageal squamous cell carcinoma.Esophagus. 2019 Oct;16(4):333-344. doi: 10.1007/s10388-019-00669-w. Epub 2019 Apr 9.
• [487] CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-1.Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5928-5937. doi: 10.26355/eurrev_201809_15922.
• [488] miR-107 functions as a tumor suppressor in human esophageal squamous cell carcinoma and targets Cdc42.Oncol Rep. 2017 May;37(5):3116-3127. doi: 10.3892/or.2017.5546. Epub 2017 Apr 3.
• [489] Chromosomal aneuploidies and combinational fluorescence in situ hybridization probe panels are useful for predicting prognosis for esophageal squamous cell carcinoma.J Gastroenterol. 2015 Feb;50(2):155-66. doi: 10.1007/s00535-014-0961-z. Epub 2014 May 11.
• [490] Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma.EBioMedicine. 2019 Aug;46:54-65. doi: 10.1016/j.ebiom.2019.07.030. Epub 2019 Jul 16.
• [491] Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma.Am J Hum Genet. 2016 Feb 4;98(2):256-74. doi: 10.1016/j.ajhg.2015.12.013. Epub 2016 Jan 28.
• [492] Loss of CDCP1 expression promotes invasiveness and poor prognosis in esophageal squamous cell carcinoma.Ann Surg Oncol. 2014 Dec;21 Suppl 4:S640-7. doi: 10.1245/s10434-014-3740-4. Epub 2014 May 22.
• [493] The strong propensity of Cadherin-23 for aggregation inhibits cell migration.Mol Oncol. 2019 May;13(5):1092-1109. doi: 10.1002/1878-0261.12469. Epub 2019 Mar 19.
• [494] Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma.Br J Cancer. 2012 Feb 28;106(5):947-54. doi: 10.1038/bjc.2012.35. Epub 2012 Feb 14.
• [495] Increased CDKL3 expression predicts poor prognosis and enhances malignant phenotypes in esophageal squamous cell carcinoma.J Cell Biochem. 2019 May;120(5):7174-7184. doi: 10.1002/jcb.27991. Epub 2018 Nov 1.
• [496] Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma.Int J Cancer. 2008 Aug 15;123(4):826-30. doi: 10.1002/ijc.23577.
• [497] Let-7b-5p inhibits proliferation and motility in squamous cell carcinoma cells through negative modulation of KIAA1377.Cell Biol Int. 2019 Jun;43(6):634-641. doi: 10.1002/cbin.11136. Epub 2019 Apr 25.
• [498] Integrated analysis of differentially expressed genes in esophageal squamous cell carcinoma using bioinformatics.Neoplasma. 2018;65(4):523-531. doi: 10.4149/neo_2018_170708N470.
• [499] ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.Life Sci. 2019 Sep 1;232:116679. doi: 10.1016/j.lfs.2019.116679. Epub 2019 Jul 21.
• [500] A genetic variant in CHRNB3-CHRNA6 increases risk of esophageal squamous cell carcinoma in Chinese populations.Carcinogenesis. 2015 May;36(5):538-42. doi: 10.1093/carcin/bgv019. Epub 2015 Mar 30.
• [501] Long noncoding RNA MALAT1 affects the efficacy of radiotherapy for esophageal squamous cell carcinoma by regulating Cks1 expression.J Oral Pathol Med. 2017 Sep;46(8):583-590. doi: 10.1111/jop.12538. Epub 2017 Jun 5.
• [502] Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma.Oncol Rep. 2014 May;31(5):1986-92. doi: 10.3892/or.2014.3062. Epub 2014 Mar 5.
• [503] CLDN1 induces autophagy to promote proliferation and metastasis of esophageal squamous carcinoma through AMPK/STAT1/ULK1 signaling.J Cell Physiol. 2020 Mar;235(3):2245-2259. doi: 10.1002/jcp.29133. Epub 2019 Sep 9.
• [504] Loss of PAR-3 protein expression is associated with invasion, lymph node metastasis, and poor survival in esophageal squamous cell carcinoma.Hum Pathol. 2017 Apr;62:134-140. doi: 10.1016/j.humpath.2017.01.009. Epub 2017 Feb 8.
• [505] Targeting CD47 Enhances the Efficacy of Anti-PD-1 and CTLA-4 in an Esophageal Squamous Cell Cancer Preclinical Model.Oncol Res. 2017 Nov 2;25(9):1579-1587. doi: 10.3727/096504017X14900505020895. Epub 2017 Mar 23.
• [506] Chemokine-like factor-like MARVEL transmembrane domain-containing 3 expression is associated with a favorable prognosis in esophageal squamous cell carcinoma.Oncol Lett. 2017 May;13(5):2982-2988. doi: 10.3892/ol.2017.5837. Epub 2017 Mar 10.
• [507] Chondromodulin-1 and vascular endothelial growth factor-A expression in esophageal squamous cell carcinoma: accelerator and brake theory for angiogenesis at the early stage of cancer progression.Esophagus. 2020 Apr;17(2):159-167. doi: 10.1007/s10388-019-00695-8. Epub 2019 Oct 8.
• [508] A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma.Hum Pathol. 2017 Aug;66:115-125. doi: 10.1016/j.humpath.2017.06.003. Epub 2017 Jun 9.
• [509] The clinical significance of collagen family gene expression in esophageal squamous cell carcinoma.PeerJ. 2019 Oct 4;7:e7705. doi: 10.7717/peerj.7705. eCollection 2019.
• [510] Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma.Mol Cancer. 2018 Feb 19;17(1):54. doi: 10.1186/s12943-018-0790-4.
• [511] Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.Cancer Chemother Pharmacol. 2019 Apr;83(4):639-647. doi: 10.1007/s00280-019-03769-7. Epub 2019 Jan 14.
• [512] Copine5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma.Oncol Rep. 2018 Dec;40(6):3772-3780. doi: 10.3892/or.2018.6742. Epub 2018 Sep 27.
• [513] Genomic alterations with impact on survival in esophageal squamous cell carcinoma identified by array comparative genomic hybridization.Genes Chromosomes Cancer. 2011 Jul;50(7):518-26. doi: 10.1002/gcc.20875. Epub 2011 Apr 11.
• [514] Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.Oncogene. 2007 Sep 27;26(44):6456-68. doi: 10.1038/sj.onc.1210459. Epub 2007 Apr 16.
• [515] Cellular Retinoic Acid Binding Protein 2 Is Strikingly Downregulated in Human Esophageal Squamous Cell Carcinoma and Functions as a Tumor Suppressor.PLoS One. 2016 Feb 3;11(2):e0148381. doi: 10.1371/journal.pone.0148381. eCollection 2016.
• [516] CRCT1 regulated by microRNA-520g inhibits proliferation and induces apoptosis in esophageal squamous cell cancer.Tumour Biol. 2016 Jun;37(6):8271-9. doi: 10.1007/s13277-015-4730-2. Epub 2015 Dec 30.
• [517] Low expression of cyclic AMP response element modulator-1 can increase the migration and invasion of esophageal squamous cell carcinoma.Tumour Biol. 2013 Dec;34(6):3649-57. doi: 10.1007/s13277-013-0946-1. Epub 2013 Aug 9.
• [518] The LIM domain protein, CRIP2, promotes apoptosis in esophageal squamous cell carcinoma.Cancer Lett. 2012 Mar;316(1):39-45. doi: 10.1016/j.canlet.2011.10.020. Epub 2011 Oct 20.
• [519] Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis.Clin Cancer Res. 2017 May 1;23(9):2335-2345. doi: 10.1158/1078-0432.CCR-16-1520. Epub 2016 Nov 15.
• [520] Sporamin suppresses growth of human esophageal squamous cell carcinoma cells by inhibition of NFB via an AKTindependent pathway.Mol Med Rep. 2017 Dec;16(6):9620-9626. doi: 10.3892/mmr.2017.7772. Epub 2017 Oct 12.
• [521] Ranking candidate genes of esophageal squamous cell carcinomas based on differentially expressed genes and the topological properties of the co-expression network.Eur J Med Res. 2014 Oct 29;19(1):52. doi: 10.1186/s40001-014-0052-x.
• [522] Research progress of cystatin SN in cancer.Onco Targets Ther. 2019 May 6;12:3411-3419. doi: 10.2147/OTT.S194332. eCollection 2019.
• [523] Clinicopathological significance of cystatin A expression in progression of esophageal squamous cell carcinoma.Medicine (Baltimore). 2018 Apr;97(15):e0357. doi: 10.1097/MD.0000000000010357.
• [524] Cancer-testis gene expression profiling in esophageal squamous cell carcinoma: identification of specific tumor marker and potential targets for immunotherapy.Cancer Biol Ther. 2011 Aug 1;12(3):191-7. doi: 10.4161/cbt.12.3.15949. Epub 2011 Aug 1.
• [525] LncRNA NEAT1 Regulates Cell Viability and Invasion in Esophageal Squamous Cell Carcinoma through the miR-129/CTBP2 Axis.Dis Markers. 2017;2017:5314649. doi: 10.1155/2017/5314649. Epub 2017 Sep 25.
• [526] Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.Int J Clin Oncol. 2020 Mar;25(3):446-455. doi: 10.1007/s10147-019-01547-2. Epub 2019 Sep 18.
• [527] MicroRNA-133b inhibits cell proliferation and promotes apoptosis by targeting cullin 4B in esophageal squamous cell carcinoma.Exp Ther Med. 2018 Apr;15(4):3743-3750. doi: 10.3892/etm.2018.5906. Epub 2018 Feb 28.
• [528] IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma.Oncoimmunology. 2017 Sep 21;7(1):e1373234. doi: 10.1080/2162402X.2017.1373234. eCollection 2017.
• [529] Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.J Biomed Sci. 2017 Jan 11;24(1):6. doi: 10.1186/s12929-016-0308-6.
• [530] CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha4 is associated with recurrence of early stage esophageal squamous cell carcinoma.Int J Cancer. 2008 Nov 1;123(9):2073-9. doi: 10.1002/ijc.23598.
• [531] Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library.Oncotarget. 2018 Jan 1;9(26):18559-18569. doi: 10.18632/oncotarget.24963. eCollection 2018 Apr 6.
• [532] SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.Ann Surg Oncol. 2008 Oct;15(10):2965-75. doi: 10.1245/s10434-008-9986-y. Epub 2008 Jul 9.
• [533] Genetic polymorphisms of microRNA machinery genes predict overall survival of esophageal squamous carcinoma.J Clin Lab Anal. 2018 Jan;32(1):e22170. doi: 10.1002/jcla.22170. Epub 2017 Dec 11.
• [534] Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells.Oncol Rep. 2016 Jul;36(1):223-30. doi: 10.3892/or.2016.4803. Epub 2016 May 11.
• [535] Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.Oncol Rep. 2014 Feb;31(2):693-700. doi: 10.3892/or.2013.2901. Epub 2013 Dec 5.
• [536] Derlin-1 is a target to improve radiotherapy effect of esophageal squamous cell carcinoma.Oncotarget. 2017 Jul 7;8(33):55135-55146. doi: 10.18632/oncotarget.19069. eCollection 2017 Aug 15.
• [537] Inverse expression of dihydrodiol dehydrogenase and glutathione-S-transferase in patients with esophageal squamous cell carcinoma.Int J Cancer. 2004 Aug 20;111(2):246-51. doi: 10.1002/ijc.11650.
• [538] Molecular pathogenesis of esophageal squamous cell carcinoma: Identification of the antitumor effects of miR?45?p on gene regulation.Int J Oncol. 2019 Feb;54(2):673-688. doi: 10.3892/ijo.2018.4657. Epub 2018 Dec 6.
• [539] Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.Cancer Res. 2013 Apr 1;73(7):2298-309. doi: 10.1158/0008-5472.CAN-12-2663. Epub 2013 Feb 22.
• [540] Long noncoding RNA DLX6AS1 is associated with malignant progression and promotes proliferation and invasion in esophageal squamous cell carcinoma.Mol Med Rep. 2019 Mar;19(3):1942-1950. doi: 10.3892/mmr.2018.9786. Epub 2018 Dec 21.
• [541] Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma.BMC Med Genet. 2019 May 3;20(1):72. doi: 10.1186/s12881-019-0796-9.
• [542] Candidate susceptibility variants for esophageal squamous cell carcinoma.Genes Chromosomes Cancer. 2017 Jun;56(6):453-459. doi: 10.1002/gcc.22448. Epub 2017 Apr 3.
• [543] Repression of DOK7 mediated by DNMT3A promotes the proliferation and invasion of KYSE410 and TE-12 ESCC cells.Biomed Pharmacother. 2017 Jun;90:93-99. doi: 10.1016/j.biopha.2017.02.111. Epub 2017 Mar 24.
• [544] Oncogenic but non-essential role of N-myc downstream regulated gene 1 in the progression of esophageal squamous cell carcinoma.Cancer Biol Ther. 2013 Feb;14(2):164-74. doi: 10.4161/cbt.22956. Epub 2012 Nov 28.
• [545] Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma.Dis Esophagus. 2011 Sep;24(7):523-30. doi: 10.1111/j.1442-2050.2011.01177.x. Epub 2011 Mar 31.
• [546] Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype.Int J Cancer. 2012 Jan 1;130(1):83-95. doi: 10.1002/ijc.25970. Epub 2011 Apr 20.
• [547] RAP1B, a DVL2 binding protein, activates Wnt/beta-catenin signaling in esophageal squamous cell carcinoma.Gene. 2017 May 5;611:15-20. doi: 10.1016/j.gene.2017.01.021. Epub 2017 Jan 21.
• [548] Role and mechanism of Dvl3 in the esophageal squamous cell carcinoma.Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):7716-7725. doi: 10.26355/eurrev_201811_16393.
• [549] MicroRNA-544 inhibits esophageal squamous cell carcinoma cell proliferation and enhances sensitivity to cisplatin by repressing E2F transcription factor 5.Oncol Lett. 2019 Oct;18(4):4203-4209. doi: 10.3892/ol.2019.10749. Epub 2019 Aug 16.
• [550] E2F transcription factor 8 promotes cell proliferation via CCND1/p21 in esophageal squamous cell carcinoma.Onco Targets Ther. 2018 Nov 15;11:8165-8173. doi: 10.2147/OTT.S180938. eCollection 2018.
• [551] Endoplasmic reticulum-localized ECM1b suppresses tumor growth and regulates MYC and MTORC1 through modulating MTORC2 activation in esophageal squamous cell carcinoma.Cancer Lett. 2019 Oct 1;461:56-64. doi: 10.1016/j.canlet.2019.07.005. Epub 2019 Jul 15.
• [552] The effect of ephrin-A1 on resistance to Photofrin-mediated photodynamic therapy in esophageal squamous cell carcinoma cells.Lasers Med Sci. 2015 Dec;30(9):2353-61. doi: 10.1007/s10103-015-1812-8. Epub 2015 Oct 8.
• [553] Effects of EHD2 interference on migration of esophageal squamous cell carcinoma.Med Oncol. 2013 Mar;30(1):396. doi: 10.1007/s12032-012-0396-4. Epub 2013 Jan 25.
• [554] Increased expression of EHF contributes to thyroid tumorigenesis through transcriptionally regulating HER2 and HER3.Oncotarget. 2016 Sep 6;7(36):57978-57990. doi: 10.18632/oncotarget.11154.
• [555] miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24.Cell Biol Int. 2016 Apr;40(4):448-55. doi: 10.1002/cbin.10585. Epub 2016 Feb 4.
• [556] TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.BMC Cancer. 2019 Sep 3;19(1):875. doi: 10.1186/s12885-019-6071-9.
• [557] Up-regulation Of EIF3e Is Associated with The Progression of Esophageal Squamous Cell Carcinoma and Poor Prognosis in Patients.J Cancer. 2018 Mar 8;9(7):1135-1144. doi: 10.7150/jca.22546. eCollection 2018.
• [558] Overexpression of Ets-like protein 1 in human esophageal squamous cell carcinoma.World J Gastroenterol. 2006 Dec 28;12(48):7859-63. doi: 10.3748/wjg.v12.i48.7859.
• [559] EPB41L3 is a potential tumor suppressor gene and prognostic indicator in esophageal squamous cell carcinoma.Int J Oncol. 2018 May;52(5):1443-1454. doi: 10.3892/ijo.2018.4316. Epub 2018 Mar 14.
• [560] Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells.J Exp Clin Cancer Res. 2017 Aug 1;36(1):101. doi: 10.1186/s13046-017-0572-7.
• [561] Association of high-dose postoperative opioids with recurrence risk in esophageal squamous cell carcinoma: reinterpreting ERAS protocols for long-term oncologic surgery outcomes.Dis Esophagus. 2017 Oct 1;30(10):1-8. doi: 10.1093/dote/dox074.
• [562] Clinical Role of Excision Repair Cross-Complementing 1 Gene Expression in Resected Esophageal Squamous Cell Carcinoma: A Meta-Analysis.Dig Dis Sci. 2020 Aug;65(8):2264-2271. doi: 10.1007/s10620-019-05941-8. Epub 2019 Nov 11.
• [563] Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study.Pharmacogenomics J. 2016 Jun;16(3):266-71. doi: 10.1038/tpj.2015.41. Epub 2015 Jun 9.
• [564] Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer.Oncol Rep. 2004 Oct;12(4):827-31.
• [565] Risk Factors Associated with Precancerous Lesions of Esophageal Squamous Cell Carcinoma: a Screening Study in a High Risk Chinese Population.J Cancer. 2019 Jun 2;10(14):3284-3290. doi: 10.7150/jca.29979. eCollection 2019.
• [566] An actin-binding protein ESPN is an independent prognosticator and regulates cell growth for esophageal squamous cell carcinoma.Cancer Cell Int. 2018 Dec 29;18:219. doi: 10.1186/s12935-018-0713-x. eCollection 2018.
• [567] Contribution of EVX1 in Aggressiveness of Esophageal Squamous Cell Carcinoma.Pathol Oncol Res. 2016 Apr;22(2):341-7. doi: 10.1007/s12253-015-0005-x. Epub 2015 Nov 9.
• [568] Aberrant methylation of EYA4 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.Cancer Sci. 2018 Jun;109(6):1811-1824. doi: 10.1111/cas.13615. Epub 2018 May 26.
• [569] FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.J Cell Mol Med. 2019 Feb;23(2):1375-1385. doi: 10.1111/jcmm.14040. Epub 2018 Dec 18.
• [570] Prognostic significance of FAM3C in esophageal squamous cell carcinoma.Diagn Pathol. 2015 Oct 24;10:192. doi: 10.1186/s13000-015-0424-8.
• [571] MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.Eur Rev Med Pharmacol Sci. 2017 Jul;21(14):3200-3206.
• [572] Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance.Theranostics. 2019 Feb 28;9(6):1599-1613. doi: 10.7150/thno.30372. eCollection 2019.
• [573] Aberrant methylation and decreased expression of the TGF-/Smad target gene FBXO32 in esophageal squamous cell carcinoma.Cancer. 2014 Aug 15;120(16):2412-23. doi: 10.1002/cncr.28764. Epub 2014 May 2.
• [574] Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma.Nat Commun. 2019 Mar 21;10(1):1296. doi: 10.1038/s41467-019-09179-w.
• [575] Flap endonuclease-1 rs174538 G>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population.Thorac Cancer. 2017 May;8(3):192-196. doi: 10.1111/1759-7714.12422. Epub 2017 Mar 20.
• [576] Identification and Validation of Fibroblast Growth Factor 12 Gene as a Novel Potential Biomarker in Esophageal Cancer Using Cancer Genomic Datasets.OMICS. 2017 Oct;21(10):616-631. doi: 10.1089/omi.2017.0116.
• [577] Inhibitory effects of Gleditsia sinensis fruit extract on telomerase activity and oncogenic expression in human esophageal squamous cell carcinoma.Int J Mol Med. 2007 Jun;19(6):953-60.
• [578] FGF5 methylation is a sensitivity marker of esophageal squamous cell carcinoma to definitive chemoradiotherapy.Sci Rep. 2019 Sep 16;9(1):13347. doi: 10.1038/s41598-019-50005-6.
• [579] FGFRL1 deficiency reduces motility and tumorigenic potential of cells derived from oesophageal squamous cell carcinomas.Oncol Lett. 2018 Jul;16(1):809-814. doi: 10.3892/ol.2018.8739. Epub 2018 May 18.
• [580] FLI-06 suppresses proliferation, induces apoptosis and cell cycle arrest by targeting LSD1 and Notch pathway in esophageal squamous cell carcinoma cells.Biomed Pharmacother. 2018 Nov;107:1370-1376. doi: 10.1016/j.biopha.2018.08.140. Epub 2018 Aug 31.
• [581] Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma.Oncotarget. 2017 Jan 24;8(4):6353-6363. doi: 10.18632/oncotarget.14087.
• [582] MicroRNA-127 is a tumor suppressor in human esophageal squamous cell carcinoma through the regulation of oncogene FMNL3.Eur J Pharmacol. 2016 Nov 15;791:603-610. doi: 10.1016/j.ejphar.2016.09.025. Epub 2016 Sep 17.
• [583] Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma.Int J Oncol. 2017 Jul;51(1):378-388. doi: 10.3892/ijo.2017.4015. Epub 2017 May 19.
• [584] Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis.Oncol Res. 2020 Feb 7;28(1):65-73. doi: 10.3727/096504019X15656904013079. Epub 2019 Sep 26.
• [585] FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma.Tumour Biol. 2017 Feb;39(2):1010428317692230. doi: 10.1177/1010428317692230.
• [586] Epigenetically Upregulated MicroRNA-602 Is Involved in a Negative Feedback Loop with FOXK2 in Esophageal Squamous Cell Carcinoma.Mol Ther. 2019 Oct 2;27(10):1796-1809. doi: 10.1016/j.ymthe.2019.07.006. Epub 2019 Jul 19.
• [587] microRNA-messenger RNA regulatory network of esophageal squamous cell carcinoma and the identification of miR-1 as a biomarker of patient survival.J Cell Biochem. 2019 Aug;120(8):12259-12272. doi: 10.1002/jcb.28166. Epub 2019 Apr 24.
• [588] FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFB-BMP Signaling Cross-talk.Cancer Res. 2017 Nov 1;77(21):5886-5899. doi: 10.1158/0008-5472.CAN-17-1411. Epub 2017 Sep 7.
• [589] Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progression.Tumour Biol. 2016 Mar;37(3):4115-26. doi: 10.1007/s13277-015-4263-8. Epub 2015 Oct 21.
• [590] Overexpression of FXYD-3 is involved in the tumorigenesis and development of esophageal squamous cell carcinoma.Dis Markers. 2013;35(3):195-202. doi: 10.1155/2013/740201. Epub 2013 Aug 27.
• [591] The prognostic role of FZD6 in esophageal squamous cell carcinoma patients.Clin Transl Oncol. 2020 Jul;22(7):1172-1179. doi: 10.1007/s12094-019-02243-3. Epub 2019 Nov 20.
• [592] Upregulation of a novel lncRNA LINC01980 promotes tumor growth of esophageal squamous cell carcinoma.Biochem Biophys Res Commun. 2019 May 21;513(1):73-80. doi: 10.1016/j.bbrc.2019.03.012. Epub 2019 Mar 29.
• [593] GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma.Oncotarget. 2017 Apr 25;8(17):29151-29160. doi: 10.18632/oncotarget.16253.
• [594] miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.Tumour Biol. 2016 Nov;37(11):14605-14614. doi: 10.1007/s13277-016-5320-7. Epub 2016 Sep 12.
• [595] Genome wide copy number analyses of superficial esophageal squamous cell carcinoma with and without metastasis.Oncotarget. 2017 Jan 17;8(3):5069-5080. doi: 10.18632/oncotarget.13847.
• [596] Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54.Nat Genet. 2010 Sep;42(9):759-63. doi: 10.1038/ng.648. Epub 2010 Aug 22.
• [597] GCNT2 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma cells.Cell Biochem Funct. 2019 Jan;37(1):42-51. doi: 10.1002/cbf.3371. Epub 2018 Dec 21.
• [598] Expression of nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues.J Cancer Res Clin Oncol. 2010 Apr;136(4):587-94. doi: 10.1007/s00432-009-0693-2. Epub 2009 Oct 13.
• [599] Identification of genes associated with histologic tumor grade of esophageal squamous cell carcinoma.FEBS Open Bio. 2017 Jul 28;7(9):1246-1257. doi: 10.1002/2211-5463.12228. eCollection 2017 Sep.
• [600] Evaluation of Salivary Exosomal Chimeric GOLM1-NAA35 RNA as a Potential Biomarker in Esophageal Carcinoma.Clin Cancer Res. 2019 May 15;25(10):3035-3045. doi: 10.1158/1078-0432.CCR-18-3169. Epub 2019 Feb 11.
• [601] GOLPH3 promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma via mTOR and Wnt/catenin signal activation.Mol Med Rep. 2017 Nov;16(5):7138-7144. doi: 10.3892/mmr.2017.7495. Epub 2017 Sep 13.
• [602] Glypican-1 Promotes Tumorigenesis by Regulating the PTEN/Akt/-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma.Dig Dis Sci. 2019 Jun;64(6):1493-1502. doi: 10.1007/s10620-019-5461-9. Epub 2019 Feb 7.
• [603] High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients.Exp Mol Pathol. 2019 Apr;107:51-56. doi: 10.1016/j.yexmp.2019.01.013. Epub 2019 Jan 29.
• [604] Overexpression of activator of G-protein signaling 3 decreases the proliferation of esophageal squamous cell carcinoma.Pathol Res Pract. 2015 Jun;211(6):449-55. doi: 10.1016/j.prp.2014.12.016. Epub 2015 Feb 19.
• [605] Identity-by-descent approaches identify regions of importance for genetic susceptibility to hereditary esophageal squamous cell carcinoma.Oncol Rep. 2014 Aug;32(2):860-70. doi: 10.3892/or.2014.3222. Epub 2014 May 29.
• [606] Promoter methylation and clinical significance of GPX3 in esophageal squamous cell carcinoma.Pathol Res Pract. 2019 Nov;215(11):152676. doi: 10.1016/j.prp.2019.152676. Epub 2019 Sep 27.
• [607] An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma.PLoS One. 2015 Oct 14;10(10):e0139808. doi: 10.1371/journal.pone.0139808. eCollection 2015.
• [608] Suppressor gene GRHL1 is associated with prognosis in patients with oesophageal squamous cell carcinoma.Oncol Lett. 2019 May;17(5):4313-4320. doi: 10.3892/ol.2019.10072. Epub 2019 Feb 25.
• [609] Over-expression of gastrin-releasing peptide in human esophageal squamous cell carcinomas.Carcinogenesis. 2004 Jun;25(6):865-71. doi: 10.1093/carcin/bgh097. Epub 2004 Feb 4.
• [610] Overexpression of TFIIB-related factor 2 is significantly correlated with tumor angiogenesis and poor survival in patients with esophageal squamous cell cancer.Med Oncol. 2013 Jun;30(2):553. doi: 10.1007/s12032-013-0553-4. Epub 2013 Apr 2.
• [611] Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis.Mol Cancer. 2011 Mar 23;10:30. doi: 10.1186/1476-4598-10-30.
• [612] RNAi screening identifies HAT1 as a potential drug target in esophageal squamous cell carcinoma.Int J Clin Exp Pathol. 2014 Jun 15;7(7):3898-907. eCollection 2014.
• [613] The E3 ligase HECTD3 promotes esophageal squamous cell carcinoma (ESCC) growth and cell survival through targeting and inhibiting caspase-9 activation.Cancer Lett. 2017 Sep 28;404:44-52. doi: 10.1016/j.canlet.2017.07.004. Epub 2017 Jul 15.
• [614] Genetic variants at 4q21, 4q23 and 12q24 are associated with esophageal squamous cell carcinoma risk in a Chinese population.Hum Genet. 2013 Jun;132(6):649-56. doi: 10.1007/s00439-013-1276-5. Epub 2013 Feb 22.
• [615] Notch Signaling Target Genes are Directly Correlated to Esophageal Squamous Cell Carcinoma Tumorigenesis.Pathol Oncol Res. 2015 Apr;21(2):463-7. doi: 10.1007/s12253-014-9849-8. Epub 2014 Nov 1.
• [616] Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.Oncotarget. 2015 Nov 10;6(35):38151-65. doi: 10.18632/oncotarget.5832.
• [617] Identification of a novel fusion gene (HLA-E and HLA-B) by RNA-seq analysis in esophageal squamous cell carcinoma.Asian Pac J Cancer Prev. 2014;15(5):2309-12. doi: 10.7314/apjcp.2014.15.5.2309.
• [618] Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma.Int J Cancer. 2013 Jan 1;132(1):82-9. doi: 10.1002/ijc.27621. Epub 2012 May 17.
• [619] Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma.Anticancer Res. 2006 Sep-Oct;26(5A):3333-5.
• [620] Silencing HMGN5 suppresses cell growth and promotes chemosensitivity in esophageal squamous cell carcinoma. J Biochem Mol Toxicol. 2017 Dec;31(12). doi: 10.1002/jbt.21996. Epub 2017 Sep 15.
• [621] LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous cell carcinoma by interacting with HNRNPC toenhance the stability of ZEB1 and ZEB2 mRNAs.Biochem Biophys Res Commun. 2019 Apr 9;511(3):566-572. doi: 10.1016/j.bbrc.2019.02.079. Epub 2019 Feb 26.
• [622] Protein and gene expression characteristics of heterogeneous nuclear ribonucleoprotein H1 in esophageal squamous cell carcinoma.World J Gastroenterol. 2016 Aug 28;22(32):7322-31. doi: 10.3748/wjg.v22.i32.7322.
• [623] HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.Mol Cancer Res. 2008 Jan;6(1):31-41. doi: 10.1158/1541-7786.MCR-07-0213.
• [624] Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.Oncotarget. 2017 Jun 6;8(23):37740-37750. doi: 10.18632/oncotarget.17147.
• [625] Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal squamous cell carcinoma.Cancer Sci. 2019 May;110(5):1735-1745. doi: 10.1111/cas.13993. Epub 2019 Apr 5.
• [626] HOXC13 promotes proliferation of esophageal squamous cell carcinoma via repressing transcription of CASP3.Cancer Sci. 2018 Feb;109(2):317-329. doi: 10.1111/cas.13453. Epub 2017 Dec 20.
• [627] Increased HOXC6 expression predicts chemotherapy sensitivity in patients with esophageal squamous cell carcinoma.Oncol Lett. 2017 Oct;14(4):4835-4840. doi: 10.3892/ol.2017.6772. Epub 2017 Aug 18.
• [628] Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.J Cell Biochem. 2019 Aug;120(8):13717-13725. doi: 10.1002/jcb.28644. Epub 2019 Apr 2.
• [629] Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma.World J Surg Oncol. 2013 Jun 18;11:141. doi: 10.1186/1477-7819-11-141.
• [630] Expression of Heat Shock Protein-27 (Hsp27) and P38MAPK in Esophageal Squamous Cell Carcinoma.Med Sci Monit. 2017 Nov 3;23:5246-5253. doi: 10.12659/msm.904912.
• [631] The protein-protein interaction network and clinical significance of heat-shock proteins in esophageal squamous cell carcinoma.Amino Acids. 2018 Jun;50(6):685-697. doi: 10.1007/s00726-018-2569-8. Epub 2018 Apr 27.
• [632] Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma.Front Oncol. 2019 Oct 25;9:1117. doi: 10.3389/fonc.2019.01117. eCollection 2019.
• [633] Transcriptome network analysis reveals potential candidate genes for esophageal squamous cell carcinoma.Asian Pac J Cancer Prev. 2012;13(3):767-73. doi: 10.7314/apjcp.2012.13.3.767.
• [634] Overexpression of IFITM3 predicts poor prognosis in stage IIA esophageal squamous cell carcinoma after Ivor Lewis esophagectomy.Thorac Cancer. 2017 Nov;8(6):592-599. doi: 10.1111/1759-7714.12488. Epub 2017 Aug 30.
• [635] Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma.Cancer Res. 1995 Feb 15;55(4):891-4.
• [636] Prognostic significance of preoperative IKBKE expression in esophageal squamous cell carcinoma.Onco Targets Ther. 2018 Mar 7;11:1305-1314. doi: 10.2147/OTT.S156818. eCollection 2018.
• [637] Interleukin 1B rs16944 G>A polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.Clin Biochem. 2013 Oct;46(15):1469-73. doi: 10.1016/j.clinbiochem.2013.05.050. Epub 2013 May 29.
• [638] NF45 promotes esophageal squamous carcinoma cell invasion by increasing Rac1 activity through 14-3-3 protein.Arch Biochem Biophys. 2019 Mar 15;663:101-108. doi: 10.1016/j.abb.2018.12.012. Epub 2018 Dec 11.
• [639] An NF90/long noncoding RNA-LET/miR-548k feedback amplification loop controls esophageal squamous cell carcinoma progression.J Cancer. 2019 Aug 28;10(21):5139-5152. doi: 10.7150/jca.30816. eCollection 2019.
• [640] Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer.Cancer Res. 2001 Jun 1;61(11):4345-9.
• [641] ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-B/MMP-9 signaling pathway.Biochem Biophys Res Commun. 2018 Feb 5;496(2):387-393. doi: 10.1016/j.bbrc.2018.01.045. Epub 2018 Jan 8.
• [642] Allelic loss on chromosome 13q14 and mutation in deleted in cancer 1 gene in esophageal squamous cell carcinoma.Oncogene. 2003 Jan 16;22(2):314-8. doi: 10.1038/sj.onc.1206098.
• [643] Overexpression of IQGAP1 promotes the angiogenesis of esophageal squamous cell carcinoma through the AKT and ERKmediated VEGFVEGFR2 signaling pathway.Oncol Rep. 2018 Sep;40(3):1795-1802. doi: 10.3892/or.2018.6558. Epub 2018 Jul 11.
• [644] RNA editing is induced by type I interferon in esophageal squamous cell carcinoma.Tumour Biol. 2017 Jul;39(7):1010428317708546. doi: 10.1177/1010428317708546.
• [645] Overexpression of OLC1 promotes tumorigenesis of human esophageal squamous cell carcinoma.PLoS One. 2014 Mar 7;9(3):e90958. doi: 10.1371/journal.pone.0090958. eCollection 2014.
• [646] Integrin 7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma.Nat Commun. 2016 Dec 7;7:13568. doi: 10.1038/ncomms13568.
• [647] MicroRNA-133b/EGFR axis regulates esophageal squamous cell carcinoma metastases by suppressing anoikis resistance and anchorage-independent growth.Cancer Cell Int. 2018 Nov 22;18:193. doi: 10.1186/s12935-018-0684-y. eCollection 2018.
• [648] NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc.Cancer Commun (Lond). 2018 Jun 5;38(1):33. doi: 10.1186/s40880-018-0307-y.
• [649] Contribution of KCTD12 to esophageal squamous cell carcinoma.BMC Cancer. 2018 Aug 29;18(1):853. doi: 10.1186/s12885-018-4765-z.
• [650] The Prognostic Significance of Histone Demethylase UTX in Esophageal Squamous Cell Carcinoma.Int J Mol Sci. 2018 Jan 19;19(1):297. doi: 10.3390/ijms19010297.
• [651] Prognostic and clinicopathological significance of kinesin family member C1 in various cancers: A meta-analysis.Medicine (Baltimore). 2019 Oct;98(40):e17346. doi: 10.1097/MD.0000000000017346.
• [652] Cell Signaling Pathway in 12-O-Tetradecanoylphorbol-13-acetate-Induced LCN2 Gene Transcription in Esophageal Squamous Cell Carcinoma.Biomed Res Int. 2017;2017:9592501. doi: 10.1155/2017/9592501. Epub 2017 Oct 2.
• [653] Krppel-like factor 9 was down-regulated in esophageal squamous cell carcinoma and negatively regulated beta-catenin/TCF signaling.Mol Carcinog. 2016 Mar;55(3):280-91. doi: 10.1002/mc.22277. Epub 2015 Jan 16.
• [654] KLK11 suppresses cellular proliferation via inhibition of Wnt/-catenin signaling pathway in esophageal squamous cell carcinoma.Am J Cancer Res. 2019 Oct 1;9(10):2264-2277. eCollection 2019.
• [655] Correction to: Expression of kallikrein-related peptidase 13 is associated with poor prognosis in esophageal squamous cell carcinoma.Gen Thorac Cardiovasc Surg. 2018 Jun;66(6):376-377. doi: 10.1007/s11748-018-0923-0.
• [656] MLL3 promotes the senescence of esophageal squamous cell carcinoma.Onco Targets Ther. 2019 Mar 1;12:1575-1582. doi: 10.2147/OTT.S187540. eCollection 2019.
• [657] shRNAmediated knockdown of KNTC1 suppresses cell viability and induces apoptosis in esophageal squamous cell carcinoma.Int J Oncol. 2019 Mar;54(3):1053-1060. doi: 10.3892/ijo.2019.4672. Epub 2019 Jan 3.
• [658] SNHG8 is upregulated in esophageal squamous cell carcinoma and directly sponges microRNA-411 to increase oncogenicity by upregulating KPNA2.Onco Targets Ther. 2019 Aug 28;12:6991-7004. doi: 10.2147/OTT.S214881. eCollection 2019.
• [659] Krppel-like Factor 4 Promotes Esophageal Squamous Cell Carcinoma Differentiation by Up-regulating Keratin 13 Expression.J Biol Chem. 2015 May 22;290(21):13567-77. doi: 10.1074/jbc.M114.629717. Epub 2015 Apr 7.
• [660] Fascin and CK4 as biomarkers for esophageal squamous cell carcinoma.Anticancer Res. 2011 Mar;31(3):945-52.
• [661] Evaluation of serum HGF and CK18 levels in patients with esophageal cancer.Genet Mol Res. 2016 Aug 29;15(3). doi: 10.4238/gmr.15038583.
• [662] Circulatory miR-98-5p levels are deregulated during diabetes and it inhibits proliferation and promotes apoptosis by targeting PPP1R15B in keratinocytes.RNA Biol. 2020 Feb;17(2):188-201. doi: 10.1080/15476286.2019.1673117. Epub 2019 Oct 15.
• [663] MicroRNA-202 inhibits tumor progression by targeting LAMA1 in esophageal squamous cell carcinoma.Biochem Biophys Res Commun. 2016 May 13;473(4):821-827. doi: 10.1016/j.bbrc.2016.03.130. Epub 2016 Apr 1.
• [664] Elevated HBXIP expression is associated with aggressive phenotype and poor prognosis in esophageal squamous cell carcinoma.Am J Cancer Res. 2017 Nov 1;7(11):2190-2198. eCollection 2017.
• [665] Clinical Significance and Phenotype of MTA1 Expression in Esophageal Squamous Cell Carcinoma.Anticancer Res. 2017 Aug;37(8):4147-4155. doi: 10.21873/anticanres.11802.
• [666] The transcription factor LEF1 promotes tumorigenicity and activates the TGF- signaling pathway in esophageal squamous cell carcinoma.J Exp Clin Cancer Res. 2019 Jul 11;38(1):304. doi: 10.1186/s13046-019-1296-7.
• [667] Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma.Hum Pathol. 2018 Nov;81:148-156. doi: 10.1016/j.humpath.2018.07.001. Epub 2018 Jul 18.
• [668] Are Serum Mac 2-Binding Protein Levels Elevated in Esophageal Cancer? A Control Study of Esophageal Squamous Cell Carcinoma Patients.Dis Markers. 2018 Apr 17;2018:3610239. doi: 10.1155/2018/3610239. eCollection 2018.
• [669] Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model.Int J Mol Sci. 2019 May 29;20(11):2634. doi: 10.3390/ijms20112634.
• [670] Downregulation of LGI1 promotes tumor metastasis in esophageal squamous cell carcinoma.Carcinogenesis. 2014 May;35(5):1154-61. doi: 10.1093/carcin/bgu040. Epub 2014 Feb 7.
• [671] Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma.Cancer Res. 2004 Jun 15;64(12):4378-84. doi: 10.1158/0008-5472.CAN-04-0372.
• [672] Hugl-1 induces apoptosis in esophageal carcinoma cells both in vitro and in vivo.World J Gastroenterol. 2013 Jul 14;19(26):4127-36. doi: 10.3748/wjg.v19.i26.4127.
• [673] Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma.Gigascience. 2016 Jan 11;5:1. doi: 10.1186/s13742-015-0107-0. eCollection 2016.
• [674] The Clinical Prognostic Value of LRG1 in Esophageal Squamous Cell Carcinoma.Curr Cancer Drug Targets. 2019;19(9):756-763. doi: 10.2174/1568009619666190204095942.
• [675] Genetic or epigenetic silencing of low density lipoprotein receptor-related protein 1B expression in oral squamous cell carcinoma.Cancer Sci. 2006 Oct;97(10):1070-4. doi: 10.1111/j.1349-7006.2006.00283.x.
• [676] LRRC8A Expression Influences Growth of Esophageal Squamous Cell Carcinoma.Am J Pathol. 2019 Oct;189(10):1973-1985. doi: 10.1016/j.ajpath.2019.06.006. Epub 2019 Jul 16.
• [677] Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma.BMC Cancer. 2017 Aug 14;17(1):544. doi: 10.1186/s12885-017-3523-y.
• [678] The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome.Int J Cancer. 2011 Aug 1;129(3):565-73. doi: 10.1002/ijc.25698. Epub 2010 Nov 9.
• [679] MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.Biomed Pharmacother. 2018 Sep;105:350-361. doi: 10.1016/j.biopha.2018.05.149. Epub 2018 Jun 1.
• [680] MACC1 induces autophagy to regulate proliferation, apoptosis, migration and invasion of squamous cell carcinoma.Oncol Rep. 2017 Oct;38(4):2369-2377. doi: 10.3892/or.2017.5889. Epub 2017 Aug 8.
• [681] REV7 confers radioresistance of esophagus squamous cell carcinoma by recruiting PRDX2.Cancer Sci. 2019 Mar;110(3):962-972. doi: 10.1111/cas.13946. Epub 2019 Feb 8.
• [682] Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer.Oncotarget. 2017 Jul 18;8(29):47518-47532. doi: 10.18632/oncotarget.17671.
• [683] Identification of novel NRAGE involved in the radioresistance of esophageal cancer cells.Tumour Biol. 2016 Jul;37(7):8741-52. doi: 10.1007/s13277-015-4747-6. Epub 2016 Jan 7.
• [684] Increased expression of MARCH8, an E3 ubiquitin ligase, is associated with growth of esophageal tumor.Cancer Cell Int. 2017 Dec 4;17:116. doi: 10.1186/s12935-017-0490-y. eCollection 2017.
• [685] Dysphagia predict the response to second cycle neoadjuvant chemotherapy in first cycle no response esophageal carcinoma.J Thorac Dis. 2019 Oct;11(10):4135-4143. doi: 10.21037/jtd.2019.10.02.
• [686] High p53 and MAP1 light chain 3A co-expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.Mol Med Rep. 2013 Jul;8(1):41-6. doi: 10.3892/mmr.2013.1451. Epub 2013 Apr 30.
• [687] Ablation of MCM10 using CRISPR/Cas9 restrains the growth and migration of esophageal squamous cell carcinoma cells through inhibition of Akt signaling.Onco Targets Ther. 2018 Jun 6;11:3323-3333. doi: 10.2147/OTT.S157025. eCollection 2018.
• [688] MSP58 knockdown inhibits the proliferation of esophageal squamous cell carcinoma in vitro and in vivo.Asian Pac J Cancer Prev. 2012;13(7):3233-8. doi: 10.7314/apjcp.2012.13.7.3233.
• [689] Monocarboxylate transporter1 is an independent prognostic factor in esophageal squamous cell carcinoma.Oncol Rep. 2019 Apr;41(4):2529-2539. doi: 10.3892/or.2019.6992. Epub 2019 Jan 31.
• [690] DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage.Cancer Sci. 2005 Sep;96(9):571-7. doi: 10.1111/j.1349-7006.2005.00082.x.
• [691] Downregulation of MED23 promoted the tumorigenecity of esophageal squamous cell carcinoma.Mol Carcinog. 2014 Oct;53(10):833-40. doi: 10.1002/mc.22041. Epub 2013 Apr 27.
• [692] Focally amplified lncRNA on chromosome 1 regulates apoptosis of esophageal cancer cells via DRP1 and mitochondrial dynamics.IUBMB Life. 2019 Feb;71(2):254-260. doi: 10.1002/iub.1971. Epub 2018 Nov 30.
• [693] MIB-1 index is unlikely to predict relapse-free survival in patients who underwent R0-esophagectomy for esophageal squamous cell carcinoma.Dis Esophagus. 2018 May 1;31(5). doi: 10.1093/dote/dox145.
• [694] Implication of Highly Cytotoxic Natural Killer Cells for Esophageal Squamous Cell Carcinoma Treatment.J Immunother. 2018 Jul/Aug;41(6):261-273. doi: 10.1097/CJI.0000000000000227.
• [695] Aquaporin 1 suppresses apoptosis and affects prognosis in esophageal squamous cell carcinoma.Oncotarget. 2018 Jul 6;9(52):29957-29974. doi: 10.18632/oncotarget.25722. eCollection 2018 Jul 6.
• [696] Polymorphisms in mTORC1 genes modulate risk of esophageal squamous cell carcinoma in eastern Chinese populations.J Thorac Oncol. 2013 Jun;8(6):788-95. doi: 10.1097/JTO.0b013e31828916c6.
• [697] Genetic variation in miR-100 rs1834306 is associated with decreased risk for esophageal squamous cell carcinoma in Kazakh patients in northwest China.Int J Clin Exp Pathol. 2015 Jun 1;8(6):7332-40. eCollection 2015.
• [698] Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.Carcinogenesis. 2004 Dec;25(12):2353-60. doi: 10.1093/carcin/bgh270. Epub 2004 Aug 27.
• [699] Down-regulation of RIP3 potentiates cisplatin chemoresistance by triggering HSP90-ERK pathway mediated DNA repair in esophageal squamous cell carcinoma.Cancer Lett. 2018 Apr 1;418:97-108. doi: 10.1016/j.canlet.2018.01.022. Epub 2018 Jan 10.
• [700] p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions.Oncol Rep. 2006 Jun;15(6):1591-7.
• [701] Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation.Mol Cancer. 2005 Dec 13;4:42. doi: 10.1186/1476-4598-4-42.
• [702] The role of mitochondrial folate enzyme MTHFD1L in esophageal squamous cell carcinoma.Scand J Gastroenterol. 2018 May;53(5):533-540. doi: 10.1080/00365521.2017.1407440. Epub 2017 Nov 24.
• [703] The impact of Metastasis Suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance.J Transl Med. 2011 Jun 22;9:95. doi: 10.1186/1479-5876-9-95.
• [704] The expression and prognostic significance of Mucin 13 and Mucin 20 in esophageal squamous cell carcinoma.J Cancer Res Ther. 2015 Aug;11 Suppl 1:C74-9. doi: 10.4103/0973-1482.163846.
• [705] Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR.Clin Cancer Res. 2005 Mar 15;11(6):2205-14. doi: 10.1158/1078-0432.CCR-04-1091.
• [706] Prognostic implications and oncogenic roles of MYBL2 protein expression in esophageal squamous-cell carcinoma.Onco Targets Ther. 2019 Mar 8;12:1917-1927. doi: 10.2147/OTT.S190145. eCollection 2019.
• [707] Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review).Oncol Rep. 2003 Sep-Oct;10(5):1615-23.
• [708] MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas.J Hum Genet. 2002;47(9):460-4. doi: 10.1007/s100380200065.
• [709] Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma.PLoS One. 2017 Apr 7;12(4):e0175280. doi: 10.1371/journal.pone.0175280. eCollection 2017.
• [710] Correlations of ALDH2 rs671 and C12orf30 rs4767364 polymorphisms with increased risk and prognosis of esophageal squamous cell carcinoma in the Kazak and Han populations in Xinjiang province.J Clin Lab Anal. 2018 Feb;32(2):e22248. doi: 10.1002/jcla.22248. Epub 2017 May 2.
• [711] Aberrant chimeric RNA GOLM1-MAK10 encoding a secreted fusion protein as a molecular signature for human esophageal squamous cell carcinoma.Oncotarget. 2013 Nov;4(11):2135-43. doi: 10.18632/oncotarget.1465.
• [712] The prognostic value of B7-H6 in esophageal squamous cell carcinoma.Sci Rep. 2019 Dec 2;9(1):18122. doi: 10.1038/s41598-019-54731-9.
• [713] Identification of hub genes and therapeutic drugs in esophageal squamous cell carcinoma based on integrated bioinformatics strategy.Cancer Cell Int. 2019 May 22;19:142. doi: 10.1186/s12935-019-0854-6. eCollection 2019.
• [714] Immediate and substantial evolution of T-cell repertoire in peripheral blood and tumor microenvironment of patients with esophageal squamous cell carcinoma treated with preoperative chemotherapy.Carcinogenesis. 2018 Dec 13;39(11):1389-1398. doi: 10.1093/carcin/bgy116.
• [715] Expression of NDRG2 in esophageal squamous cell carcinoma.Cancer Sci. 2010 May;101(5):1292-9. doi: 10.1111/j.1349-7006.2010.01529.x. Epub 2010 Feb 11.
• [716] Elevated Nectin-2 expression is involved in esophageal squamous cell carcinoma by promoting cell migration and invasion.Oncol Lett. 2018 Apr;15(4):4731-4736. doi: 10.3892/ol.2018.7953. Epub 2018 Feb 5.
• [717] Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma.PLoS One. 2010 Feb 3;5(2):e9003. doi: 10.1371/journal.pone.0009003.
• [718] A NEIL1 single nucleotide polymorphism (rs4462560) predicts the risk of radiation-induced toxicities in esophageal cancer patients treated with definitive radiotherapy.Cancer. 2013 Dec 1;119(23):4205-11. doi: 10.1002/cncr.28338. Epub 2013 Sep 10.
• [719] The noncoding function of NELFA mRNA promotes the development of oesophageal squamous cell carcinoma by regulating the Rad17-RFC2-5 complex.Mol Oncol. 2020 Mar;14(3):611-624. doi: 10.1002/1878-0261.12619. Epub 2020 Jan 28.
• [720] Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC.Clin Cancer Res. 2001 Aug;7(8):2213-21.
• [721] NFAT1 promotes cell motility through MMP-3 in esophageal squamous cell carcinoma.Biomed Pharmacother. 2017 Feb;86:541-546. doi: 10.1016/j.biopha.2016.12.050. Epub 2016 Dec 23.
• [722] Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma.Cancer Med. 2018 May;7(5):1756-1765. doi: 10.1002/cam4.1434. Epub 2018 Mar 25.
• [723] MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC).Biomed Pharmacother. 2015 Dec;76:82-93. doi: 10.1016/j.biopha.2015.10.005. Epub 2015 Nov 10.
• [724] Association of single nucleotide polymorphisms in ERCC2 gene and their haplotypes with esophageal squamous cell carcinoma.Tumour Biol. 2014 May;35(5):4225-31. doi: 10.1007/s13277-013-1553-x. Epub 2014 Jan 4.
• [725] Inhibition of PC4 radiosensitizes non-small cell lung cancer by transcriptionally suppressing XLF.Cancer Med. 2018 Apr;7(4):1326-1337. doi: 10.1002/cam4.1332. Epub 2018 Mar 9.
• [726] Elevated levels of serum nidogen-2 in esophageal squamous cell carcinoma.Cancer Biomark. 2018 Feb 14;21(3):583-590. doi: 10.3233/CBM-170484.
• [727] Nkx2-8 downregulation promotes angiogenesis and activates NF-B in esophageal cancer.Cancer Res. 2013 Jun 15;73(12):3638-48. doi: 10.1158/0008-5472.CAN-12-4028. Epub 2013 Apr 19.
• [728] Downregulation of NONO induces apoptosis, suppressing growth and invasion in esophageal squamous cell carcinoma.Oncol Rep. 2018 Jun;39(6):2575-2583. doi: 10.3892/or.2018.6334. Epub 2018 Mar 27.
• [729] Positive transforming growth factor- activated kinase-1 expression has an unfavorable impact on survival in T3N1-3M0 esophageal squamous cell carcinomas.Ann Thorac Surg. 2013 Jan;95(1):285-90. doi: 10.1016/j.athoracsur.2012.09.050. Epub 2012 Dec 25.
• [730] NR2F1-induced NR2F1-AS1 promotes esophageal squamous cell carcinoma progression via activating Hedgehog signaling pathway.Biochem Biophys Res Commun. 2019 Nov 12;519(3):497-504. doi: 10.1016/j.bbrc.2019.09.015. Epub 2019 Sep 14.
• [731] NRD1, which encodes nardilysin protein, promotes esophageal cancer cell invasion through induction of MMP2 and MMP3 expression.Cancer Sci. 2014 Jan;105(1):134-40. doi: 10.1111/cas.12316. Epub 2013 Nov 29.
• [732] MicroRNA-548-3p and MicroRNA-576-5p enhance the migration and invasion of esophageal squamous cell carcinoma cells via NRIP1 down-regulation.Neoplasma. 2018 Nov 15;65(6):881-887. doi: 10.4149/neo_2018_171206N803. Epub 2018 Jun 17.
• [733] Discovery and Validation of a Serologic Autoantibody Panel for Early Diagnosis of Esophageal Squamous Cell Carcinoma.Cancer Epidemiol Biomarkers Prev. 2019 Sep;28(9):1454-1460. doi: 10.1158/1055-9965.EPI-18-1269. Epub 2019 Jun 25.
• [734] Prognostic impact of MutT homolog-1 expression on esophageal squamous cell carcinoma.Cancer Med. 2017 Jan;6(1):258-266. doi: 10.1002/cam4.979. Epub 2016 Dec 5.
• [735] Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients.Cancer Biol Ther. 2018 Jan 2;19(1):34-41. doi: 10.1080/15384047.2016.1276131. Epub 2017 Dec 18.
• [736] Nucleolar spindle-associated protein 1 promotes tumorigenesis and predicts poor prognosis in human esophageal squamous cell carcinoma.J Cell Biochem. 2019 Jul;120(7):11726-11737. doi: 10.1002/jcb.28452. Epub 2019 Feb 21.
• [737] OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability.Oncogene. 2018 Jun;37(25):3356-3368. doi: 10.1038/s41388-018-0224-1. Epub 2018 Mar 21.
• [738] Suppressor PAQR3 associated with the clinical significance and prognosis in esophageal squamous cell carcinoma.Oncol Lett. 2018 Apr;15(4):5703-5711. doi: 10.3892/ol.2018.8004. Epub 2018 Feb 8.
• [739] Singlecell intratumoral stemness analysis reveals the involvement of cell cycle and DNA damage repair in two different types of esophageal cancer.Oncol Rep. 2019 Jun;41(6):3201-3208. doi: 10.3892/or.2019.7117. Epub 2019 Apr 15.
• [740] Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma.Biomed Pharmacother. 2019 Dec;120:109488. doi: 10.1016/j.biopha.2019.109488. Epub 2019 Oct 16.
• [741] Prognostic value of PAX9 in patients with esophageal squamous cell carcinoma and its prediction value to radiation sensitivity.Mol Med Rep. 2017 Jul;16(1):806-816. doi: 10.3892/mmr.2017.6626. Epub 2017 May 25.
• [742] Poly (C)-binding protein 2 (PCBP2) promotes the progression of esophageal squamous cell carcinoma (ESCC) through regulating cellular proliferation and apoptosis.Pathol Res Pract. 2016 Aug;212(8):717-25. doi: 10.1016/j.prp.2016.05.008. Epub 2016 May 27.
• [743] Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma.Carcinogenesis. 2010 Jun;31(6):1027-36. doi: 10.1093/carcin/bgq053. Epub 2010 Mar 3.
• [744] Cancers Due to Smoking and High Alcohol Consumption.Dtsch Arztebl Int. 2018 Sep 3;115(35-36):571-577. doi: 10.3238/arztebl.2018.0571.
• [745] Piccolo mediates EGFR signaling and acts as a prognostic biomarker in esophageal squamous cell carcinoma.Oncogene. 2017 Jul 6;36(27):3890-3902. doi: 10.1038/onc.2017.15. Epub 2017 Mar 6.
• [746] Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.Int J Oncol. 2007 Jan;30(1):97-103.
• [747] PDHA1 Gene Knockout In Human Esophageal Squamous Cancer Cells Resulted In Greater Warburg Effect And Aggressive Features In Vitro And In Vivo.Onco Targets Ther. 2019 Nov 18;12:9899-9913. doi: 10.2147/OTT.S226851. eCollection 2019.
• [748] Systematic profiling identifies PDLIM2 as a novel prognostic predictor for oesophageal squamous cell carcinoma (ESCC).J Cell Mol Med. 2019 Aug;23(8):5751-5761. doi: 10.1111/jcmm.14491. Epub 2019 Jun 20.
• [749] Overexpression of LASP1 is associated with proliferation, migration and invasion in esophageal squamous cell carcinoma.Oncol Rep. 2013 Mar;29(3):1115-23. doi: 10.3892/or.2012.2199. Epub 2012 Dec 19.
• [750] The expression of podoplanin protein is a diagnostic marker to distinguish the early infiltration of esophageal squamous cell carcinoma.Oncotarget. 2017 Mar 21;8(12):19013-19020. doi: 10.18632/oncotarget.14596.
• [751] Enhanced Expression of Fibroblast Growth Factor Receptor 3 IIIc Promotes Human Esophageal Carcinoma Cell Proliferation.J Histochem Cytochem. 2016 Jan;64(1):7-17. doi: 10.1369/0022155415616161. Epub 2015 Oct 20.
• [752] Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 axis.Cancer Lett. 2019 May 28;450:22-31. doi: 10.1016/j.canlet.2019.02.014. Epub 2019 Feb 13.
• [753] miRNA-Related Polymorphisms in miR-423 (rs6505162) and PEX6 (rs1129186) and Risk of Esophageal Squamous Cell Carcinoma in an Iranian Cohort.Genet Test Mol Biomarkers. 2017 Jun;21(6):382-390. doi: 10.1089/gtmb.2016.0346. Epub 2017 Apr 21.
• [754] Tissue-based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma.Cancer Med. 2018 Jun;7(6):2504-2517. doi: 10.1002/cam4.1463. Epub 2018 Apr 23.
• [755] Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma.Acta Histochem. 2013 Jan;115(1):56-62. doi: 10.1016/j.acthis.2012.04.001. Epub 2012 Apr 23.
• [756] Low PHLDA3 expression in oesophageal squamous cell carcinomas is associated with poor prognosis.Anticancer Res. 2015 Feb;35(2):949-54.
• [757] Histone Demethylase LSD1 Inhibitors Prevent Cell Growth by Regulating Gene Expression in Esophageal Squamous Cell Carcinoma Cells.Ann Surg Oncol. 2016 Jan;23(1):312-20. doi: 10.1245/s10434-015-4488-1. Epub 2015 Mar 20.
• [758] Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma.BMC Cancer. 2015 Aug 6;15:575. doi: 10.1186/s12885-015-1581-6.
• [759] MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.Biochem Biophys Res Commun. 2018 Jun 22;501(2):507-513. doi: 10.1016/j.bbrc.2018.05.025. Epub 2018 May 16.
• [760] Phosphatidylinositol 3-kinase-C2 inhibits cisplatin-mediated apoptosis via the Akt pathway in oesophageal squamous cell carcinoma.J Int Med Res. 2011;39(4):1319-32. doi: 10.1177/147323001103900419.
• [761] MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.Int J Clin Exp Pathol. 2015 May 1;8(5):4745-54. eCollection 2015.
• [762] Esophageal squamous cell carcinoma transcriptome reveals the effect of FOXM1 on patient outcome through novel PIK3R3 mediated activation of PI3K signaling pathway.Oncotarget. 2018 Mar 30;9(24):16634-16647. doi: 10.18632/oncotarget.24621. eCollection 2018 Mar 30.
• [763] High Expression of the Mitophagy-Related Protein Pink1 is Associated with a Poor Response to Chemotherapy and a Poor Prognosis for Patients Treated with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.Ann Surg Oncol. 2017 Dec;24(13):4025-4032. doi: 10.1245/s10434-017-6096-8. Epub 2017 Oct 11.
• [764] DNA hypermethyation and silencing of PITX1 correlated with advanced stage and poor postoperative prognosis of esophageal squamous cell carcinoma.Oncotarget. 2017 Sep 28;8(48):84434-84448. doi: 10.18632/oncotarget.21375. eCollection 2017 Oct 13.
• [765] Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell-like Phenotype via Dysregulation of PITX2.Clin Cancer Res. 2017 Jan 1;23(1):298-310. doi: 10.1158/1078-0432.CCR-16-0414. Epub 2016 Jul 12.
• [766] Association of single nucleotide polymorphisms in the prostaglandin-endoperoxide synthase 2 (PTGS2) and phospholipase A?group IIA (PLA2G2A) genes with susceptibility to esophageal squamous cell carcinoma.Asian Pac J Cancer Prev. 2014;15(4):1797-802. doi: 10.7314/apjcp.2014.15.4.1797.
• [767] Characterization of a novel tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous cell carcinoma.Cancer Res. 2007 Nov 15;67(22):10720-6. doi: 10.1158/0008-5472.CAN-07-2411.
• [768] Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population.Mol Biol Rep. 2012 Sep;39(9):9105-11. doi: 10.1007/s11033-012-1782-x. Epub 2012 Jun 29.
• [769] The down-regulation of TAPP2 inhibits the migration of esophageal squamous cell carcinoma and predicts favorable outcome.Pathol Res Pract. 2017 Dec;213(12):1556-1562. doi: 10.1016/j.prp.2017.09.010. Epub 2017 Sep 12.
• [770] MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway.EBioMedicine. 2019 Aug;46:66-78. doi: 10.1016/j.ebiom.2019.07.050. Epub 2019 Aug 2.
• [771] Phosphorylation of ETS-1 is a critical event in DNA polymerase iota-induced invasion and metastasis of esophageal squamous cell carcinoma.Cancer Sci. 2017 Dec;108(12):2503-2510. doi: 10.1111/cas.13399. Epub 2017 Oct 8.
• [772] Long noncoding RNAs POLR2E rs3787016 C/T and HULC rs7763881 A/C polymorphisms are associated with decreased risk of esophageal cancer.Tumour Biol. 2015 Aug;36(8):6401-8. doi: 10.1007/s13277-015-3328-z. Epub 2015 Mar 31.
• [773] Down-regulation of POTEG predicts poor prognosis in esophageal squamous cell carcinoma patients.Mol Carcinog. 2018 Jul;57(7):886-895. doi: 10.1002/mc.22809. Epub 2018 Apr 6.
• [774] Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma.Tumour Biol. 2015 Mar;36(3):1643-51. doi: 10.1007/s13277-014-2763-6. Epub 2014 Oct 31.
• [775] Interaction between alcohol consumption and CYP 2C19 gene polymorphism in relation to oesophageal squamous cell carcinoma.PLoS One. 2012;7(9):e43412. doi: 10.1371/journal.pone.0043412. Epub 2012 Sep 11.
• [776] Aberrant DNA hypermethylation reduces the expression of the desmosome-related molecule periplakin in esophageal squamous cell carcinoma.Cancer Med. 2015 Mar;4(3):415-25. doi: 10.1002/cam4.369. Epub 2015 Jan 12.
• [777] PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.BMC Cancer. 2019 Jun 14;19(1):585. doi: 10.1186/s12885-019-5818-7.
• [778] Clinicopathological significance of pRb2/p130 expression in squamous cell carcinoma of the esophagus.J Cancer Res Clin Oncol. 2002 Dec;128(12):691-6. doi: 10.1007/s00432-002-0395-5. Epub 2002 Nov 26.
• [779] Effect of the downregulation of SMYD3 expression by RNAi on RIZ1 expression and proliferation of esophageal squamous cell carcinoma.Oncol Rep. 2014 Sep;32(3):1064-70. doi: 10.3892/or.2014.3307. Epub 2014 Jul 3.
• [780] Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma.Oncol Rep. 2013 Nov;30(5):2297-303. doi: 10.3892/or.2013.2714. Epub 2013 Sep 4.
• [781] Overexpression of Peroxiredoxin 6 (PRDX6) Promotes the Aggressive Phenotypes of Esophageal Squamous Cell Carcinoma.J Cancer. 2018 Oct 10;9(21):3939-3949. doi: 10.7150/jca.26041. eCollection 2018.
• [782] PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.Cancer Sci. 2018 Feb;109(2):412-421. doi: 10.1111/cas.13454. Epub 2017 Dec 28.
• [783] Overexpression of PRR11 promotes tumorigenic capability and is associated with progression in esophageal squamous cell carcinoma.Onco Targets Ther. 2019 Apr 9;12:2677-2693. doi: 10.2147/OTT.S180255. eCollection 2019.
• [784] Epigenetic silencing of the PRSS3 putative tumor suppressor gene in non-small cell lung cancer.Mol Carcinog. 2005 Oct;44(2):146-50. doi: 10.1002/mc.20125.
• [785] Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.Cancer Lett. 2018 Apr 1;418:125-134. doi: 10.1016/j.canlet.2018.01.025. Epub 2018 Jan 10.
• [786] PSMD7 downregulation induces apoptosis and suppresses tumorigenesis of esophageal squamous cell carcinoma via the mTOR/p70S6K pathway.FEBS Open Bio. 2018 Mar 7;8(4):533-543. doi: 10.1002/2211-5463.12394. eCollection 2018 Apr.
• [787] Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma.Tumour Biol. 2017 Jun;39(6):1010428317705013. doi: 10.1177/1010428317705013.
• [788] Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.Ann Thorac Surg. 2012 May;93(5):1674-80. doi: 10.1016/j.athoracsur.2011.12.056. Epub 2012 Mar 17.
• [789] PTPN9 promotes cell proliferation and invasion in Eca109 cells and is negatively regulated by microRNA-126.Oncol Lett. 2017 Aug;14(2):1419-1426. doi: 10.3892/ol.2017.6315. Epub 2017 Jun 6.
• [790] Aberrant methylation of the PTPRO gene in peripheral blood as a potential biomarker in esophageal squamous cell carcinoma patients.Cancer Lett. 2012 Feb 28;315(2):138-44. doi: 10.1016/j.canlet.2011.08.032. Epub 2011 Sep 12.
• [791] The Functional Variant in the 3'UTR of PTPRT with the Risk of Esophageal Squamous Cell Carcinoma in a Chinese Population.Cell Physiol Biochem. 2015;36(1):306-14. doi: 10.1159/000374073. Epub 2015 May 5.
• [792] Preliminary evaluation for Bit1 as a potential biomarker for squamous cell carcinoma and adenocarcinoma of esophagus.Tumour Biol. 2017 May;39(5):1010428317708267. doi: 10.1177/1010428317708267.
• [793] The Pseudogene PTTG3P Promotes Cell Migration and Invasion in Esophageal Squamous Cell Carcinoma.Open Med (Wars). 2019 Jun 30;14:516-522. doi: 10.1515/med-2019-0057. eCollection 2019.
• [794] Increased expression of paxillin is found in human oesophageal squamous cell carcinoma: a tissue microarray study.J Int Med Res. 2008 Mar-Apr;36(2):273-8. doi: 10.1177/147323000803600209.
• [795] Association of PYGO2 and EGFR in esophageal squamous cell carcinoma.Med Oncol. 2013 Jun;30(2):516. doi: 10.1007/s12032-013-0516-9. Epub 2013 Mar 3.
• [796] MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma.Mol Cancer. 2016 Jun 29;15(1):51. doi: 10.1186/s12943-016-0533-3.
• [797] Long Non-Coding RNA LINC00152 Regulates Cell Proliferation, Migration And Invasion In Esophageal Squamous Cell Carcinoma Via miR-107/Rab10 Axis.Onco Targets Ther. 2019 Oct 17;12:8553-8567. doi: 10.2147/OTT.S221515. eCollection 2019.
• [798] RAB23, regulated by miR-92b, promotes the progression of esophageal squamous cell carcinoma.Gene. 2016 Dec 20;595(1):31-38. doi: 10.1016/j.gene.2016.09.028. Epub 2016 Sep 19.
• [799] Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma.Cancer Res. 2012 Nov 15;72(22):6024-35. doi: 10.1158/0008-5472.CAN-12-1269. Epub 2012 Sep 18.
• [800] Inhibitory effect of microRNA-455-5p on biological functions of esophageal squamous cell carcinoma Eca109 cells via Rab31.Exp Ther Med. 2018 Dec;16(6):4959-4966. doi: 10.3892/etm.2018.6820. Epub 2018 Oct 2.
• [801] Silencing of Rab3D suppresses the proliferation and invasion of esophageal squamous cell carcinoma cells.Biomed Pharmacother. 2017 Jul;91:402-407. doi: 10.1016/j.biopha.2017.04.010. Epub 2017 May 2.
• [802] Transcriptional gene expression profile of human esophageal squamous cell carcinoma.Genomics. 2003 May;81(5):481-8. doi: 10.1016/s0888-7543(03)00023-5.
• [803] RAD18 promotes the migration and invasion of esophageal squamous cell cancer via the JNK-MMPs pathway.Cancer Lett. 2018 Mar 28;417:65-74. doi: 10.1016/j.canlet.2017.12.034. Epub 2018 Jan 3.
• [804] Rap1A promotes esophageal squamous cell carcinoma metastasis through the AKT signaling pathway.Oncol Rep. 2019 Nov;42(5):1815-1824. doi: 10.3892/or.2019.7309. Epub 2019 Sep 12.
• [805] RasGRP3, a Ras guanyl releasing protein 3 that contributes to malignant proliferation and aggressiveness in human esophageal squamous cell carcinoma.Clin Exp Pharmacol Physiol. 2018 Jul;45(7):720-728. doi: 10.1111/1440-1681.12926. Epub 2018 Apr 10.
• [806] Epigenetic silencing of RASSF10 promotes tumor growth in esophageal squamous cell carcinoma.Discov Med. 2014 Apr;17(94):169-78.
• [807] Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.Clin Exp Metastasis. 2016 Jan;33(1):73-85. doi: 10.1007/s10585-015-9759-5.
• [808] RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.Clin Exp Metastasis. 2015 Jan;32(1):83-98. doi: 10.1007/s10585-015-9693-6. Epub 2015 Jan 13.
• [809] RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.J Genet Genomics. 2019 Oct 20;46(10):477-488. doi: 10.1016/j.jgg.2019.10.004. Epub 2019 Nov 14.
• [810] RASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma.Oncotarget. 2015 Oct 27;6(33):34510-24. doi: 10.18632/oncotarget.5923.
• [811] RBBP7 is a prognostic biomarker in patients with esophageal squamous cell carcinoma.Oncol Lett. 2018 Dec;16(6):7204-7211. doi: 10.3892/ol.2018.9543. Epub 2018 Oct 3.
• [812] Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.BMC Cancer. 2018 Nov 12;18(1):1106. doi: 10.1186/s12885-018-5032-z.
• [813] miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L.Pathol Res Pract. 2019 Jul;215(7):152427. doi: 10.1016/j.prp.2019.04.019. Epub 2019 Apr 28.
• [814] Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.Ann Surg Oncol. 2007 Dec;14(12):3593-601. doi: 10.1245/s10434-007-9562-x. Epub 2007 Sep 25.
• [815] KLF4 activates NFB signaling and esophageal epithelial inflammation via the Rho-related GTP-binding protein RHOF.PLoS One. 2019 Apr 18;14(4):e0215746. doi: 10.1371/journal.pone.0215746. eCollection 2019.
• [816] RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.Cell Death Dis. 2018 Oct 22;9(11):1085. doi: 10.1038/s41419-018-0979-x.
• [817] Expression of Rac-1 related to tumor depth, lymph node metastasis and patient prognosis in esophageal squamous cell carcinoma.Med Oncol. 2013 Dec;30(4):689. doi: 10.1007/s12032-013-0689-2. Epub 2013 Sep 12.
• [818] The Rho GTPase RhoE exerts tumor-suppressing effects in human esophageal squamous cell carcinoma via negatively regulating epidermal growth factor receptor.J Cancer Res Ther. 2016 Oct;12(Supplement):60-63. doi: 10.4103/0973-1482.191633.
• [819] RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.Int J Oncol. 2018 Mar;52(3):861-871. doi: 10.3892/ijo.2018.4253. Epub 2018 Jan 24.
• [820] RNF128 Promotes Invasion and Metastasis Via the EGFR/MAPK/MMP-2 Pathway in Esophageal Squamous Cell Carcinoma.Cancers (Basel). 2019 Jun 18;11(6):840. doi: 10.3390/cancers11060840.
• [821] Association between RNF2+P-AKT expression in pretreatment biopsy specimens, and poor survival following radiotherapy in patients with esophageal squamous cell carcinoma.Oncol Lett. 2019 Oct;18(4):3734-3742. doi: 10.3892/ol.2019.10727. Epub 2019 Aug 7.
• [822] Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.Anticancer Agents Med Chem. 2019;19(8):1021-1028. doi: 10.2174/1871520619666190307120811.
• [823] RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.Br J Cancer. 2012 Oct 9;107(8):1233-8. doi: 10.1038/bjc.2012.396. Epub 2012 Sep 6.
• [824] Prognostic significance and function of phosphorylated ribosomal protein S6 in esophageal squamous cell carcinoma.Mod Pathol. 2013 Mar;26(3):327-35. doi: 10.1038/modpathol.2012.161. Epub 2012 Sep 21.
• [825] Aberrant methylation of the Ras-related associated with diabetes gene in human primary esophageal cancer.Anticancer Res. 2013 Nov;33(11):5199-203.
• [826] Effects of PLCE1 gene silencing by RNA interference on cell cycling and apoptosis in esophageal carcinoma cells.Asian Pac J Cancer Prev. 2014;15(13):5437-42. doi: 10.7314/apjcp.2014.15.13.5437.
• [827] siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin.World J Gastroenterol. 2012 Aug 21;18(31):4127-35. doi: 10.3748/wjg.v18.i31.4127.
• [828] A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients.Int J Oncol. 2007 Feb;30(2):421-8.
• [829] Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma.Mol Med Rep. 2017 Feb;15(2):605-612. doi: 10.3892/mmr.2016.6056. Epub 2016 Dec 16.
• [830] Differential expression of S100 gene family in human esophageal squamous cell carcinoma.J Cancer Res Clin Oncol. 2004 Aug;130(8):480-6. doi: 10.1007/s00432-004-0555-x. Epub 2004 Jun 4.
• [831] S100A14 rs11548103 G>A polymorphism is associated with a decreased risk of esophageal cancer in a Chinese population.Oncotarget. 2017 Sep 14;8(49):86917-86923. doi: 10.18632/oncotarget.20868. eCollection 2017 Oct 17.
• [832] Downregulation of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.Oncol Lett. 2018 Aug;16(2):1801-1808. doi: 10.3892/ol.2018.8797. Epub 2018 May 24.
• [833] mRNA and methylation profiling of radioresistant esophageal cancer cells: the involvement of Sall2 in acquired aggressive phenotypes.J Cancer. 2017 Feb 25;8(4):646-656. doi: 10.7150/jca.15652. eCollection 2017.
• [834] Correlation between SALL4 stemness marker and bone morphogenetic protein signaling genes in esophageal squamous cell carcinoma.J Biochem Mol Toxicol. 2019 Mar;33(3):e22262. doi: 10.1002/jbt.22262. Epub 2018 Nov 15.
• [835] MiR-130b promotes the progression of oesophageal squamous cell carcinoma by targeting SASH1.J Cell Mol Med. 2019 Jan;23(1):93-103. doi: 10.1111/jcmm.13887. Epub 2018 Nov 15.
• [836] Prognostic value of SATB2 expression in patients with esophageal squamous cell carcinoma.Int J Clin Exp Pathol. 2015 Jan 1;8(1):423-31. eCollection 2015.
• [837] Upregulated long non-coding RNA SBF2-AS1 promotes proliferation in esophageal squamous cell carcinoma.Oncol Lett. 2018 Apr;15(4):5071-5080. doi: 10.3892/ol.2018.7968. Epub 2018 Feb 6.
• [838] Human SBK1 is dysregulated in multiple cancers and promotes survival of ovary cancer SK-OV-3 cells.Mol Biol Rep. 2011 Jun;38(5):3551-9. doi: 10.1007/s11033-010-0465-8. Epub 2010 Nov 20.
• [839] Overexpression of Suprabasin is Associated with Proliferation and Tumorigenicity of Esophageal Squamous Cell Carcinoma.Sci Rep. 2016 Feb 22;6:21549. doi: 10.1038/srep21549.
• [840] MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.World J Gastroenterol. 2015 Mar 21;21(11):3245-55. doi: 10.3748/wjg.v21.i11.3245.
• [841] Analysis of Sciellin (SCEL) as a candidate gene in esophageal squamous cell carcinoma.Anticancer Res. 2004 May-Jun;24(3a):1417-9.
• [842] SEL1L and squamous cell carcinoma of the esophagus.Clin Cancer Res. 2004 Sep 1;10(17):5857-61. doi: 10.1158/1078-0432.CCR-04-0075.
• [843] Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.Clin Exp Metastasis. 2019 Jun;36(3):225-241. doi: 10.1007/s10585-019-09964-3. Epub 2019 Mar 27.
• [844] Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma.Am J Pathol. 2000 Feb;156(2):567-75. doi: 10.1016/S0002-9440(10)64761-X.
• [845] SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4.Cancer Lett. 2020 Jan 28;469:390-398. doi: 10.1016/j.canlet.2019.11.011. Epub 2019 Nov 12.
• [846] Characterization of a novel mechanism of genomic instability involving the SEI1/SET/NM23H1 pathway in esophageal cancers.Cancer Res. 2010 Jul 15;70(14):5695-705. doi: 10.1158/0008-5472.CAN-10-0392. Epub 2010 Jun 22.
• [847] Directional Migration in Esophageal Squamous Cell Carcinoma (ESCC) is Epigenetically Regulated by SET Nuclear Oncogene, a Member of the Inhibitor of Histone Acetyltransferase Complex.Neoplasia. 2017 Nov;19(11):868-884. doi: 10.1016/j.neo.2017.08.003. Epub 2017 Sep 19.
• [848] The Silencing of SFRP2 Expression in ESCC Is Due to Methylation of the Gene Promoter.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819877977. doi: 10.1177/1533033819877977.
• [849] High expression of SGTA in esophageal squamous cell carcinoma correlates with proliferation and poor prognosis.J Cell Biochem. 2014 Jan;115(1):141-50. doi: 10.1002/jcb.24641.
• [850] MiR-375 suppresses invasion and metastasis by direct targeting of SHOX2 in esophageal squamous cell carcinoma.Acta Biochim Biophys Sin (Shanghai). 2017 Feb 6;49(2):159-169. doi: 10.1093/abbs/gmw131.
• [851] Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma.Oncology. 2016;90(6):347-55. doi: 10.1159/000445323. Epub 2016 Apr 16.
• [852] SIX1 overexpression predicts poor prognosis and induces radioresistance through AKT signaling in esophageal squamous cell carcinoma.Onco Targets Ther. 2017 Feb 21;10:1071-1079. doi: 10.2147/OTT.S125330. eCollection 2017.
• [853] SKA1 overexpression is associated with theprognosis of esophageal squamous cell carcinoma and regulates cell proliferation and migration.Int J Mol Med. 2019 Nov;44(5):1971-1978. doi: 10.3892/ijmm.2019.4343. Epub 2019 Sep 17.
• [854] Prediagnostic circulating inflammation biomarkers and esophageal squamous cell carcinoma: A case-cohort study in Japan.Int J Cancer. 2020 Aug 1;147(3):686-691. doi: 10.1002/ijc.32763. Epub 2019 Dec 3.
• [855] SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.Sci Rep. 2019 Aug 12;9(1):11661. doi: 10.1038/s41598-019-48152-x.
• [856] Inhibition of SOX15 Sensitizes Esophageal Squamous Carcinoma Cells to Paclitaxel.Curr Mol Med. 2019;19(5):349-356. doi: 10.2174/1566524019666190405121139.
• [857] The effect of high Sox3 expression on lymphangiogenesis and lymph node metastasis in esophageal squamous cell carcinoma.Am J Transl Res. 2017 Jun 15;9(6):2684-2693. eCollection 2017.
• [858] Propofol Suppresses Esophageal Squamous Cell Carcinoma Cell Migration and Invasion by Down-Regulation of Sex-Determining Region Y-box 4 (SOX4).Med Sci Monit. 2017 Jan 24;23:419-427. doi: 10.12659/msm.899732.
• [859] LINC00473/miR-374a-5p regulates esophageal squamous cell carcinoma via targeting SPIN1 to weaken the effect of radiotherapy.J Cell Biochem. 2019 Sep;120(9):14562-14572. doi: 10.1002/jcb.28717. Epub 2019 Apr 24.
• [860] MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma.Mol Carcinog. 2013 Aug;52(8):581-90. doi: 10.1002/mc.21880. Epub 2012 Feb 7.
• [861] Decreased expression of SPINT1-AS1 and SPINT1 mRNA might be independent unfavorable prognostic indicators in esophageal squamous cell carcinoma.Onco Targets Ther. 2019 Jun 20;12:4755-4763. doi: 10.2147/OTT.S206448. eCollection 2019.
• [862] Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma.Exp Cell Res. 2014 Mar 10;322(1):149-58. doi: 10.1016/j.yexcr.2013.11.009. Epub 2013 Nov 21.
• [863] Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray.Oncogene. 2004 Feb 12;23(6):1291-9. doi: 10.1038/sj.onc.1207218.
• [864] Quantitative evaluation of SPRR3 expression in esophageal squamous cell carcinoma by qPCR and its potential use as a biomarker.Exp Mol Pathol. 2011 Oct;91(2):584-9. doi: 10.1016/j.yexmp.2011.06.006. Epub 2011 Jul 12.
• [865] SPSB3 targets SNAIL for degradation in GSK-3 phosphorylation-dependent manner and regulates metastasis.Oncogene. 2018 Feb 8;37(6):768-776. doi: 10.1038/onc.2017.370. Epub 2017 Oct 23.
• [866] SRPX2 knockdown inhibits cell proliferation and metastasis and promotes chemosensitivity in esophageal squamous cell carcinoma.Biomed Pharmacother. 2019 Jan;109:671-678. doi: 10.1016/j.biopha.2018.10.042. Epub 2018 Nov 5.
• [867] Downregulation of ST6GALNAC1 is associated with esophageal squamous cell carcinoma development.Int J Oncol. 2017 Feb;50(2):441-447. doi: 10.3892/ijo.2016.3817. Epub 2016 Dec 22.
• [868] Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma.Dis Markers. 2017;2017:5384091. doi: 10.1155/2017/5384091. Epub 2017 Aug 9.
• [869] Essential role of STX6 in esophageal squamous cell carcinoma growth and migration.Biochem Biophys Res Commun. 2016 Mar 25;472(1):60-7. doi: 10.1016/j.bbrc.2016.02.061. Epub 2016 Feb 22.
• [870] TAB3 promotes human esophageal squamous cell carcinoma proliferation and invasion via the NFB pathway.Oncol Rep. 2018 Nov;40(5):2876-2885. doi: 10.3892/or.2018.6686. Epub 2018 Sep 6.
• [871] Polymorphisms in the 5' upstream regulatory region of p21(WAF1/CIP1) and susceptibility to oesophageal squamous cell carcinoma.Sci Rep. 2016 Mar 2;6:22564. doi: 10.1038/srep22564.
• [872] Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma.Med Sci Monit. 2018 Jun 17;24:4128-4136. doi: 10.12659/MSM.909138.
• [873] MiR-216a-5p targets TCTN1 to inhibit cell proliferation and induce apoptosis in esophageal squamous cell carcinoma.Cell Mol Biol Lett. 2019 Jun 28;24:46. doi: 10.1186/s11658-019-0166-9. eCollection 2019.
• [874] Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma.PLoS One. 2016 Apr 6;11(4):e0153100. doi: 10.1371/journal.pone.0153100. eCollection 2016.
• [875] Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/catenin pathway.Oncol Rep. 2019 Dec;42(6):2600-2610. doi: 10.3892/or.2019.7376. Epub 2019 Oct 16.
• [876] Expression and prognostic significance of MAGE-A11 and transcription factors (SP1,TFCP2 and ZEB1) in ESCC tissues.Pathol Res Pract. 2019 Jul;215(7):152446. doi: 10.1016/j.prp.2019.152446. Epub 2019 May 8.
• [877] HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression.Cell Death Dis. 2019 Nov 18;10(12):873. doi: 10.1038/s41419-019-2114-z.
• [878] TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.Ann Surg Oncol. 2016 Jan;23(1):282-9. doi: 10.1245/s10434-014-4259-4. Epub 2014 Dec 2.
• [879] Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.Mol Cancer Res. 2008 Apr;6(4):592-603. doi: 10.1158/1541-7786.MCR-07-0154.
• [880] Expression, prognosis and functional role of Thsd7a in esophageal squamous cell carcinoma of Kazakh patients, Xinjiang.Oncotarget. 2017 Apr 8;8(36):60539-60557. doi: 10.18632/oncotarget.16966. eCollection 2017 Sep 1.
• [881] THUMP domain containing 2 protein possibly induces resistance to cisplatin and 5-fluorouracil in in vitro human esophageal squamous cell carcinoma cells as revealed by transposon activation mutagenesis.J Gene Med. 2019 Dec;21(12):e3135. doi: 10.1002/jgm.3135. Epub 2019 Dec 18.
• [882] CD90 positive cells exhibit aggressive radioresistance in esophageal squamous cell carcinoma.J Thorac Dis. 2017 Mar;9(3):610-620. doi: 10.21037/jtd.2017.03.28.
• [883] Integrin 1 is a critical effector in promoting metastasis and chemo-resistance of esophageal squamous cell carcinoma.Am J Cancer Res. 2017 Mar 1;7(3):531-542. eCollection 2017.
• [884] MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma.Dig Dis Sci. 2013 Jul;58(7):1863-70. doi: 10.1007/s10620-013-2612-2. Epub 2013 Mar 17.
• [885] TM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141.Oncotarget. 2017 Mar 21;8(12):19274-19284. doi: 10.18632/oncotarget.13866.
• [886] Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development.Oncotarget. 2017 Jul 25;8(41):70035-70048. doi: 10.18632/oncotarget.19550. eCollection 2017 Sep 19.
• [887] Modification of risk, but not survival of esophageal cancer patients by esophageal cancer-related gene 1 Arg290Gln polymorphism: a case-control study and meta-analysis.J Gastroenterol Hepatol. 2013 Nov;28(11):1717-24. doi: 10.1111/jgh.12335.
• [888] LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.J Exp Clin Cancer Res. 2018 Mar 12;37(1):56. doi: 10.1186/s13046-018-0724-4.
• [889] Relationship between transmembrane serine protease expression and prognosis of esophageal squamous cell carcinoma.J Biol Regul Homeost Agents. 2017 Oct-Dec;31(4):1067-1072.
• [890] Downregulation of TNFAIP2 suppresses proliferation and metastasis in esophageal squamous cell carcinoma through activation of the Wnt/-catenin signaling pathway.Oncol Rep. 2017 May;37(5):2920-2928. doi: 10.3892/or.2017.5557. Epub 2017 Apr 5.
• [891] Decreased Srcasm expression in esophageal squamous cell carcinoma in a Chinese population.Anticancer Res. 2010 Sep;30(9):3535-9.
• [892] Expression and significance of ASPP2 in squamous carcinoma of esophagus.Kaohsiung J Med Sci. 2018 Jun;34(6):321-329. doi: 10.1016/j.kjms.2017.12.011. Epub 2018 Jan 19.
• [893] A cancer-array approach elucidates the immune escape mechanism and defects in the DNA repair system in esophageal squamous cell carcinoma.Arch Iran Med. 2013 Aug;16(8):463-70.
• [894] Considering the downregulation of Tpm1.6 and Tpm1.7 in squamous cell carcinoma of esophagus as a potent biomarker.Per Med. 2018 Sep;15(5):361-370. doi: 10.2217/pme-2018-0015. Epub 2018 Sep 27.
• [895] TPM4 promotes cell migration by modulating F-actin formation in lung cancer.Onco Targets Ther. 2019 May 31;12:4055-4063. doi: 10.2147/OTT.S198542. eCollection 2019.
• [896] Expression and Association of Tumor Necrosis Factor Receptor Associated Factor 4 (TRAF4) in Esophageal Squamous Cell Carcinoma.Med Sci Monit. 2019 Apr 1;25:2368-2376. doi: 10.12659/MSM.915474.
• [897] Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells.FEBS J. 2014 Jun;281(12):2805-19. doi: 10.1111/febs.12822. Epub 2014 May 21.
• [898] Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.Tumour Biol. 2017 Jun;39(6):1010428317700409. doi: 10.1177/1010428317700409.
• [899] TRIP13 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma.Pathol Res Pract. 2019 Jun;215(6):152415. doi: 10.1016/j.prp.2019.04.007. Epub 2019 Apr 17.
• [900] Effects and interactions of MiR-577 and TSGA10 in regulating esophageal squamous cell carcinoma.Int J Clin Exp Pathol. 2013 Nov 15;6(12):2651-67. eCollection 2013.
• [901] Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.Am J Cancer Res. 2019 Jun 1;9(6):1183-1200. eCollection 2019.
• [902] Circ-TTC17 Promotes Proliferation and Migration of Esophageal Squamous Cell Carcinoma.Dig Dis Sci. 2019 Mar;64(3):751-758. doi: 10.1007/s10620-018-5382-z. Epub 2018 Dec 5.
• [903] Overexpression of AKIP1 promotes angiogenesis and lymphangiogenesis in human esophageal squamous cell carcinoma.Oncogene. 2015 Jan 15;34(3):384-93. doi: 10.1038/onc.2013.559. Epub 2014 Jan 13.
• [904] The expression and role of Aquaporin 5 in esophageal squamous cell carcinoma.J Gastroenterol. 2014 Apr;49(4):655-66. doi: 10.1007/s00535-013-0827-9. Epub 2013 May 9.
• [905] Analysis of the methylation status of genes up-regulated by the demethylating agent, 5-aza-2'-deoxycytidine, in esophageal squamous cell carcinoma.Oncol Rep. 2008 Aug;20(2):405-12.
• [906] Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation.Oncotarget. 2015 Mar 20;6(8):6218-34. doi: 10.18632/oncotarget.3358.
• [907] Pathway analysis of differentially expressed genes in human esophageal squamous cell carcinoma.Eur Rev Med Pharmacol Sci. 2015;19(9):1652-61.
• [908] Prognostic relevance and therapeutic implications of centromere protein F expression in patients with esophageal squamous cell carcinoma.Dis Esophagus. 2013 Aug;26(6):636-43. doi: 10.1111/dote.12002. Epub 2012 Nov 16.
• [909] Oncogenic properties of a novel gene JK-1 located in chromosome 5p and its overexpression in human esophageal squamous cell carcinoma.Int J Mol Med. 2007 Jun;19(6):915-23.
• [910] DCC promoter hypermethylation in esophageal squamous cell carcinoma.Int J Cancer. 2008 Jun 1;122(11):2498-502. doi: 10.1002/ijc.23434.
• [911] Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3.Cancer Res. 1999 Apr 15;59(8):1966-72.
• [912] Expression of ECRG4 is associated with lower proliferative potential of esophageal cancer cells.Pathol Int. 2013 Aug;63(8):391-7. doi: 10.1111/pin.12079.
• [913] Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.Exp Mol Pathol. 2013 Dec;95(3):313-8. doi: 10.1016/j.yexmp.2013.07.001. Epub 2013 Aug 3.
• [914] Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy.J Transl Med. 2016 May 31;14(1):154. doi: 10.1186/s12967-016-0903-z.
• [915] Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma.BMC Cancer. 2009 Sep 3;9:310. doi: 10.1186/1471-2407-9-310.
• [916] Genetic landscape of esophageal squamous cell carcinoma.Nat Genet. 2014 Oct;46(10):1097-102. doi: 10.1038/ng.3076. Epub 2014 Aug 24.
• [917] Guanylate-binding protein 1 (GBP1) promotes lymph node metastasis in human esophageal squamous cell carcinoma.Discov Med. 2015 Dec;20(112):369-78.
• [918] Interactions between Glutathione-S-Transferase M1, T1 and P1 polymorphisms and smoking, and increased susceptibility to esophageal squamous cell carcinoma.Cancer Epidemiol. 2010 Jun;34(3):285-90. doi: 10.1016/j.canep.2010.03.009. Epub 2010 Apr 20.
• [919] Usefulness of microRNA?75 as a prognostic and therapeutic tool in esophageal squamous cell carcinoma.Int J Oncol. 2015 Mar;46(3):1059-66. doi: 10.3892/ijo.2014.2789. Epub 2014 Dec 9.
• [920] Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production.Oncotarget. 2014 May 30;5(10):2962-73. doi: 10.18632/oncotarget.1561.
• [921] The expression of LC-3 is related to tumor suppression through angiogenesis in esophageal cancer.Med Oncol. 2013 Dec;30(4):701. doi: 10.1007/s12032-013-0701-x. Epub 2013 Oct 13.
• [922] Methyl-CpG binding domain 4 tagging polymorphisms and esophageal cancer risk in a Chinese population.Eur J Cancer Prev. 2015 Mar;24(2):100-5. doi: 10.1097/CEJ.0000000000000081.
• [923] Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling.Oncotarget. 2016 Jan 26;7(4):4531-41. doi: 10.18632/oncotarget.6554.
• [924] Over expression of p21-activated kinase 7 associates with lymph node metastasis in esophageal squamous cell cancers.Cancer Biomark. 2016;16(2):203-9. doi: 10.3233/CBM-150557.
• [925] Co-inhibition of BMI1 and Mel18 enhances chemosensitivity of esophageal squamous cell carcinoma in vitro and in vivo.Oncol Lett. 2019 Jun;17(6):5012-5022. doi: 10.3892/ol.2019.10160. Epub 2019 Mar 19.
• [926] LMP gene promoter hypermethylation is a mechanism for its down regulation in Kazak's esophageal squamous cell carcinomas.Mol Biol Rep. 2013 Mar;40(3):2069-75. doi: 10.1007/s11033-012-2138-2. Epub 2013 Jan 3.
• [927] Elevated DNA polymerase iota (Poli) is involved in the acquisition of aggressive phenotypes of human esophageal squamous cell cancer.Int J Clin Exp Pathol. 2015 Apr 1;8(4):3591-601. eCollection 2015.
• [928] DRD2/DARPP-32 expression correlates with lymph node metastasis and tumor progression in patients with esophageal squamous cell carcinoma.World J Surg. 2006 Sep;30(9):1672-9; discussion 1680-1. doi: 10.1007/s00268-006-0035-3.
• [929] Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1 Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma.Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1566-73. doi: 10.1245/s10434-015-4831-6. Epub 2015 Aug 27.
• [930] Inhibitory Role of Pentraxin-3 in Esophageal Squamous Cell Carcinoma.Chin Med J (Engl). 2016 Sep 20;129(18):2233-40. doi: 10.4103/0366-6999.189921.
• [931] RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma.Med Oncol. 2015 Feb;32(2):459. doi: 10.1007/s12032-014-0459-9. Epub 2015 Jan 15.
• [932] miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.Oncotarget. 2016 May 24;7(21):30730-47. doi: 10.18632/oncotarget.8950.
• [933] Chromosome 1 open reading frame 10 (C1orf10) gene is frequently down-regulated and inhibits cell proliferation in oral squamous cell carcinoma.Int J Biochem Cell Biol. 2005 Aug;37(8):1641-55. doi: 10.1016/j.biocel.2005.02.005. Epub 2005 Mar 5.
• [934] Expression and clinical significance of S100A2 and p63 in esophageal carcinoma.World J Gastroenterol. 2009 Sep 7;15(33):4183-8. doi: 10.3748/wjg.15.4183.
• [935] The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis.Tumour Biol. 2017 May;39(5):1010428317705508. doi: 10.1177/1010428317705508.
• [936] Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma.Oncol Rep. 2009 Apr;21(4):1067-73. doi: 10.3892/or_00000325.